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General introduction and outline of this thesis
General introduction and outline of this thesis
This thesis is about diagnosis and treatment of dysfunction of the lower urinary tract in 
people with neurogenic disorders. Spinal cord injury (SCI) is one of the neurological 
conditions that cause a neurogenic bladder. Spinal cord injury can be of traumatic or 
non-traumatic origin. Traumatic causes include traffic accidents, accidental falls, 
industrial accidents, sport accidents, violence and iatrogenic injury. Non-traumatic 
causes are for example vascular, inflammatory and oncological diseases that compress 
or affect the myelum. Inflammatory diseases comprise infections and non-infectious 
diseases, like multiple sclerosis.
The exact incidence of SCI is not known in the Netherlands. SCI is not registered as an 
entity, because it is not considered a disease, but a consequence of disease. Moreover, 
studies concerning incidence and prevalence of SCI used different definitions of SCI 
and inclusion criteria of patients. Reported incidences worldwide vary between 9.2 and 
83 per million inhabitants per year.1 If patients who died during their hospital 
admission are taken into account, incidences vary between 10.4 and 83 per million 
inhabitants per year.
The bladder and the closing mechanism of the bladder have a opposite function in 
people with a normal function of the lower urinary tract. During the filling phase of the 
voiding cycle the bladder is relaxed and the urethral sphincter is contracted to store 
urine at a low intravesical pressure. During micturition, the urethral sphincter is 
relaxed and the bladder contracts. SCI patients often suffer from lower urinary tract 
dysfunction. Lower urinary tract dysfunction consists either of detrusor overactivity 
(DO) or an acontractile bladder. A dysfunction between bladder and closing 
mechanism results in simultaneous contraction of the detrusor muscles of the bladder 
and the urethral sphincter, which is called detrusor-external sphincter dyssynergia 
(DESD). DO and/or DESD is present in 94.9%, 14.3% and 69.7% of patients with 
suprasacral, sacral and sacral with combined suprasacral SCI, respectively. SCI 
patients with damage at the sacral level or below, mostly suffer from a hypocontractile 
detrusor with urinary retention. Hypocontractility is caused by damage to the
9
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micturition centre in the spinal cord, which is located at the sacral level, or the 
peripheral nerves that innervate the bladder.
DO in combination with DESD might cause high intravesical pressures and no or 
incomplete bladder emptying. Subsequent reflux and urinary tract infections (UTI) can 
cause renal deterioration. DO can trigger autonomic dysreflexia, which causes 
symptoms or signs like headache, hypertension, flushing, muscular spasms and 
perspiration. A major goal in SCI patient management is protection of the upper 
urinary tract to preserve renal function. This should be accomplished by ensuring 
detrusor pressures within safe limits during both the filling and voiding phase and 
prevention of UTI’s by improving bladder emptying.
The diagnosis of the type of lower urinary tract dysfunction in neurogenic as well as 
non-neurogenic patients is done by urodynamics. Urodynamics aim at reproducing the 
complaints of patients while monitoring activity of the detrusor muscle in the bladder 
wall during the voiding cycle. The voiding cycle includes the filling phase of the 
bladder and the voiding phase. DO can be diagnosed during the filling phase using 
conventional urodynamics. Conventional urodynamics use artificial filling of the 
bladder at non-physiological filling rate via a transurethral catheter. Detrusor activity 
is estimated as the subtraction of the intravesical pressure minus the intra-abdominal 
pressure, which can be measured using transurethral and transrectal pressure catheters, 
respectively. Ambulatory urodynamics use the physiological filling of the bladder by 
the kidneys. Comparable catheters are used as in conventional urodynamics, but these 
catheters are connected to a portable recorder. This enables measurement of detrusor 
activity during a longer period, at physiological filling rate and during daily activities. 
Treatment of lower urinary tract dysfunction implies the aim to establish a medically 
speaking safe lower urinary tract behaviour in such a way that it optimizes quality of 
life of the neurogenic patient. The primary aim of neurogenic bladder treatment like 
DO is to accomplish a low-pressure urinary reservoir for preservation of renal function 
and treatment of urgency, frequency and incontinence to prevent complications and 
improve quality of life. Conservative treatment consists of anticholinergics with or 
without clean intermittent catheterisation.4-6 Surgical interventions for patients who are 
refractory to conservative treatment are injections of Botulinum toxin A into the
10
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bladder wall, bladder augmentation, continuous electrical stimulation of the sacral
1 12nerve roots (neuromodulation), urinary diversion and a Brindley procedure. - The 
Brindley procedure combines sacral anterior root stimulation for bladder emptying 
with a dorsal rhizotomy to treat DO and to prevent DESD during stimulation.
This thesis deals with some aspects of diagnosis and treatment of neurogenic lower 
urinary tract dysfunction. The first part of this thesis concerns current and new 
diagnostic tools to diagnose DO. The role of ambulatory urodynamics will be 
compared to conventional urodynamics in SCI patients in Chapter 2. Near infrared 
spectroscopy (NIRS) is an optical technology, which can detect haemodynamic 
changes in tissues via non-invasive measurement of changes in the concentration of 
tissue chromophores like oxyhaemoglobin and deoxyhaemoglobin. The feasibility of 
near infrared spectroscopy as a non-invasive urodynamic technique to diagnose DO is 
studied in Chapter 3 in neurogenic as well as non-neurogenic patients with symptoms 
of overactive bladder syndrome. The second part of this thesis consists of Chapter 4 
and Chapter 5. An overview of publications on the clinical results of the Brindley 
procedure is given in Chapter 4. Chapter 5 describes a study about the effects on 
quality of life of the Brindley procedure compared to various treatment strategies in 
SCI patients in the Netherlands. The third part of this thesis comprises conditional 
stimulation, in which stimulation is only activated or stimulation amplitude is 
increased when an involuntary detrusor contraction (IDC) occurs. Important 
advantages of conditional stimulation compared to continuous stimulation could be a 
reduction in stimulation time and an increase in warning time for patients between the 
start of the first IDC and the maximum capacity. Chapter 6 gives a review of the 
anatomy and possibilities for electrical stimulation of the pudendal nerve and its 
branches, including the dorsal genital nerves (DGN) that comprise the dorsal penile 
nerves in males and dorsal clitoral nerves in females. Chapter 7 and Chapter 8 
describe the application of conditional stimulation of the DGN using a needle 
electrode in mostly neurogenic patients. In Chapter 9, the possibility of patient 
controlled stimulation using sensation of involuntary detrusor contractions by SCI 
patients with DO in daily life is studied.
11
Chapter 1
Algemene introductie en overzicht van dit proefschrift
Deze thesis omvat de diagnostiek en behandeling van dysfunctie van de lage 
urinewegen bij patiënten met neurogene aandoeningen. Een dwarslaesie is één van de 
neurogene oorzaken die een neurogene blaas kan veroorzaken. Een dwarslaesie kan 
een traumatische of niet-traumatische oorzaak hebben. Traumatische oorzaken 
omvatten onder andere verkeersongelukken, valincidenten, bedrijfsongevallen, 
sportblessures, geweld en iatrogene schade. Niet-traumatische oorzaken zijn 
bijvoorbeeld vaatziekten, ontstekingen en oncologische ziekten die compressie van het 
ruggenmerg geven of het ruggenmerg aantasten. Ontstekingsziekten omvatten zowel 
infectieuze als niet-infectieuze ziekten, zoals multipele sclerose.
De exacte incidentie van dwarslaesies in Nederland is niet bekend. Dwarslaesies 
worden niet als een aparte entiteit geregistreerd, omdat het niet als ziekte wordt 
beschouwd, maar als een gevolg van een ziekte. Bovendien gebruiken studies naar 
incidentie en prevalentie van dwarslaesies verschillende definities van dwarslaesie en 
verschillende inclusie criteria voor patiënten. Incidenties variëren wereldwijd tussen 
9,2 en 83 per miljoen inwoners per jaar.1 Indien ook de patiënten in acht worden 
genomen die tijdens hun ziekenhuisopname overlijden, variëren de incidenties tussen 
10,4 en 83 per miljoen inwoners per jaar.
De blaas en het sluitingsmechanisme van de blaas hebben een tegengestelde functie bij 
mensen met een normaal functioneren van de lage urinewegen. Gedurende de vulfase 
van de mictiecyclus is de blaas ontspannen en de urethrale sphincter aangespannen om 
urine op te slaan met een lage intravesicale druk. Tijdens mictie ontspant de urethrale 
sphincter en knijpt de blaas samen. Dwarslaesiepatiënten hebben vaak problemen met 
de functie van de lage urinewegen. Disfunctie van de lage urinewegen bestaat uit 
detrusor overactiviteit (DO) ofwel een acontractiele blaas. Een dysfunctie tussen blaas 
en sluitingsmechanisme resulteert in gelijktijdige contractie van de m. detrusor van de 
blaas en de urethrale sphincter, wat detrusor-external sphincter dyssynergia (DESD) 
wordt genoemd. DO en/of DESD komt voor bij 94,9%, 14,3% en 69,7% van patiënten 
met respectievelijk supra-sacrale, sacrale en gecombineerde sacrale met supra-sacrale
o
ruggenmergschade. Dwarslaesiepatiënten met ruggenmergschade op het sacrale
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niveau of lager hebben meestal een hypocontractiele detrusor met urineretentie. 
Hypocontractiliteit wordt veroorzaakt door schade aan het mictiecentrum in het 
ruggemerg dat gelokaliseerd is op sacraal niveau of de perifere zenuwen die de blaas 
innerveren.
DO in combinatie met DESD kan hoge intravesicale drukken veroorzaken, waarbij 
geen of incomplete blaaslediging optreedt. Hierbij kunnen reflux en urineweginfecties 
(UWI) voorkomen, die nierfunctieverlies tot gevolg hebben. DO kan tevens autonome 
disregulatie uitlokken, waarbij symptomen en klachten zoals hoofdpijn, hypertensie, 
opvliegers, spierspasmen en zweten voorkomen. Een belangrijk doel bij de 
behandeling van dwarslaesiepatiënten is de bescherming van de hogere urinewegen 
om de nierfunctie te behouden. Dit kan worden bereikt door de detrusor drukken 
binnen veilige grenzen te houden gedurende zowel de vul- als mictiefase en het 
voorkomen van UWI’s door blaaslediging te verbeteren.
Urodynamica hebben als doel de klachten van de patiënt te reproduceren terwijl de 
activiteit van de musculus detrusor van de blaaswand wordt beoordeeld. De 
mictiecyclus bestaat uit de vulfase van de blaas en de mictiefase. DO kan tijdens de 
vullingsfase van de mictiecyclus van de blaas worden gediagnosticeerd met behulp 
van conventionele urodynamica. Conventionele urodynamica maken gebruik van 
kunstmatige vulling van de blaas met een onnatuurlijke vullingssnelheid met behulp 
van een transurethrale katheter. Detrusor activiteit wordt bepaald door de intra­
abdominale druk van de intra-vesicale druk af te trekken, die via respectievelijk een 
transurethrale en transrectale drukkatheter worden gemeten. Ambulante urodynamica 
gebruiken de fysiologische vulling van de blaas door de nieren. Er worden 
vergelijkbare katheters als bij conventionele urodynamica gebruikt, maar deze 
katheters worden op een draagbare recorder aangesloten. Dit maakt het mogelijk om 
gedurende een langere periode, met fysiologische vulsnelheid en gedurende dagelijkse 
activiteiten te meten.
De behandeling van DO heeft als primaire doel het verkrijgen van een lage druk 
reservoir ter bescherming van de nierfunctie en om urgency, frequente mictie en 
incontinentie te verhelpen ter preventie van complicaties en verbetering van kwaliteit 
van leven. Conservatieve behandeling bestaat uit anticholinergica in combinatie met of
13
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zonder schone intermitterende katheterisatie.4-6 Chirurgische 
behandelingsmogelijkheden voor patiënten die niet op conservatieve therapie reageren, 
zijn Botuline toxine A injecties in de blaaswand, een blaasaugmentatie, continue 
elektrische stimulatie van de sacrale zenuwwortels (neuromodulatie), een urinedeviatie
7 12en een Brindley procedure. - De Brindley procedure combineert stimulatie van de 
sacrale voorwortels om de blaas te legen met een dorsale rhizotomy om de DO te 
behandelen.
Het eerste deel van dit proefschrift betreft de huidige en nieuwe methoden om DO te 
diagnosticeren. De rol van ambulante urodynamica bij dwarslaesiepatiënten wordt in 
Hoofdstuk 2 vergeleken met conventionele urodynamica. De toepasbaarheid van near 
infrared spectroscopie als een niet-invasieve urodynamische techniek wordt in 
Hoofdstuk 3 bij zowel neurogene als niet-neurogene patiënten met klachten van een 
overactief blaassyndroom bestudeerd. Het tweede deel van dit proefschrift bestaat uit 
Hoofdstuk 4 en Hoofdstuk 5, waarin een overzicht van publicaties van de klinische 
resultaten en het effect van een Brindley procedure op de kwaliteit van leven bij 
dwarslaesiepatiënten worden beschreven. Het derde deel van dit proefschrift beschrijft 
de toepassing van conditionele stimulatie. Hoofdstuk 6 geeft een review van de 
anatomie en de mogelijkheden voor elektrische stimulatie van de nervus pudendus en 
de aftakkingen van deze zenuw, waaronder de dorsale genitale zenuw (DGN). De 
DGN betreft de nervus dorsalis penis bij mannen en nervus dorsalis clitoridis bij 
vrouwen. Hoofdstuk 7 en Hoofdstuk 8 beschrijven de toepassing van conditionele 
stimulatie van de DGN met behulp van een naaldelektrode bij voornamelijk neurogene 
patiënten. In Hoofdstuk 9 wordt tevens de mogelijkheid van door dwarslaesiepatiënten 
zelf aangestuurde stimulatie bestudeerd, waarbij gebruik wordt gemaakt van het 
gevoel van onvrijwillige detrusor contracties.
14
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Abstract
Aims. Adequate urodynamic assessment of bladder behaviour is essential in spinal 
cord injury (SCI) patients. Ambulatory urodynamics are more sensitive to detect 
detrusor overactivity (DO) than conventional urodynamics. The primary objective of 
this study was to determine the value of ambulatory urodynamics for the diagnosis of 
DO in SCI patients compared to conventional urodynamics.
Methods. Twenty-seven SCI patients who were suspected of DO underwent both 
conventional and ambulatory urodynamics at one day. A single involuntary detrusor 
contraction (IDC) was defined as a detrusor pressure rise of at least 10 cmH2O. DO 
according to the ICS definition was used in addition to minimise the influence of 
catheter artefacts. Outcome of urodynamics was used for decisions on 
treatment.
Results. Ambulatory urodynamics were more sensitive to diagnose IDC and DO. 
Conventional urodynamics had a sensitivity of S2% and specificity of 75% for DO 
diagnosis compared to ambulatory urodynamics. Mean maximum detrusor pressures 
did not differ significantly between both urodynamics. When the maximum detrusor 
pressure at conventional urodynamics did not exceed 40 cmH2O, 83% (10/12) of 
patients had a mean maximum detrusor pressure under 40 cmH2O at ambulatory 
urodynamics. Although the inter-individual DO diagnostic agreement was lower for 
ambulatory than conventional urodynamics (58%, K=0.201 versus 77%, K=0.552), the 
treatment agreement was higher for ambulatory urodynamics (58% versus 
42%).
Conclusions. Ambulatory urodynamics do not seem necessary for diagnosis and risk 
assessment in SCI patients suspected for DO when conventional urodynamics are done 
properly. The exact role of urodynamics in treatment decision remains to be 
determined.
1S
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Introduction
Neurogenic detrusor overactivity (DO) and/or detrusor external sphincter dyssynergia 
is mainly present in suprasacral and combined suprasacral and sacral spinal cord injury 
(SCI), whereas sacral SCI in most patients results in an areflexic bladder.1 SCI patients 
suffer from urologic complications, despite improvements in urologic and medical 
management. Mortality due to diseases of the urinary system remains higher than in 
the general population. The primary objectives in the care of SCI patients are the 
prevention of complications, the preservation of renal function and improvement of 
Quality of Life.
There are many bladder management strategies for DO to accomplish a low-pressure 
urinary reservoir. Conservative treatment consists of anticholinergics alone or in 
combination with intermittent or indwelling catheterisation.4-6 Patients who are 
refractory to conservative therapy can be treated by Botulinum toxin detrusor 
injections, neuromodulation, a bladder augmentation, or a dorsal rhizotomy together 
with sacral anterior root stimulation to treat DO and enable bladder
7 - 12emptying.
An adequate urodynamic assessment of bladder behaviour is needed for risk 
assessment. Ambulatory urodynamics at physiological bladder filling rate have a 
higher detection rate of DO than conventional urodynamics at supra-physiological 
filling rates.13-16 Although the results of conventional and ambulatory urodynamics 
have been reported in mostly non-neurogenic patients, the role of both conventional 
and ambulatory urodynamics as a guide for therapy in these patients remains to be 
defined.
The primary objective of this study was to determine the value of ambulatory 
urodynamics for the diagnosis of DO compared to conventional urodynamics. The 






Consecutive SCI patients who visited the Department of Rehabilitation Medicine (St. 
Maartenskliniek Nijmegen, the Netherlands) and the Department of Urology (Radboud 
University Nijmegen Medical Centre, the Netherlands) from January 2008 till October 
2008 were eligible for inclusion. Both complete and incomplete SCI patients were 
included if conventional urodynamics were indicated in their regular health care and 
they were clinically suspected of DO due to suprasacral spinal cord injury and/or 
urinary incontinence in between spontaneous micturition or intermittent catheterisation 
that was not related to physical activities. The study was approved by the local ethical 
committee and written informed consent was obtained from the patients.
Protocol
Anticholinergics were stopped at least three days prior to urodynamics except in 
patients who still had overactive bladder symptoms despite anticholinergics (3 
patients) or refused to stop medication temporarily (1 patient). Patients underwent 
conventional as well as ambulatory urodynamics on the same day.
First, conventional urodynamics (Medical Measurement Systems, Enschede, the 
Netherlands) were started after the bladder had been emptied by catheterisation. 
Cystometry with water-filled catheters (8 Fr) or air-charged catheters (7 Fr) for 
pressure recording was carried out at a filling rate of 20 ml/min with sterile saline at 
room temperature in upright or supine position, depending on the ability of the patient 
to make a transfer to the urodynamics chair or bed, respectively. Bladder filling was 
stopped at maximum cystometric capacity or a bladder capacity of 500 ml or a 
sustained involuntary detrusor contraction (IDC).
Directly after completion of conventional urodynamics, the water-filled catheters were 
changed for microtip catheters (8 Fr); air-charged catheters were not changed. The 
microtip catheters or air-charged catheters were connected to a portable recorder 
(Luna, Medical Measurement Systems, Enschede, the Netherlands). Catheters were 
carefully fixed to prevent dislocation and 6-hour ambulatory urodynamics were started 
(Figure 1). Six-hour ambulatory urodynamics were thought to be an adequate period to
20
No primary role of ambulatory urodynamics for the management of SCI patients compared to conventional urodynamics
detect DO according to the experience with ambulatory urodynamics of the 
departments. Total study time was about 7 hours per patient, so assistance was 
available during office hours in case of any problem. Data recording and catheter 
positioning were checked at least once during recording time. Patients were instructed 
to do normal daily activities and to use the event buttons on the ambulatory recorder to 
mark events: micturition or intermittent catheterisation, physical activities (e.g. 
moving around in a wheelchair, walking and sports), specific or a-specific bladder
17sensations of DO or bladder fullness and incontinence. Additionally, an event diary 
was filled out by the patients to compare with the recorded events and to correct for 
wrongly recorded events at the end of ambulatory urodynamics. Incontinence markers 
were not taken into account for data analysis, because the majority of patients had no 
or unreliable sensations of incontinence.
Figure 1. A) Transurethral and transanal pressure catheters for ambulatory urodynamics with event recording (Luna, 
Medical Measurement Systems, Enschede, the Netherlands). B) An example of recorded data. Pves, vesical pressure; Pabd, 
abdominal pressure; Pdet, detrusor pressure; IDC, involuntary detrusor contraction. (*): Recording of events ‘bladder 




A single IDC was defined for both urodynamic studies as a detrusor pressure rise of at 
least 10 cmH2O that was not related to desired micturition. This threshold was used to 
avoid false-positive IDC recording due to artefacts, like body and catheters 
movements. The International Continence Society (ICS) defined DO as a urodynamic
observation characterised by involuntary detrusor contractions during the filling phase
18that may be spontaneous or provoked. In addition to data analysis according to the 
definition of IDC, urodynamic results were assessed according to this ICS definition of 
DO. In our study, a urodynamic study could have zero, one or more IDC’s, but the 
diagnosis of DO could only be present or absent. As some patients with an incomplete 
spinal cord injury were able to start voluntary voiding at a desired moment, the 
concomitant detrusor pressure rise of micturition was not regarded as an IDC 
or DO.
Recorded data of conventional and ambulatory urodynamics were analysed manually. 
The number of IDC, IDC frequency per hour, IDC duration and detrusor pressure rise 
>40 cmH2O duration (seconds and percentage of total recording time), maximum IDC 
amplitudes and mean of all maximum IDC amplitudes were calculated for each patient 
according to the definition of IDC. The urodynamic results were evaluated separately 
for the presence of DO according to the definition of the International Continence 
Society (clinically denoted DO).
The influence of conventional versus ambulatory urodynamics on therapy 
management was analysed by the difference in decision to change or not to change 
therapy and the choice of treatment by two urologists (JH, KD). Anonymous medical 
history data, including gender, age and lesion level (Table I), were presented as 
separated cases together with urodynamics in random order. Firstly, each urologist 
determined the presence of DO at conventional urodynamics and selected an 
appropriate therapy for each case. The cases were evaluated the same way in a re­
randomised order for the ambulatory urodynamics one week later. The time delay and 
re-randomisation was used to prevent recognition of cases and their results of 
conventional urodynamics.
22
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Analysis
Data management and analysis were performed using SPSS 16.0. Significance levels 
were set at the 5% level (two-tailed) using McNemar test for analysis of differences 
between binominal data, and Wilcoxon Signed Ranks test and Mann-Whitney for 
analysis of differences in means between dependent and independent groups, 
respectively. Spearman’s rho was used for correlation analysis and Kappa statistic was 
used for dichotomous variables to calculate whether agreement was beyond chance.
Results
Informed consent for conventional and ambulatory urodynamics was obtained from 21 
male and 6 female SCI patients. Twenty-six patients finished the study according to 
the protocol, except for patient 7 and 15, who underwent conventional urodynamics at 
a filling rate of 50 ml/min. Patient 7 also had conventional urodynamics and 
ambulatory urodynamics at different days. One of the 27 patients was excluded, 
because conventional urodynamics could not be performed. Table I summarises 
baseline clinical characteristics of the 26 patients who were suitable for analysis. 
Median age was 33.5 years (range 15-72) at SCI diagnosis and 41.5 years (range 21­
72) at urodynamics. Nineteen patients emptied their bladder by clean intermittent 
catheterisation (CIC) and 20 patients were incontinent.
Results of conventional and ambulatory urodynamics are shown in Table II, including 
the change in therapy based on urodynamics and clinical evaluation of the patients. 
The median maximum cystometric capacity was 360 ml (range 1S-505) with IDC 
occurring in 1S patients (69%) at a median volume of 192 ml (range 13-435) during 
conventional urodynamics. IDC’s were diagnosed more often (p=0.031) during 
ambulatory urodynamics (92%) with a mean analysable recording time of 4 hours and 
5S minutes. When the clinical diagnosis of DO was used, ambulatory urodynamics 
were still more sensitive than conventional urodynamics in detecting DO; however, 
this was not significant (S5% versus 75%, p=0.375). When conventional urodynamics 
are compared to ambulatory urodynamics for DO diagnosis, sensitivity and specificity 
for conventional urodynamics were S2% and 75%, respectively. Sensitivity and
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specificity for IDC diagnosis by conventional urodynamics were 75% and 100%, 
respectively.
Table I  Patient characteristics and therapy at the time of urodynamics.




Age a t 
lesion 
(year) Lesion level Lesion cause
Bladder
em ptying Incontinence A nticholinergics
1 Male 21 20 C4 Complete T raum atic CIC - +
2 Male 25 25 C3 Incom plete M yelitis tran s  versa Spontaneous
micturition®
+





4 Male 45 24 C5 Incom plete T raum atic T apotage CIC + -
5 Male 25 15 ThlO Complete A rteria spinalis 
an terio r syndrom e
ac + -





7 Male 48 43 Th4 Complete T raum atic ac + -
8 Male 26 25 Th2 Complete T raum atic Spontaneous
m icturition
- -
9 Male 47 27 Th6 Incom plete T raum atic ac - -
10 Female 38 38 C4 Incom plete T raum atic Spontaneous
m icturition
11 Female 72 72 Th8 Complete H ernia nucleus pulposus ac + -
12 Male 34 20 C6 Complete T raum atic ac + +
13 Male 38 36 C5 Incom plete T raum atic ac + + b
14 Male 55 55 T h l2 Incom plete H ernia nucleus pulposus ac + -
15 Male 41 40 Th6 Incom plete T raum atic ac + -
16 Male 45 44 Th4 Complete A orta dissecans ac + -
17 Male 40 31 Th4 Complete T raum atic ac + -
18 Female 39 39 Th6 Incom plete Iatrogenic (surgery) ac - -
19 Female 65 64 L3 Incom plete Iatrogenic (surgery) Spontaneous
m icturition
+ -
20 Male 42 24 C6 Incom plete T raum atic ac + -
21 Male 67 63 Th5 Complete T raum atic ac + +
22 Male 48 42 Th7 Complete T raum atic ac + -
23 Male 28 28 14 Incom plete T raum atic ac + -
24 Male 30 29 Th3 Complete T raum atic ac + -
25 Female 71 70 Th2 Complete M yelum  ischem ia ac + +
26 Male 42 26 Th4 Complete Traumatic Only by incontinence + -
CIC, clean intermittent catheterisation. 
a Afterwards denoted as incontinence 
b Anticholinergics stopped before urodynamics
Therapy was changed compared to treatment before urodynamics in 15 patients when 
both conventional and ambulatory urodynamics were taken into account according to 
the patients’ medical records (Table II). Table III shows the suggested treatment 
changes based on conventional urodynamics compared to ambulatory urodynamics by 
two urologists. Urologist 1 found conventional urodynamics inconclusive in one 
patient and asked for ambulatory urodynamics before to decide on treatment change. 
Inter-individual DO diagnostic agreement was 77% (K=0.552, p=0.002) for 
conventional urodynamics and 5S% (K=0.201, p=0.225) for ambulatory urodynamics. 
Intra-individual DO diagnostic agreement was S1% (K=0.454, p=0.022) for urologist 1 
and 77% (K=0.536, p=0.016) for urologist 2. Treatment agreement was higher after 
ambulatory urodynamics than conventional urodynamics (5S% versus 42%). This
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Table II. Results of conventional and ambulatory urodynamics and treatment change based on conventional as well as ambulatory urodynamics according to the medical records.
Urodynamics
Conventional Ambulatory
s ï ? ! I % ! „ &






¡ 1  I f  I I I  S i  I I  Change in treatm ent
I !  1  £  ■§ I  £ ~  I  e  3  1  compared to ü ie
9 P* -d * * 5  . . O £ B O  p B -  P ■treatment before 
CO and AU
1 - - - — — - -
2 + + 69 + + 7.7 40
3 + - 13 + + 2.6 25
4 67 0l6 59
5 - - - -  [sin) + 4.4 19
6 + + 51 + + 46.2 29
7 + + 69 + + 10.7 17
8 - - - + + 0.9 77
9 - - - - + 4.3 34
10 - - - - + 7.0 43
11 + - 14 + + 5.1 119
12 + + 44 + + 0.6 88
13 42 3.6 65
14 + + 66 + + 12.2 144
15 + + 60 + + 13.1 56
16 + - 24 + + fLO 178
17 + + 62 + + 3.5 246
IB - - - - + 4.5 123
19 - - - - + 2.6 45
20 + + 99 + + 0l7 143
21 19 5.4 111
22 + + 57 + + 2.3 315
23 — - - — — - -
24 + + 69 + -f- 2.1 127
25 + + 45 + + 5.2 113












1 7 -3 1
8.5 2.0 56 + Antic hoiinergics
1.8 0.0 23 + Anticholinergics stopped'
1.1 OlO 37 + Antic hoiinergics
2.3 0.0 19 + -
37.5 6l4 66 + -
5.2 0.7 24 + -
1.9 0.0 22 - CIC — anticholinergics
4.0 0.0 28 + -
8.3 16 39 + -
16.8 19 38 + -
1.5 oli 43 + Botulinum toxin
6.5 0.8 39 _
48.6 18.9 57 + Antic hoiinergics
20.4 2.8 35 + Antic hoiinergics
39.4 2.1 38 + Antic hoiinergics
241 12.9 86 + Antic hoiinergics
15.5 3.3 70 + Antic hoiinergics
3.3 OlO 25 - Pelvic floor physiotherapy
2.8 15 77 + Tapotage
16.7 0.9 41
19.8 2.5 42 + Botulinum toxin
- — — - -
7.5 4.6 77 + Antic hoiinergics
16.3 16 41 + Botulinum toxin











With anticholinergics completely diy; incontinent without anticholinergics
Low pressure rises at both conventional and ambulatory urodynamics; 
continent without anticholinergics
SUI due to sphincter damage after traumatic indwelling catheter removal
Low pressure rises at ambulatory urodynamics
Low and infrequent pressure rises at ambulatory urodynamics 
No urological complaints. low pressure rises. Clinical neurological improving 
Low pressure rises at ambulatory urodynamics
Several anticholinergics were tried before Botulinum toxin was applied, 
but without adequate response
Pressure rises >443 cmHjO a t ambulatory urodynamics 
Frequency /urgency. Anticholinergics in case of inccmv orient physiotherapy 
results (not needed at last control)
The patient started CIC just before urodynamics. because tapotage did not 
sufficiently empty the bladder anymore The patient restarted tapotage 
after urodynamics and declined to perform the recommended QC
SUI, stress urinary incontinence; CIC, clean intermittent catheterisation; IDC, involuntary detrusor contraction; DO, detrusor overactivity; DPR, detrusor pressure rise; CU, 
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agreement increased if only the patients with an agreement in diagnosis are taken into 
account; conventional urodynamics treatment agreement 50% (n=20) versus 
ambulatory treatment agreement 67% (n=15).
Table III. Comparison between conventional and ambulatory urodynamics’ based treatment changes of two urologists as 
compared to pre-urodynamics’ treatments as shown in Table I.
Treatment changes compared to 
the treatment in Table I
Ambulatory urodynamics Conventional urodynamics
Urologist 1 Urologist 2 Urologist 1 Urologist 2
Start anticholinergics 13 S 10 6
Stop anticholinergics 1 0 0 0
Start intermittent catheterisation 0 1 2 2
Botulinum toxin A injections 0 1 4 7
Tension free tape 2 0 2 0
Pelvic floor muscle training 0 5 0 1
Total 16 15 18 16
The differences between conventional and ambulatory urodynamics in treatment changes were not significant for both 
urologists.
Mean maximum detrusor pressures at IDC could be compared between conventional 
(mean 52.5 cmH2O, SD 23.3 cmH2O) and ambulatory urodynamics (mean 49.6, SD 
18.9) in 18 patients with IDC diagnosed at both conventional and ambulatory 
urodynamics. This small difference was not significant. However, a significant 
difference (p<0.002) was found in mean maximum detrusor pressure at IDC during 
ambulatory urodynamics for patients with and without detrusor pressure rises of 40 
cmH2O at conventional urodynamics (Figure 2A). There was a positive relationship 
between the mean maximum detrusor pressure at IDC of conventional and ambulatory 
urodynamics (Figure 2B, r=.51).
Discussion
Ambulatory urodynamics can be regarded as a useful tool for the detection and risk 
assessment of detrusor overactivity. It assesses detrusor behaviour at a physiological 
filling rate during daily life activities and provides information about maximum 
detrusor pressures, frequency of involuntary detrusor contractions and relative duration
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of high detrusor pressures. Nowadays, ambulatory urodynamics have a complementary 
function as it is used when conventional are inconclusive.
Figure 2. A) Boxplot: difference in mean Pdet max at IDC during ambulatory urodynamics for patients with and without 
detrusor pressure rises of >40 cmH2O at conventional urodynamics. B) Scatterplot: positive relationship between the mean 
maximum detrusor pressure at IDC of conventional and ambulatory urodynamics (r=.51). Pdet max, maximum detrusor 
pressure; IDC, involuntary detrusor contraction.
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The objectives of this study were to determine the value of ambulatory urodynamics to 
diagnose and treat DO in SCI patients compared to conventional urodynamics. It was 
questioned whether ambulatory urodynamics can be used as primary diagnostic tool in 
DO diagnosis compared to conventional urodynamics. Important urodynamic 
parameters in the storage phase to determine the medical strategy in SCI patients are 
the presence of DO, the duration of DO, the height of pressures during DO and the 
functional bladder capacity.
It was decided to perform both conventional and ambulatory urodynamics 
consecutively in one day to have comparable neurological and urological symptoms 
and signs during both urodynamic investigations. The urodynamics order was not 
randomised and no patients were included for a control group of non-DO suspected 
patients. Only patients suspected for DO, because of their incontinence symptoms or 
suprasacral spinal cord injury level, were included. This pre-selection of patients 
logically resulted in a high incidence of DO.
Two patients with IDC diagnosis did not have DO diagnosis, when the ICS definition 
of DO is used for ambulatory urodynamics in clinical practice with detrusor pressure 
rises assessment for IDC’s and artefacts regardless of detrusor pressure rise high. The 
ICS defines DO as a urodynamic observation characterised by involuntary detrusor
contractions during the filling phase that may be spontaneous or provoked.19
20Misdiagnosed detrusor contractions can occur due to catheter artefacts. Artefacts can 
be caused by catheter movement and bladder wall contact. In this study, IDC was 
defined as a detrusor pressure rise of at least 10 cmH2O. Although this was thought to 
be a safe margin to rule out artefacts, detrusor pressure rises can still false-positively 
be regarded as an IDC. As expected, conventional urodynamics were less sensitive to 
detect IDC. Movement artefacts that are false-positively interpreted as IDC are more 
likely to occur during ambulatory urodynamics due to mobility of patients during the 
recording as compared to conventional urodynamics. This lowers the specificity of 
ambulatory urodynamics. True IDC diagnosis can be determined in ambulatory 
urodynamics if more artefacts are ruled out. This will reduce the number of IDC’s 
within one patient and the total number of patients with IDC. Consequently, the
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difference in the number of patients with an IDC diagnosis between conventional and 
ambulatory urodynamics will be reduced.
Conventional urodynamics had a sensitivity of 82% to diagnose DO compared to 
ambulatory urodynamics. In clinical practice, this implies that conventional 
urodynamics miss the correct diagnosis in some patients. It is not known whether 
missing one diagnosis of DO has clinical implications with regard to for instance the 
risk of renal deterioration. Following state of the art guidelines, SCI patients have a 
regular follow-up, which includes repeated detrusor assessment with urodynamics. 
Repetition of conventional urodynamics will increase the rate of correct diagnosis and 
reduce the need for ambulatory urodynamics.
Although the mean maximum detrusor pressure during conventional urodynamics was 
not representative for the mean maximum detrusor pressures during ambulatory 
urodynamics in individual patients (Figure 2B), the maximum detrusor pressure during 
conventional urodynamics was valuable to assess the risk of high mean maximum
detrusor pressures (Figure 2A). High detrusor pressures are a risk for upper urinary
21' 22tract deterioration, especially when pressures exceed 40 cmH2O. ; Thyberg et al. 
reported a positive correlation between the mean maximum detrusor pressure during 
cystometry at physiological filling and the mean maximum detrusor pressure during
23cystometry at non-physiological filling rate in SCI patients with DO. We found a 
bigger variation in mean maximum detrusor pressures between patients (Figure 2B) 
compared to Thyberg despite a strong positive correlation between the mean 
maximum detrusor pressure at IDC of non-physiological filling rates during 
conventional urodynamics and physiological filling rates during ambulatory 
urodynamics. As a result, the mean maximum detrusor pressure at IDC of 
conventional urodynamics cannot be regarded as representative for the detrusor 
pressures of ambulatory urodynamics in each patient and ambulatory urodynamics are 
of additional value in individual patients. In our study, the mean maximum detrusor 
pressure at IDC during conventional urodynamics was slightly higher in all patients 
compared to ambulatory urodynamics. However, when the maximum detrusor 
pressure at conventional urodynamics did not exceed 40 cmH2O, 10 out of 12 patients 
(83%) had a relatively safe mean maximum detrusor pressure under 40 cmH2O during
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daily life (Figure 2A). This enables a conventional urodynamics-based treatment 
regime that was described by Nosseir et al to be feasible without ambulatory
24urodynamics. None of the 80 SCI patients who were described had signs of renal 
damage after 5-year follow-up.
IDC’s lasted for about 7.9% of the recording time, but detrusor pressure exceeded 40 
cmH2O for only about 1.6% the recording time. This information cannot be obtained 
from conventional urodynamcs as bladder filling will be stopped at different moments 
during end filling DO. Ambulatory urodynamics provide more information about 
bladder behaviour during daily life. Up to now, it is not known whether the height of 
the detrusor pressure rises or the duration of the detrusor pressure rises is more 
important for prognosis and treatment decision.
The majority of SCI patients had no or unreliable sensations of incontinence and did 
not push the button when incontinence occurred during ambulatory urodynamics. The 
exact moment at which incontinence occurs, is a valuable parameter to determine leak 
point pressures and to estimate the risk for upper urinary tract deterioration. 
Conventional urodynamics have the advantage that the clinician who is doing the 
urodynamics can observe and mark leak point if the patient is not able to 
do this.
We did not measure to what extent the urodynamics’ results were representative for 
the SCI patients’ symptoms. A questionnaire evaluation by Radley et al. showed that 
80.5% of non-neurogenic female patients with urgency with or without incontinence 
believed usual symptoms were reproduced during ambulatory urodynamics compared 
to 66.7% during video cystometry.14 Nor did we evaluate the bother and costs of 
ambulatory urodynamics, which should be taken into account compared to bother and 
costs of conventional urodynamics in order to determine the value of both diagnostic 
tools in clinical practice. The complication rate of ambulatory urodynamics, like
25urinary tract infections, is low.
The inter-individual DO diagnostic agreement was higher for conventional 
urodynamics than for ambulatory urodynamics (K=0.552 and K=0.201, respectively), 
which could be explained by a more difficult interpretation of ambulatory recordings 
to diagnose DO. Difficulties of interpretation include movement artefacts and
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dependence on patients for suitable data recording without a medical assistant. These 
difficulties of interpretation question the additional value and reliability of ambulatory 
urodynamics as it may reduce its sensitivity and specificity. Furthermore, conventional 
urodynamics might be regarded as representative for DO diagnosis.
Although DO was diagnosed more often by ambulatory urodynamics compared to 
conventional urodynamics, it is not obvious whether this can be translated into better 
treatment. In our study, the inter-individual agreement to diagnose DO was higher for 
conventional urodynamics compared to ambulatory urodynamics. The Kappa value of 
ambulatory urodynamics indicated only a slight agreement for inter-individual DO 
diagnosis. However, agreement for patient treatment was higher for ambulatory 
urodynamics than conventional urodynamics (58% versus 42%). The reason for this is 
that the treatment advice was also based on additional given patient information about 
the clinical state and the interpretation of the clinical details of each case (Table I). The 
provided information was the same for conventional as well as ambulatory 
urodynamics. Moreover, ambulatory urodynamics provide a better impression of 
bladder behaviour during daily life when both clinical data and urodynamics are 
considered for diagnosis and treatment decision. Overall, treatment choices were more 
conservative after ambulatory urodynamics compared to conventional urodynamics.
Conclusions
Ambulatory urodynamics do not seem to be necessary as a standard tool for diagnosis 
and risk assessment in SCI patients suspected for DO when conventional urodynamics 
are done properly. However, conventional urodynamics are not completely 
representative for detrusor behaviour in daily life and ambulatory urodynamics may 
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Abstract
Background. Near infrared spectroscopy (NIRS) is an optical technology. It detects the 
haemodynamic changes in tissues via non-invasive measurement of changes in the 
concentration of tissue chromophores such as oxyhaemoglobin (O2Hb) and 
deoxyhaemoglobin (HHb). Involuntary bladder contractions may cause detectable 
changes for NIRS.
Objective. To address the accuracy and reproducibility of NIRS to detect the 
haemodynamic effects of detrusor overactivity (DO).
Design, setting, and participants. A prospective cohort study was carried out on 41 
patients with overactive bladder symptoms.
Measurements. Forty one patients underwent one or more filling cystometries with 
simultaneous NIRS of the bladder. The separated graphs representing both tests were 
presented to 3 urodynamicists on 2 occasions, 3 weeks apart. The graphs showed 
curves with and without DO episodes with the bladder sensations marked. Thirteen out 
of 47 (28%) graphs with DO and 16 out of 58 (28%) graphs without DO were 
excluded due to motion artefacts. The urodynamicists marked pressure changes 
suggestive of DO in the cystometry curves. For NIRS curves they marked definite 
deviations from baseline. The sensitivity and specificity of NIRS for DO were 
determined. The inter- and intra-observer agreements were determined.
Results and limitations. Valid data from 33 out of 41(80%) patients were included in 
the analysis. The inter-observer agreement to trace the effect of DO on NIRS curves 
was ‘substantial’ (Fleiss’ kappa >0.6). The sensitivity of the Hbsum (O2Hb + HHb) 
curves for DO was 62-97% with a specificity of 62-79% (AUC 0.80-0.82; p<0.001). 
O2Hb curves had 79-85% sensitivity and 82-91% specificity for DO (AUC 0.80-0.85; 
p<0.001). The sensitivity and specificity of the HHb curves for DO were 71-82% and 
77-82% respectively (AUC 0.73-0.84; p<0.001). These values represent the 
performance of NIRS in a data sample that is not contaminated with motion artefacts, 
but not in a real clinical setting.
Conclusion. NIRS is a potential non-invasive, reproducible diagnostic method to 
detect DO.
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Introduction
Overactive bladder (OAB) syndrome is highly prevalent in the western community.1 It 
negatively affects the patient's quality of life. Filling cystometry is the standard 
urodynamic test to detect detrusor overactivity (DO). However, it is invasive and may 
cause patient's discomfort and urinary tract infections.4 Therefore, a non-invasive 
diagnostic tool that can replace conventional cystometry is recommendable, especially 
for patients who undergo regular urodynamic evaluation.
Doppler ultrasound studies have revealed significant variations in blood flow of the
5 7bladder wall during the voiding cycle, and bladder contractions in animal models. - 
DO is assumed to cause substantial variations in oxygen supply and consumption of 
the bladder wall during involuntary muscle contraction.
Near infrared spectroscopy (NIRS) as an imaging technology can monitor the 
haemodynamic changes during bladder filling and voiding. Light in the near infrared 
area is capable of penetrating the skin to the underlying tissues, to be absorbed by 
naturally occurring chromophores, such as oxyhaemoglobin (O2 Hb) and 
deoxyhaemoglobin (HHb). NIRS enables detection of oxygen dependant 
haemodynamic changes in biological tissues by measurement of the relevant changes 
in the concentration of tissue chromophores relative to baseline. Total haemoglobin 
(Hbsum) is an indicator of total blood perfusion that can be derived from the sum of 
O2 Hb and HHb.8
Urological applications of NIRS covers various urological disorders.9 NIRS was 
previously reported to be an independent predictor of BOO with a good correlation 
between NIRS and pressure flow parameters.10
Previously, we showed that transcutaneous NIRS of the bladder is feasible to detect 
DO episodes as the involuntary detrusor contractions have characteristic imprints on 
NIRS signals.11 The objective of this study was to determine the accuracy and 
reproducibility of NIRS during cystometry in detecting DO episodes. Therefore, the 
sensitivity and specificity of NIRS changes compared to cystometry were investigated 
after exclusion of NIRS data contaminated with motion artefacts. Moreover, the inter- 





The study group consisted of 41 consecutive adult patients referred to Radboud 
University Nijmegen Medical Centre, the Netherlands, for urodynamics between 20 
August 2009 and 28 December 2009. Inclusion criteria were men or women >18 y old 
with urgency with or without incontinence, frequency and nucturia. Exclusion criteria 
were abdominal scars, haematuria and a history of mixed incontinence. One patient 
was diabetic and one was treated for hypertension. Antimuscarinics were stopped >3 
days before urodynamics. This study was approved by the local ethical committee.
Procedure
Patients completed a 24 hr voiding diary. Patients with clinical BPH and voiding 
symptoms suggestive of BOO, completed an IPSS questionnaire. Urinalysis was 
performed to exclude urinary tract infections and haematuria. All patients underwent 
cystometry (Solar™, MMS, Enschede, the Netherlands). A gas-filled urethral catheter 
6 Ch was inserted to monitor intravesical pressure (Pves), while abdominal pressure 
(Pabd) was monitored using a rectal balloon. Water was infused at room temperature 
with filling rates of 10-50 ml/min as requested by the patient's physician. The same 
rate was used when several cystometries were performed in the same 
patient.
Trans-cutaneous non-invasive bladder monitoring with NIRS (URO-NIRS™, 
Urodynamix Technologies Ltd., Vancouver, Canada) was performed simultaneous 
with cystometry. An emitter and a sensor were connected to a rubbery self adhesive
patch, 4 cm apart. The patch was placed on the abdomen 2 cm above the pubic
12symphysis across the midline.
Baseline NIRS reading for 30 seconds was followed by testing the effect of cough and 
Valsalva’s manoeuvres on NIRS signals. Patient movements, straining and urine 
withholding were restricted. Surface EMG-monitoring of the abdominal wall muscles 
(EMGabd) was used to rule out motion artefacts. Bladder sensations and events were 
recorded.
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Figure 1. The method followed in deriving graphs representing cases o f detrusor overactivity and 
controls. OAB, overactive bladder; DO, detrusor overactivity.
The cystometries were diagnosed by a urodynamicist according to the ICS guidelines 
to identify patients with and without DO. NIRS data were imported and automatically 
synchronized in the urodynamics database. Graphs contaminated with motion artefacts 
were excluded (Figure 1). For rating purpose, the cystometry graphs and NIRS graphs 
were separated and coded. Graphs with DO were used as cases (Figure 2), and graphs 
without DO as controls.
Inter- and intra-observer variability
The cystometry graphs consisted of three curves representing Pves, Pabd and Pdet. NIRS 
graphs consisted of three curves representing HHb, O2Hb and Hbsum. Flowmetry and 
EMGabd curves were added to the cystometry as well as NIRS graphs.
Rating was done by three experienced urodynamicists on two occasions, three weeks 
apart. The cystometry graphs and the NIRS graphs were presented separately and 
randomly to the raters. The raters did not know which NIRS graph belonged to which 
cystometry graph. The urodynamicsts had to look for pressure changes suggestive of
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DO for the cystometry graphs and definite deviations from baseline in each NIRS 
curve (O2Hb, HHb and Hbsum).
Statistical method
The intra- and inter-observer agreements were analyzed using Cohen’s Kappa (kc) and 
Fleiss' Kappa (kf) statistics.13 Kappa values were interpreted based on the convention 
by Landis and Koch: <0 no agreement; 0-0.20 slight agreement; 0,21-0.40 fair 
agreement; 0.41-0.60 moderate agreement; 0.61-0.80 substantial agreement and 0.81­
1.0 almost perfect agreement.14 ROC-curves were used to determine the diagnostic 
value of NIRS in predicting DO. Mann Whitney U test was used for differences 
between groups.
Figure 2. Detrusor overactivity as detected by cystometry and NIRS. Part of the cystometry (upper part) with 
simultaneous NIRS bladder monitoring (lower part) of a male patient 69 yr old who presented with OAB symptoms 
showing the haemodynamic effects of DO represented by relative NIRS changes. An initial upward slope of Hbsum, O2Hb 
and HHb curves concomitant with the start of DO as evidenced by sudden increase in Pdet curve with urine leakage. This 
initial hyperaemia was followed by sustained downward slope in all NIRS curves till the end of DO episode.
Pves, vesical pressure; Pabd, abdominal pressure; Pdet, detrusor pressure; Qura, uroflowmetry; EMGabd, EMG of the 
abdominal muscles; vin, bladder filling volume; HHb, deoxyhaemoglobin; O2Hb, oxyhaemoglobin; Hbsum, total 
haemoglobin.
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Results
This study included 34 men and 7 women (mean age 62±14 yr) with OAB symptoms 
(Figure 1). The mean BMI was 26 kg/m (range 20-33). Seventeen patients had 
neurogenic disorders, 21 men had BPH and 3 patients had idiopathic OAB. The mean 
frequency was 12±3 voids/day (range 6-17).The mean IPSS score was 17 (range 5-33) 
for patients with BPH.
Fifty two cystometry sessions with simultaneous NIRS were performed. The 
cystometries identified 23 patients with DO who underwent 34 cystometry sessions. 
Forty seven DO episodes were identified. To get the optimal NIRS graphs, only 34 out 
of 47 DO graphs were selected for the final analysis based on the stability of Pabd and 
EMGabd curves. Each DO episode was considered as an individual case. The median 
bladder filling at start of DO episodes was 137 ml (range 12-492). The median Pdet 
change at DO was 42 cmH2O (range 6-215).
Cystometry identified 18 patients without DO, who underwent 18 cystometries. Their 
data were used as controls. Each control cystometry session was divided into equal 
parts. These parts included sensation marks. A total of 58 control graphs were obtained 
of which 16 (28%) graphs were excluded based on the stability of Pabd and EMGabd. 
Thirty four out of the remaining 42 graphs were randomly selected as individual 
control cases using SPSS.
Table I  Results of the two rating sessions.
n = 34
(%)
Session I Session II
Cystometry HHb O2Hb Hbsum Cystometry HHb O2Hb Hbsum
Observer I Cases 100 82 85 97 100 82 88 97
Controls 9 18 18 38 9 23 21 53
Observer II Cases 100 71 79 88 97 68 65 73
Controls 21 23 9 26 9 26 9 38
Observer III Cases 100 79 82 91 97 62 62 65
Controls 0 18 15 21 0 18 18 21
The Table shows, for each observer, the ratio (%) of the graphs which were rated with the answer “yes” to the total 
number of DO graphs in the upper row (true positives) and the ratio (%) of the graphs which were rated with the answer 
“yes” to the total number of control graphs in the upper row (false positives). The columns in the Table represent the 
results of rating the cystometry and the individual NIRS curves, respectively during the two rating sessions. HHb, 
deoxyhaemoglobin; O2Hb, oxyhaemoglobin; Hbsum, total haemoglobin.
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Table I shows the results of the two rating sessions. The overall diagnostic agreement 
for the three observers was 92% for cystometry graphs (kf 0.84). For the NIRS, the 
observers agreed on 81% of the HHb curves (kf 0.63), 84% of the O2Hb curves (kf 
0.69) and 81% of the Hbsum curves (kf 0.61). The ranges of AUC values of the 
diagnostic performance of NIRS for the three observers were 0.73-0.84 for HHb; 0.80­
0.85 for O2Hb and 0.80-0.82 for Hbsum (p<0.001). The intra-observer agreement for 
cystometry was kc 0.85-0.97 and for NIRS kc 0.53-0.79 (HHb), 0.65-0.76 (O2Hb ) and 
0.67-0.75 (Hbsum). The sensitivity of NIRS for DO as an average of the three 
observers was Hbsum 92%, O2Hb 82% and HHb 77%. The specificity was O2Hb 86%, 
HHb 80% and Hbsum 72%. However, it is to be mentioned that these high values do 
not represent the actual sensitivity and specificity in general clinical setting, but only 
in an optimal study sample (72%) not contaminated with motion artefacts. The 
performance of NIRS would have been lower if analysis of the whole group, including 
motion artefacts, was done.
Table II. A comparison of some demographic and urodynamic parameters between the true positive and false negative
cases based on NIRS diagnosis.
n=17 patients True positives False negatives
n=34 graphs n=14 patients n=3 patients P value a
n=29 graphs n=5 graphs
Mean BMI (kg/m2) 25.8, SD 3 25.4, SD 4 0.63
(20.5-31) (20.8-28.4)
Median filling volume at DO (ml) 131 149 0.51
(12-492) (59-171)
Median peak pressure at DO (cmH2O) 47 20 0.004
(11-215) (6-24)
BMI, body mass index; DO, detrusor overactivity; SD, standard deviation 
a Mann Whitney U test
To rate false positive and false negative DO diagnosis in NIRS graphs, only graphs 
with >2 curves marked with a deviation were counted as positive. Although 16 out of 
58 (28%) control graphs were excluded for motion artefacts, the NIRS graphs were 
rated false positively in 6 out of 34 (18%) controls. The NIRS curves showed no 
deviation in 5 out of 34 (15%) DO episodes. The median change in Pdet at DO was 
significantly lower in these false negative cases as compared to the true positive cases
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(20 vs. 47 cmH2O; p<0.005) (Table II). Twenty out of 29 true positive cases had DO at 
a filling volume <100 ml, while 1 out of 5 false negative cases had DO at a volume 
<100 ml.
No adverse events related to NIRS occurred.
Discussion
This is the first clinical study that tests the application of NIRS during the filling phase 
of the voiding cycle. Our objective was to determine the accuracy and reproducibility 
of NIRS in detecting DO episodes during cystometry.
Cystometry detects the mechanical effect of DO. NIRS assumes the changes in 
concentration of bladder wall chromophores relative to baseline in response to bladder 
events. The assumption is that changes in activity and consequent oxygen consumption 
cause chromophore changes. This real time feature of NIRS is unique in comparison to 
other non-invasive diagnostic techniques that are examined for DO.1516 
There are three possible reasons that can explain the characteristic imprint of DO on 
NIRS signals. The first possibility is an auto-regulatory haemodynamic mechanism in 
the bladder. The second possibility is the mechanical compressive effect of DO on the 
bladder wall vasculature. The third possibility is the effect of bladder wall movements 
during DO, leading to momentary changes in blood volume lying within the NIRS 
imaging scale.
For assessment of the clinical applicability of any new diagnostic test, high inter- and 
intra-observer agreements are mandatory. Inter-urodynamicists agreement was ‘almost 
perfect’ for cystometry, while it was ‘substantial’ for NIRS (Kf 0.84, 0.61, 0.69, and 
0.63 for cystometry, Hbsum, O2Hb, and HHb curves, respectively). This might be 
explained by the familiarity of the urodynamicists with the classic setup of the 
conventional cystometry. NIRS curves had a good diagnostic performance as 
predictors of DO, giving a range of AUC values of 0.80-0.85 for O2Hb curves, 0.73­
0.84 for HHb curves and 0.80-0.82 for Hbsum curves, as calculated for the three 
observers. NIRS was highly sensitive to detect DO episodes; Hbsum 92%, O2Hb 82%
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and HHb 78%. Hbsum curve being the sum of O2Hb and HHb, can explain its higher 
sensitivity for DO.
j l j  _ _ _ _ _ I ± j
Figure 3. Effect of cough and Valsalva's manoeuvre on NIRS curves and EMGabd (lower part) when tested at the 
beginning of the filling session. Cough causes sharp rise in all NIRS curves and EMGabd (between two red lines).
Valsalva's manoeuvre leads to a slower and more sustained rise in NIRS curves (between two black lines). The NIRS 
changes started earlier than the actual rise in abdominal pressure because the patient leaned forward prior to straining. The 
blue arrow points to re-zero NIRS to normalize all NIRS parameters before filling starts.
Pves, vesical pressure; Pabd, abdominal pressure; Pdet, detrusor pressure; Qura, uroflowmetry; EMGabd, EMG of the 
abdominal muscles; HHb, deoxyhaemoglobin; O2Hb, oxyhaemoglobin; Hbsum, total haemoglobin.
17NIRS is liable for motion artefacts. In order to have NIRS applied reliably, artefacts 
should be avoided. Figure 3 shows the imprint of cough and Valsalva's maneuver on 
NIRS. Therefore, 28% of the graphs were excluded from analysis. The overall 
specificity of NIRS parameters for DO was 86% for O2 Hb, 80% for HHb and 72% for 
Hbsum. There were six false positive cases out of the 34 control graphs. This implies 
that observers still see some deviations in NIRS curves in absence of DO. One 
explanation could be a DO episode that was not detected by cystometry. Radley et al 
found that conventional cystometry classified only 32 out of 106 women with OAB
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symptoms as having DO, while ambulatory urodynamics classified 70 women as
18having DO. Another explanation could be the wash out effect of accumulated 
vasodilator substances as part of the regulatory mechanisms to maintain blood 
perfusion to the bladder wall during filling.19 A third possibility would be a 
misinterpretation of the physiological systemic haemodynamic fluctuations of
17respiratory signals or cardiac pulsations. This is unlikely because normally these 
fluctuations are regular, rhythmic and of low amplitude.
NIRS failed to identify 5 out of 34 cases with DO as compared to urodynamics. 
Explanations could be a bladder contraction with low amplitude or the bladder lying 
out of reach of the NIRS imaging scale, due to a small bladder volume or a thick 
abdominal wall. Twenty out of 29 true positives had DO at filling volumes <100 ml, 
while only 1 out of 5 false negative cases had DO at <100 ml. Only the difference in 
Pdet was significant between the false negative and true positive cases. Therefore, a 
bladder contraction with a low Pdet seems to be the main reason for the false- 
negativity.
Our study has some limitations. More men were included than women, while generally 
OAB symptoms are more prevalent in women. This can be explained by the high 
inclusion number of men with BPH. Twenty eight percent of the graphs were excluded 
due to motion artefacts. It was mandatory in our methodology to have non­
contaminated data in order to evaluate the scientific value of NIRS in the diagnosis of 
DO. We believe that the sensitivity and specificity were high in our series, because 
they were tested only within a selected data sample. However, the situation should be
different when the clinical applicability of NIRS will be addressed. Recently,
20algorithms were developed for cancellation of motion artefacts. This could be 
applied to improve future study setups.
No laboratory screening was done to exclude systemic vasculopathies.
In the current study, we showed that this technique is non-invasive, reproducible with 
high sensitivity for detecting DO. Its value for clinical trials evaluating treatments for 




NIRS curves correlate well with DO episodes detected by conventional urodynamics. 
NIRS seems to detect the haemodynamic changes caused by detrusor contractions. 
This implies that NIRS can be used to study the regulatory mechanisms of blood 
perfusion to the bladder during filling as well as the haemodynamic phenomenon 
accompanying DO. NIRS can be a potential non-invasive diagnostic tool for DO in 
patients with OAB symptoms.
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Clinical results of the Brindley procedure: SARS in combination with a rhizotomy of the dorsal roots
The Brindley procedure consists of a stimulator for sacral anterior root stimulation 
(SARS) and a rhizotomy of the dorsal sacral roots to abolish detrusor overactivity. 
Stimulation of the sacral anterior roots enables micturition, defecation and erections. 
The technique, selection of patients and clinical results are discussed in this overview.
Brindley stimulator
The Brindley system is composed of an external and implanted part. The implanted 
part consists of electrodes, connecting cables, and a receiver block. Patients have to 
position an external stimulating device on the skin over the implanted receiver to 
evoke stimuli. The receiver does not have a battery. Electrical stimuli are evoked by 
radiofrequency waves. With the availability of separate stimulation of the sacral levels 
and various stimulation settings, it is possible to set various stimulation programs to 
optimize micturition, defecation and penile erections.
A tripolar electrode cuff is used for intradural stimulation of the sacral anterior roots. 
A three-channel implant is composed of two books. The upper book contains three 
parallel slots for S3 (one slot) and S2 roots (two slots at one channel) and the lower 
contains one slot for S4 roots. Each slot contains one cathode in the centre and an 
anode at each of the two ends to avoid stimulation of tissue structures outside the slot. 
The two-channel implant allows stimulation of two root levels or sets of root levels. 
The four-channel implant has the same configuration as the three-channel implant, but 
allows independent stimulation of four sets of roots. The choice for the number of 
channels depends on the number of different rootlet combinations that have to be able 
to be stimulated. Each channel is connected to the subcutaneous receiver block by a 
silicone-coated cable.
Extradural electrodes are used in patients in whom intradural electrodes could not be 
placed due to for example arachnoiditis or a previous intradural electrode implantation 
that failed. Some centres prefer to use extradural electrodes primarily for nearly all 
patients. The extradural implant has three helical electrodes at its end, which are also 




Most of the small diameter parasympathetic efferent nerve fibres for innervation of the 
bladder are located in the sacral anterior roots (S2-S4/5). Small diameter nerve fibres 
need a higher stimulus for their excitation than large diameter fibres. Consequently, 
electrical stimulation of the anterior roots for detrusor contractions also causes 
contraction of the urethral sphincter due to stimulation of somatic large diameter nerve 
fibres. This prevents emptying of the bladder. To overcome this problem post-stimulus 
voiding is used. The time to relax of striated muscles of the urethral sphincter is 
shorter than the relaxation time of smooth muscles of the detrusor. When intermittent 
stimulation pulse trains are applied, the difference in muscle relaxation time can be 
used to achieve a sustained detrusor muscle contraction with intervals of urethral 
sphincter relaxation (Figure 1). These intervals in between stimulation allow a 
decrease of the urethral sphincter pressure, while a high intravesical pressure remains. 
This results in post-stimulus voiding with an intermittent pattern of the micturition 
flow. A comparable mechanism has been used for defecation.
Dorsal rhizotomy o f the sacral nerves
Sauerwein structurally expanded SARS with a dorsal rhizotomy (deafferentation) of
sacral roots S2 till S5.1 A dorsal rhizotomy is important, because it suppresses
1'2neurogenic detrusor overactivity and detrusor-external sphincter dyssynergia. ’ This 
results in a low pressure bladder without reflex contractions of the detrusor and
2' 3subsequently continence. Moreover, it reduces autonomic dysreflexia. ’
Patient selection
A Brindley procedure is suitable for a selected group of skeletally mature patients with 
complete spinal cord injury en detrusor overactivity. Patients with severe autonomic 
dysreflexia or detrusor-external sphincter dyssynergia will benefit especially from the 
dorsal rhizotomy. Patients with incomplete injury will lose their sensory function due 
to the dorsal rhizotomy and have the risk to experience pain sensation during 
stimulation due to an incomplete rhizotomy. Patients need to have intact efferent nerve 
pathways to the bladder and a bladder that is able to contract.
50
Clinical results of the Brindley procedure: SARS in combination with a rhizotomy of the dorsal roots
Contractions of at least 50 cmH2O in males or 30 cmH2O in females need to be present 
during filling cystometry.4 If no sufficient spontaneous contraction occurs, suitable 
patients can be selected by rectal stimulation according to electro-ejaculation 
procedures or direct needle stimulation of the sacral roots to provoke bladder 
contractions.
Preoperative magnetic resonance imaging is used to exclude arachnoiditis at the level 
of the conus and cauda equine or other neurological disorder of the spinal cord. 
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Figure 1. Example of post-stimulus voiding using a Brindley stimulator. The three upper traces show the intravesical 
(Pves), intra-abdominal (Pabd) and detrusor pressure (Pdet) during stimulation with a Brindley stimulator. The increase in 
EMG signal reflects the activation of the stimulus during 5 seconds. Stimulation is activated every 12 seconds. The 
intermittent stimulation pattern allows the urethral sphincter to relax while the detrusor pressure remains elevated. This 
results in an intermittent flow pattern.
Implantation
A laminectomy from L3-L4 to S1-S2 is done for an intradural rhizotomy and 
intradural implantation of the electrode cuff. The dura and arachnoid are opened at
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midline to expose the sacral nerve roots. The anterior and dorsal components of the 
roots, especially relevant anterior roots for micturition, can be identified intradurally 
by electrical stimulation of these components while monitoring the effects on detrusor 
activity, blood pressure and somatomotor responses. A rhizotomy of the identified 
dorsal sacral roots is done. The anterior sacral roots are positioned into the electrode 
cuff. The connecting cables are subcutaneously tunnelled to a subcutaneous pocket for 
the receiver.
Implantation of extradural electrodes requires a laminectomy from L5-S1 to S3-S4. 
The dorsal rhizotomy is done at the level of the ganglia of S2-S5. Electrical 
stimulation tests are used to identify the anterior and dorsal component of the sacral 
roots. The extradural electrode is implanted and fixated to the nerve using a strip of 
silicone rubber sheet which is sewn to itself and surrounds the nerve. The connecting 
cables and receiver are implanted the same way as the intradural procedure.
Clinical results
Table I shows an overview of publications on the clinical results of the Brindley
3 20procedure. - These results comprise both the Brindley stimulator that enables 
stimulation for micturition, defecation and erections, and the dorsal rhizotomy to 
achieve continence. The use of the Brindley procedure for micturition and defecation, 
and the ability to evoke erections are summarised in Figure 2, including urinary 
continence rates. No accumulation of results is possible due to the overlap of results of 
several reports, especially the multicentre reports.
The Brindley stimulator is used for micturition in 73% to 100% of patients during 
follow-up. These are considerable percentages, but it should be noted that this includes 
patients who use additional methods to empty their bladder. Additional methods 
comprise intermittent catheterization, abdominal straining (Valsalva manoeuvre), 
abdominal compression (Crede manoeuvre) or suprapubic tapping for reflex 
contractions. That stimulation is not always completely successful can be found back 
in the percentages of patients that have less than 50 ml residual urine after stimulation 
for micturition. These percentages are lower than the percentages of patients that use 
the stimulator for micturition. Overall, the percentages of patients having urinary tract
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infections and the frequency of urinary tract infections decrease after the Brindley 
procedure compared to the pre-operative treatment.
Figure 2. Results of the Brindley procedure on micturition, continence, defecation 
and erections are summarised.
The Brindley stimulator is used for defecation in 29% to 100% of patients in different 
degrees. Not all patients achieve complete evacuation of defecation using only 
stimulation. Some patients need laxatives in addition to prevent constipation or enable 
defecation. Many patients only use the stimulator to get the defecation into the rectum, 
to enable digital evacuation.
Erections can be evoked in a substantial number of patients, but results vary 
considerably. This can be explained by the relatively low number of patients that 
actually use the stimulator to evoke erections for sexual intercourse (0-32%), due to 
qualitatively inadequate erections for sexual intercourse or deterioration of the 
stimulation effect over time.
Autonomic dysreflexia mostly decreased after the Brindley procedure as a result of the 
dorsal rhizotomy. Only a few studies reported stimulation induced autonomic 
dysreflexia.
Continence is achieved in 57% to 100% of patients and bladder capacity increased. 
However, continence is not only achieved by a dorsal rhizotomy. Results on 
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This overview includes several multicentre studies (**) which include overlapping results with the reports of various single centre studies. Therefore, no accumulation of results is 
(-), unreported data or incomplete data for calculation; UTI, urinary tract infection.
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Abstract
Aims. To determine the effects on Quality of Life (QoL) of a Brindley procedure, 
which combines a sacral dorsal root rhizotomy to treat neurogenic detrusor 
overactivity with sacral anterior root stimulation to enable micturition, defecation and 
penile erections in complete spinal cord injury (SCI) patients compared to a matched 
control group.
Methods. Cross-sectional study. The Qualiveen questionnaire, SF-36 questionnaire, 
and multiple choice questions about urinary continence and urinary tract infections 
were sent to 93 patients who had a Brindley stimulator implanted in the Netherlands 
and a matched control group of 70 complete SCI patients with neurogenic detrusor 
overactivity. Primary study outcomes were Specific Impact of Urinary Problems score 
and general QoL index of the Qualiveen.
Results. Response rates were 78% and 40% for patients with a Brindley stimulator and 
controls, respectively. Stimulators were still used for micturition in 46 (63%). These 
patients had a significant better Specific Impact of Urinary Problems score, general 
QoL index (Qualiveen) and continence rate, and less urinary tract infections compared 
to the control group. Patients also benefited of the rhizotomy with regard to QoL and 
continence rate if the stimulator was not used anymore. The subscales of the SF-36 
had better scores for the patients who used their stimulator as compared to those who 
did not use the stimulator and compared to the control group.
Conclusions. The Brindley stimulator for complete spinal cord injury patients 
improves Quality of Life, continence and urinary tract infection rate compared to a 
matched control group.
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Introduction
Urological disorders have been known as a major cause of death for spinal cord injury 
(SCI) patients in the past.1 Improvements in patient management decreased mortality
2'3rates, and urinary complications as a cause of death decreased. ; Although mortality 
decreased, morbidity and patient well-being are important issues in patient 
management, including upper urinary tract disorders, urinary tract infections (UTI), 
urolithiasis and urinary incontinence.4
Nowadays, the major goal in SCI patient management is protection of the upper 
urinary tract to preserve renal function.5 This should be accomplished by ensuring 
detrusor pressures within safe limits during both the filling and voiding phase and 
prevention of UTI’s by improving bladder emptying. Urological management of SCI 
patients made a considerable progress with the introduction by Giles Brindley of the 
Brindley stimulator (Finetech Medical Ltd, United Kingdom). This technique made 
use of sacral anterior root stimulation (SARS).6-8 SARS is applied intermittently, 
which results in post-stimulation voiding as the striated muscles of the sphincter relax 
faster than the smooth detrusor muscles of the bladder. Sauerwein expanded SARS 
with a dorsal rhizotomy (deafferentation) of sacral roots S2 till S5.9 A dorsal 
rhizotomy is important, because it suppresses neurogenic detrusor overactivity (NDO) 
and detrusor-external sphincter dyssynergia.910 This results in a low pressure bladder 
and good compliance, no reflex contractions and subsequently continence. Moreover, 
it reduces autonomic dysreflexia.1011 The intention of SARS is not only to enable 
micturition, but also to restore penile erectile function, to support defecation and to 
achieve faecal continence.11-14 Improvement of UTI’s and upper urinary tract 
deterioration, such as vesico-ureteral reflux and hydronephrosis, can be achieved. This 
results in less renal failure.11-14
Although urinary problems are no longer a major cause of death, their impact on 
morbidity, health and wellbeing of SCI patients, still plays an important role. Despite 
this, studies on the specific impact of neurogenic bladder problems on Quality of Life 
(QoL) and its treatment are rare. Only 1 study reported the effect of the Brindley 
stimulator on QoL using the Qualiveen questionnaire, which measures specific impact 
of bladder problems on QoL in neurogenic patients.14 This study used data of a
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heterogeneous control group of neurogenic patients, which did not only include 
complete spinal cord injury patients.
The primary objective of this study in patients with SCI was to evaluate the effect on 
Qol of the Brindley stimulator and that of rhizotomy of the dorsal sacral roots only as 
compared to a matched control group.
Materials and Methods
A cross-sectional descriptive study was conducted between July and October 2008 to 
compare differences in urological impact on QoL in SCI patients who underwent a 
Brindley stimulator implantation to patients with complete SCI and NDO who used 
other methods for bladder control. Patients for the latter group were selected from the 
SCI database of the department of Urology of the Radboud University Nijmegen MC. 
Inclusion criteria for this matched Control Group were complete SCI with detrusor 
overactivity (DO) according to the definition of the International Continence Society.15 
A third patient group was composed of patients that underwent the implantation of a 
Brindley stimulator, but did not use the stimulator anymore.
The translated and validated Qualiveen questionnaire and the SF-36 health survey 
were used to determine the impact of urinary problems on QoL in study and control 
groups.1617 Specific multiple choice questions regarding the presence of urinary 
continence and yearly incidence of UTI’s at the time of questionnaire administering 
were added to both questionnaires (Figure 1). The questionnaires were sent to 93 
patients who received a Brindley stimulator in 2 Dutch centres between 1987 and 
2007, and to 70 patients of the Control Group.
Yj
The Qualiveen consists of 2 sections. The first section “Specific Impact of Urinary 
Problems” (SIUP) measures bladder disease-specific impact on QoL in 4 scales; 
Limitations, Constraints, Fears and Feelings. Scores range from 0 to 4; 0 indicating no 
impact of urinary disorders on QoL and 4 indicating a high impact on QoL. The mean 
score of these 4 scales results in the SIUP index. The second section measures general 
QoL using a nine-item general QoL questionnaire. These QoL scores range from
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minus 2 to plus 2; minus 2 indicating a very bad QoL and plus 2 indicating a very 
good QoL. The mean of these QoL scores results in the QoL index.
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The SF-36 measures general health in 8 dimensions; Physical Functioning, Role of 
Limitations due to Physical health problems, Bodily Pain, General Health, Vitality, 
Social Functioning, Role of Limitations due to Emotional problems and Mental 
Health.16 In our study the Physical Functioning scale was omitted, because questions 
regarding walking, standing and climbing stairs are not applicable in our study 
population. Item scores for the other 7 dimensions were converted to a 0 to 100 scale 
for each dimension, indicating 0 as worst and 100 as best health. It was not possible to 




Mann-Whitney test was used to analyze differences between means of asymmetric 
data. Differences in urinary continence and UTI rates were analyzed with the Chi- 
Square test. Differences with p<0.05 (two-tailed / two-sided) were considered 
significant (SPSS 16.0).
Results
Of the 93 contacted patients who underwent a dorsal rhizotomy and implantation of a 
Brindley stimulator, 73 agreed to participate and returned completed questionnaires 
(Figure 1). Of these patients, 46 patients (63%) still used the Brindley stimulator for 
micturition (Brindley Group). The other patients who did not use the stimulator 
anymore (37%) were defined as the ‘Rhizotomy Group’. Stimulators were not used for 
micturition anymore, due to defect stimulators or implants, inconvenience of leg 
spasms during stimulation, removal of infected implant and preference of other 
bladder emptying methods. Of the 70 eligible patients for the Control Group, 28 (40%) 
returned completed questionnaires.
Table I  Patients’ characteristics of the Brindley, Rhizotomy and Control Group
Brindley Group Rhizotomy Group Control Group
Gender
Male 36 (78%) 22 (81%) 22 (79%)
Female 10 (22%) 5 (19%) 6 (21%)
Mean (range) age at time of investigation (yr) 48 (33-67) 47 (26-66) 42 (20-75)
Mean (range) post-injury period (yr) 21 (5-40) n=45 19 (7-36) n=26 9 (2-32) n=27
Mean (range) follow up since Brindley Procedure (yr) 13 (1-19) n=40 14 (3-21) n=22 N.A.
Method of voiding (%)
Brindley stimulator 100 N/A N/A
Intermittent catheterization 9 78 71
Suprapubic tappinga 2 4 14
Indwelling catheter 2 26 14
Spontaneous micturitiona 0 4 14
N.A, not applicable.
a Suprapubic tapping and detrusor overactivity in the Brindley Group and Rhizotomy Group could be possible due to an 
incomplete sacral dorsal root rhizotomy. Some patients regarded bladder emptying by abdominal pressure increase or due 
to urinary incontinence caused by detrusor overactivity as spontaneous micturition.
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Table I describes characteristics of the 3 groups. DO in the Control Group was treated 
by anticholinergics (10) or Botulinum toxin A injections (4). The remaining patients of 
the Control Group did not have specific DO treatment and only emptied their bladder 
regularly. Information on DO treatment was not available in 2 patients.
Qualiveen Questionnaire
Figure 2 shows the results for the SIUP index, the separate SIUP scales and QoL index 
of the Qualiveen questionnaire for each group. In all 4 dimensions of the SIUP index, 
significant better results were found in the Brindley Group compared to controls. This 
indicated that patients who used a bladder stimulator experienced less Limitations, 
Constraints , Fears and bad Feelings (all p=0.000) concerning their urinary problems. 
The SIUP index was significantly better in SCI patients using the bladder stimulator 
(p=0.000) compared to controls. The Brindley Group had a significantly higher QoL 
index (p=0.046), indicating that they experienced a better general QoL. The same 
results were found for the Rhizotomy Group, although the findings were not 
statistically significant. The SIUP index was lower and the QoL index was higher in 
the Rhizotomy Group compared to the Control Group, implying less impact of urinary 
problems in daily life and better general QoL.
SF-36 Questionnaire
Figure 3 shows the differences in scores of the SF-36 in the 7 dimensions. Higher 
scores were seen in the Brindley Group compared to the Rhizotomy Group and 
Control Group. This indicated that the bladder stimulator improves these different 
aspects of general QoL, especially the dimensions of General Health and Social 




Figure 2. Results of the Qualiveen questionnaire; bladder disease specific impact on Quality of Life. SIUP index, 
Specific Impact of Urinary Problems index; the lower the score, the better the Quality of Life. QoL index, Quality of Life 
index; the higher the score, the better the Quality of Life.
(*) Significant
Figure 3. Results of the SF-36 questionnaire; general health status. The higher the score, the better the Quality of Life. 
(*) Significant
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Clinical outcomes
The continence rate was higher and incidence of UTI’s was lower in the Brindley 
Group compared to the Control Group (Table II). Fifty-two percent of patients who 
used the Brindley stimulator were completely continent at the time of investigation 
compared to respectively 14% in the Control Group (p=0.002) and 33% in the 
Rhizotomy Group (p=0.214). Half of the patients in the Brindley Group did not suffer 
from UTI’s. If UTI’s occurred in this group, it was less frequently than in the Control 
Group (p=0.038) and Rhizotomy Group (p=0.000). The incidence of UTI’s increased 
when the Brindley stimulator was not used anymore (Rhizotomy Group).
Table II. Incontinence prevalence and urinary tract infection incidence per year o f the 
Brindley, Rhizotomy and Control Group.
Brindley Group Rhizotomy Group Control Group
Urinary continence a
Yes 24 (52%) 9 (33%) 4 (14%)
No 21 (46%) 16 (59%) 23 (82%)
Missing Data 1 (2%) 2 (7%) 1 (4%)
Urinary tract infections / year b
None 23 (50%) 4 (15%) 10 (36%)
1-2 17 (37%) 8 (30%) 6 (21%)
3-4 3 (7%) 4 (15%) 5 (18%)
>5 3 (7%) 11 (41%) 7 (25%)
a Significant versus the Control Group
b Significant versus the Rhizotomy Group and the Control Group, respectively
Discussion
The main urological objective of the Brindley procedure is to restore controlled 
voiding of the urinary bladder.68 This is achieved by electrical stimulation of the sacral 
anterior roots for bladder contraction. Besides enabling micturition, implant driven 
defecation and penile erection are possible. Moreover, Brindley observed an increase 
in bladder capacity and continence in patients with accidental damage to posterior
n. o
roots. ; Sauerwein structurally combined SARS with a dorsal rhizotomy from S2 to 
S5, which results in the disappearance of DO, increased bladder capacity and
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restoration of continence.9 Clinical results of the majority of the patients selected for 
the present study have been reported before and show improvement in bladder 
capacity, continence rate, bladder emptying, defecation, upper urinary tract function,
UTI’s and autonomic dysreflexia.111314 More recently, Kutzenberger et al reported
12comparable results with a follow-up of up to 17 years.
Clinical benefit was observed in these studies. The differences between behaviour and 
control of pelvic organs before and after operations are striking and substantial. Leg 
spasms and autonomic dysreflexia periods decreased in favour of the patients. To 
focus on the impact of these changes on patients’ daily life is not easy as the changes 
are numerous. Therefore, concise QoL assessment is needed in order to appreciate the 
impact of the procedure. This is of major importance, because the surgery is difficult 
and patients need an extensive work-up and a long recovery with extensive adaptations 
to their new situation towards daily life.
Patient satisfaction, overall well-being and QoL have been studied in patients with a 
Brindley stimulator, but data about QoL are rare.14;18;19 Vastenholt et al assessed the 
QoL in 37 SCI patients with a functioning Brindley stimulator with the Qualiveen 
questionnaire.14 They found that the impact of urinary problems on QoL was reduced 
and the overall QoL improved in patients who used the Brindley stimulator compared 
to the results of the validation group of the Qualiveen questionnaire that had a 
diversity of neurologic disorders. They did not compare the Brindley group to 
comparable complete SCI patients who had standard state of the art care. Since 
rhizotomy only also has a major impact on bladder, bowel, penile erections, autonomic 
dysreflexia and muscle spasms, it is not obvious to compare the outcome of the 
Brindley procedure on QoL to other treatment in neurogenic patients. Therefore the 
comparison of a separate group with only a dorsal rhizotomy in our study is perhaps 
more clarifying.
To assess the influence of a dorsal rhizotomy and a Brindley stimulator on QoL, our 
study applied the Qualiveen questionnaire in SCI patients who used a Brindley bladder 
stimulator compared to a matched Control Group and to a group of patients who did 
not use their stimulator for micturition anymore and only profited from the rhizotomy.
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The Qualiveen had better scores on every item and more patients were continent in the 
Brindley and Rhizotomy Group as compared to controls. Rhizotomy only, with a 
flaccid bladder, less spasms and less incontinence episodes tended to be better than a 
state of the art ‘standard’ therapy that was practiced in the majority of these patients. If 
a rhizotomy is combined with voiding by a stimulator without or with less frequent 
intermittent catheterization, this clearly had additional value.
The Rhizotomy Group had more UTI’s than the Control Group. Perhaps this was due 
to a higher percentage of indwelling catheter use, higher bladder volumes and more 
patients who were suspected for an incomplete rhizotomy. It did not lead to a decrease 
in QoL score in the Qualiveen questionnaire.
The SF-36 did not give good insight in the differences between groups. Concern has
been raised in the rehabilitation community in regard to the inclusion of questions
20referring to walking and climbing stairs. Lee et al modified the SF-36 to improve
21validity and responsiveness in SCI patients. In questions of physical function, 
“Walking” was replaced by “Wheeling”. However, it remains debatable whether this 
would make the SF-36 really valid for this patient group, since the perception of QoL 
for patients that experienced such a dramatic life event entirely differs from a general 
population. This could mean that the SF-36 is not suitable in this group of very 
specific patients and one should be cautious with interpretation of the results. 
Therefore the SF-36 can better be omitted in favour of the disease specific Qualiveen 
to measure QoL.
Although the Brindley stimulator was superior regarding QoL, UTI’s and continence 
rate to the other standard treatments in patients with complete SCI, including treatment 
with anticholinergics and Botulinum Toxin A injections, it is not a procedure that is 
easy to apply in clinical practice. Firstly, not every patient is suited for the procedure 
and the success depends on selection of appropriate patients. Prerequisites are a 
complete spinal cord lesion, since neurostimulation can cause pain in incomplete 
spinal cord lesions; an intact sacral motor neuron pathway enabling stimulation of the 
bladder; and a detrusor muscle that is capable to contract on stimulation. Secondly, a 
dorsal rhizotomy and implantation of a Brindley stimulator is complex and not a 
routine procedure for urologists and should be reserved for specialized centres.
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Thirdly, 37% of the patients with a Brindley stimulator who returned their 
questionnaire stopped using the stimulator after implantation. The stimulator 
utilisation rate is low compared to previous studies.7’9’11’12’13’14 This could be explained 
by national legislation with respect to certain aspects of the surgical procedure for 
revision of the implant, like burning the insulation of the implanted electrode cables. 
This excluded these patients from revision surgery and use of their stimulator. A 
straight forward solution for analysis and revision of the implanted system without 
major surgery is not easy to obtain. As most SCI patients in the Netherlands have 
become increasingly familiar with intermittent catheterization and bowel rinsing, they 
accept the dysfunction of the stimulator as they remain continent in combination with 
controlled emptying of their bladder and bowels.
A main issue for patients is the irreversibility of the rhizotomy and the possibility that 
future treatment options are not within reach anymore. Although SARS can restore 
penile erections after a rhizotomy, qualitative useful stimulation of erections is not 
possible in a substantial number of patients. It should be an incentive to look for 
solutions that enable low pressure bladders without performing a rhizotomy.
22'23Continuous or conditional neuromodulation could be one of the solutions. ’ Sacral 
Posterior and Anterior Root Stimulation combines neuromodulation and SARS 
without a rhizotomy of the dorsal roots for micturition. These new developments are 
however not generally introduced as a standard treatment. Sacral Posterior and 
Anterior Root Stimulation effectively suppresses DO, but does not result in complete
24emptying in all patients due to persisting detrusor-external sphincter dyssynergia.
The treatment of the NDO is heterogenous in the Control Group, including 
anticholinergics (36%), Botulinum toxin A injections (14%) or no special treatment 
beside regular bladder emptying (43%). The percentages of intermittent catheterization 
were comparable between the Rhizotomy Group as well as the Control Group, but the 
use of indwelling catheters was higher in the Rhizotomy Group as suprapubic tapping 
and spontaneous micturition on DO or abdominal straining were less possible. A low 
number of patients who used the bladder stimulator for micturition performed 
intermittent catheterization in addition. Some patients in the Brindley Group and the 
Rhizotomy Group were able to void or used suprapubic tapping. This could imply that
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the rhizotomy was not complete in all patients and it is likely that this affected the QoL 
scores.
Bias caused by the response rates of 78% for patients with a Brindley bladder 
stimulator and 40% for the Control Group should be taken into account. Various biases 
can be imagined, like less response of patients who are less satisfied with their 
treatment and less response of patients of the Control Group who have been referred 
back to general hospitals for regular follow-up of the neurogenic bladder and kidneys 
as no specialized follow-up in a university medical centre is needed in most of these 
patients. Patients with a Brindley stimulator have also been referred back to general 
hospitals when the stimulator function was stable or the stimulator was not in use 
anymore.
Conclusions
Keeping the limitations of the data and the procedure in mind, it can be concluded that 
the Brindley stimulator in combination with a dorsal rhizotomy in complete SCI 
patients with NDO improved continence rate, incidence of UTI’s and QoL regarding 
both disease specific QoL and general QoL aspects as compared to a matched Control 
Group. Patients benefited from a rhizotomy in terms of QoL and continence rate if the 
Brindley stimulator was not used anymore. The Brindley stimulator is an excellent 
treatment for a selected group of SCI patients and should be known to urologists in 
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Abstract
Purpose. The anatomy of the pudendal nerve and its nerve branches, especially the 
dorsal nerve of the penis and clitoris (dorsal genital nerves), and the clinical 
application of electrical stimulation of these nerves in patients with overactive bladder 
syndrome and detrusor overactivity are reviewed.
Materials and Methods. A literature search was performed using the Pubmed database 
and reference lists of relevant studies to obtain articles concerning the anatomy and 
electrical stimulation of the pudendal nerve and its nerve branches in patients with 
overactive bladder syndrome.
Results. According to the anatomy, electrical stimulation of the pudendal nerve and the 
dorsal genital nerves to suppress involuntary detrusor contractions is possible at 
several sites along their course from the sacral nerves to the penis or clitoris. The 
nerves are accessible by minimal invasive percutaneous methods. Stimulation of the 
pudendal nerve and dorsal genital nerves effectively increases bladder capacity, 
inhibits involuntary detrusor contractions and overactive bladder 
symptoms.
Conclusions. More clinically applied studies are recommended for stimulation of the 
dorsal genital nerves to assess its value and feasibility, because most studies have been 
done in an acute and experimental setting. The preferred type of electrode is not 
known, but if electrodes like wires can be implanted and fixated well by a minimal 
invasive procedure, cuff electrodes are not necessary. Before deciding for continuous 
or conditional stimulation, chronic clinical studies are recommended, because acute 
studies remain inconclusive. The feasibility of conditional stimulation depends on the 
availability of a reliable and clinically applicable detrusor activity sensor.
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Introduction
Various sites have been used for electrical stimulation of the PN and its branches to 
treat patients with overactive bladder syndrome (OAB) and urinary incontinence. 
Early studies to manage incontinence by electrical stimulation mainly used perineal, 
trans-vaginal or rectal stimulation of the PN branches. Inhibition of bladder activity 
using these techniques has been investigated, but it did not develop into a generally 
applied treatment for OAB.
The PN originates from the sacral nerve roots. Sacral nerve root stimulation (SNS) 
evolved as a widely used treatment for patients with OAB. SNS does not completely 
resolve symptoms in the majority of patients. Stimulation is reported to be effective at 
5-year follow-up in a considerable number of patients, but only after selection of 
patients who passed a screening phase.1
Stimulation of other nerve fibers at other stimulation sites might result in a better 
outcome. Such a site might be the PN, and especially the dorsal nerve of the penis or 
clitoris. In this review the dorsal nerve of the penis and clitoris will be mentioned 
together as the dorsal genital nerves (DGN). This review describes the anatomy of the 
PN and the DGN to evaluate sites and methods for electrode implantation and 
stimulation of these nerves. The feasibility of automatic conditional stimulation will be 
discussed.
Anatomy of the pudendal nerve and its branches
2 11Most anatomy studies have been done by dissection of male and female cadavers. - 
Some studies included patients referred for autopsy and children who underwent 
surgery.1213
Pudendal nerve
The PN originates primarily from the second, third and fourth sacral nerve roots, and 
sometimes gains contributions from the adjacent roots of S1 and S5.6;8;10 The sacral 
nerve roots are composed of autonomic and somatic nerve fibers. The autonomic 
branches traverse more ventrally and form the pelvic plexus for parasympathetic
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innervation of, among others, the detrusor muscle. Nerve branches of the somatic 
component combine to one major trunk of the PN.5
The PN lies medial and caudal to the sciatic nerve trunk and enters the gluteal region 
via the greater sciatic foramen. At the level of the ischial spine, the PN passes between 
the sacrospinous ligament anteriorly and the sacrotuberous ligament posteriorly. More 
caudal, the PN enters laterally the ischiorectal fossa at the medial side in a fascial
5' 8sheath (pudendal canal, Alcock's canal) close to the obturator internus muscle. ’
Pudendal nerve branches
The PN has three major branches: the inferior rectal nerve, the DGN and the perineal 
nerve, with a high variation in branching patterns. Adjacent to the ischial spine and the 
sacrotuberous ligament the PN consists of one, two and three trunks in 56-75%, 14­
35% and 6-12% of PN’s, respectively.2’3’6’7 Schraffordt et al reported that in 96% of 
PN’s the inferior rectal nerve arises from the PN at the beginning of Alcock’s canal to 
enter the proximal part of the ischiorectal fossa. Mahakkanukrauh et al found that in 
21% of PN’s the inferior rectal nerve originates independently from the S4 root and 
never branched from the main PN.6 The remainder of the PN divides within Alcock’s
7‘8canal into the perineal nerve and the DGN. ’ O’Bichere et al showed that the DGN
n
originates independently from the S2 root in 25% of PN’s.
Dorsal nerve o f the penis or clitoris
Huang et al stimulated the DGN electrically and recorded sacral dorsal root action 
potentials during selective dorsal rhizotomy surgery in 105 children. Activity was 
recorded in S1 roots in 21%, S2 in 84% and S3 in 62% of the children. The DGN is 
confined to a single level in 18% and to a single root in 8% of the children. S1 roots
contribute 4%, S2 roots 60.5%, and S3 roots 35.5% of the overall afferent activity of
12the DGN, indicating that S2 on average contains most of the DGN fibers.
Dorsal nerve o f the penis
After leaving the Alcock’s canal anteriorly, the dorsal nerve of the penis continues 
cranially where it contacts the inferior ramus of the pubis and subsequently courses
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along the inferior border and anterior surface of the body of the pubis. Inferior to the 
pubis, the nerve courses proximal to the insertion of the cavernous body, and continues 
between the cavernous body and the anterior surface of the pubis to the dorsum of the 
penis.9 When the nerve enters the dorsum of the penis it runs between the bone of the 
pubic symphysis dorsocranially, the inferior pubic ramus and a strong ligamentous 
portion of the suspensory ligament laterally, and the ischiocavernous body and the 
tunica albuginea inferomedially.4 The nerve runs bilaterally on the dorsal site of the 
penis between the tunica albuginea and Buck’s fascia.5 Dorsal branches travel as a 
straight trunk for most of the penile shaft to terminate in the penile gland. Lateral 
branches curve laterally and ventrally over the penile shaft. An undulation of the nerve 
fibers overlying the penile shaft allows distention without damage of the nerve fibers
1 o
during penile erections.
Dorsal nerve o f the clitoris
The course of the dorsal nerve of the clitoris and its position relative to the inferior 
ramus of the pubis are similar to that of the dorsal nerve of the penis. Distally, the 
nerve travels through the perineal membrane lateral to the external urethral meatus. It 
traverses along the bulbospongiosus muscle before traversing posterior to the crura. 
The nerve hooks over the crura to lie on the anterolateral surface of the body of the 
clitoris, before dividing into two cords and terminating short of the tip of the clitoral 
gland.11
Surgical access to the PN and DGN
The anatomy of the PN and its branches, including the DGN, enables implantation of 
an electrode at several sites (Figure 1). In this review we only consider wire electrodes. 
If electrodes can be fixated well by a minimal invasive procedure, cuff electrodes are 
not necessarily. Cuffs have the advantage that they can be fixated to the nerve to 
prevent migration. However, they require more extensive surgery exposing the nerve 
over at least 2-3 cm, which is time consuming and makes the nerve vulnerable to 
damage or nerve entrapment. Wires can be used non-invasively without open surgery.
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Percutaneous implantation of a wire electrode lacks direct vision to the nerve during 
implantation. X-ray screening and neuro-physiological monitoring of PN and DGN 
stimulation with EMG-electrodes applied at the peri-anal region or in the external anal 
sphincter muscle can be used to determine the correct electrode-to-nerve position.14-16
Figure 1. Approaches for electrical stimulation of the pudendal nerve and dorsal nerve of the penis or clitoris. The PN 
originates primarily from the second, third and fourth sacral nerve roots, and it sometimes gains contributions from the 
adjacent roots of S1 and S5. The PN can be accessed for stimulation at the ischial spine by a posterior (A) or perineum 
approach (B) for insertion of an electrode. With a perineum approach the PN can also be reached at Alcock’s canal (C). 
The DGN can be stimulated using surface electrodes or percutaneously implanted electrodes (D).
Pudendal nerve: posterior approach ischial spine
The ischial spine is useful as a landmark to locate the PN. The ischial spine can be 
accessed by a dorsal approach by inserting a wire electrode perpendicular at the 
intersection of a horizontal line from the greater trochanter and a vertical line from the 
ischial tuberosity tip. The ischial spine can also be located by palpating the lower 
margin of the sacrotuberous ligament where it forms an angle with the ischial
17tuberosity. Schmidt et al reported implantation of a cuff electrode on the PN by a
18posterior surgical approach in two patients.
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Pudendal nerve: perineum approach ischial spine andAlcock’s canal 
A perineum approach comparable to a PN block has been used by inserting a wire 
electrode near the PN at the ischial spine or Alcock’s canal.14’16’19-22 The electrode is 
inserted perpendicularly to the perineum between the ischial tuberosity and the anus. A 
finger in the vagina or rectum helps to prevent puncturing of the bowel or vagina and 
helps to guide the electrode to the ischial spine or Alcock’s canal.14’16’21
Dorsal nerve of the penis or clitoris
Because part of the DGN lies superficially to the skin outside the pelvis, this nerve can
23 35be stimulated using surface electrodes attached to the overlying skin. - The 
application of stimulation using surface electrodes is limited, due to intolerance to 
required high stimulation amplitude. In patients with intact sensitivity, this leads to 
stimulation amplitudes that are less effective or too low to be effective, which 
subsequently results in incontinence.36 Neurogenic patients with absent or decreased 
sensitivity might be more suitable due to higher tolerability. Surface electrodes have 
additional limitations such as difficulties in daily proper placement and hygiene.
Implanted electrodes would be more suitable. Surface electrodes and wire electrodes
28do not differ significantly in stimulation effect. Implantation of electrodes in the 
penis is not preferred. In the penis and near the clitoris, electrodes have to endure 
mechanical stress of penile erections and external pressure. To decrease mechanical 
stress, electrodes should be inserted more proximal along the tract of the DGN. In 
addition to the use of the sensory function of the nerve for locating the stimulus in the 
penile gland or clitoris, electrodes can be positioned near the DGN using this genito- 
anal reflex.15 The nearer the electrode is to nerve, the lower the required stimulation 
current to evoke the reflex.
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Electrical stimulation of the PN and the DGN
Pudendal nerve stimulation
Table I shows an overview of studies with pudendal nerve stimulation. Peters et al and 
Spinelli et al used a tined lead (Interstim, Medtronic Minneapolis, US), which has 
been used in SNS.1622 In SNS proper positioning of the electrode is ensured by pelvic 
motor response and fluoroscopic localization. PN stimulation requires intraoperative 
electrophysiologic monitoring of EMG of the external anal sphincter to confirm proper 
electrode positioning for PN stimulation. In a single blinded study, patients randomly 
received both a test with SNS and PN stimulation by the perineum approach for OAB 
(90%) or urinary retention (10%). Eighty percent of patients had a more than 50% 
improvement in symptoms. Patients with PN stimulation reported an overall 63% 
improvement in symptoms, whereas patients with SNS patients reported an overall
46% improvement. Of patients whose symptoms improved more than 50%, 79%
22desired to have PN stimulation compared to 21% for SNS. For this moment, the 
number of published studies and the experience with PN stimulation are limited 
compared to SNS. Therefore, SNS remains the primary therapy, but PN stimulation 
should be considered as a primary treatment if more successful long-term clinical 
results of PN stimulation become available.
Another technique for PN stimulation is a leadless mini-stimulator, like the Bion. It is 
implanted via the perineum approach to the PN at Alcock’s canal. The reported results 
are increased bladder capacity and decreased incontinence episodes in patients with 
idiopathic detrusor overactivity (DO). Vaginal dryness, altered bowel function and 
mechanical irritation during bicycle riding are mentioned as device related side 
effects.14
Stimulation of the dorsal nerve of the penis or clitoris
Studies using stimulation of the DGN have been done in acute and experimental 
settings without extensive chronic clinical trials (Table II). Only one larger study using
'xncontinuous stimulation during 1 week is available. Therefore, results of studies with 
DGN stimulation should be interpreted carefully from a clinical point of view when 
comparing them with PN stimulation or SNS.
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Table I  Electrical stimulation of the pudendal nerve.















Bion (C) Continuous; 
cycling 4.92 s 
on/off 
(chronic)
- 36% positive PST a
- 6/14 implanted
- 43% increase in cystometric capacity
- 15% increase in voided volume









- 80% >50% improvement during PST b
- 63% improvement in symptoms with pudendal lead
Spinelli et 8& 7? 5 Hz Tined lead (9 Continuous - Screening: 63% decrease in incontinence episodes,




A and 6 B) or conditional 
(chronic)
53% continent 
- Implant c same clinical efficacy as with screening.









- 8 patients with NDO in whom vaginal/rectal 
stimulation failed, were treated with PN stimulation
- 5/8 had a decrease in frequency and 4/8 an increase 
in capacity
Schmidt
et al 18 O 









- Improvement of incontinence







- 184% increase in cystometric capacity
CVD, cerebral vascular disease; IDO, idiopathic detrusor overactivity; MES, maximal electrical stimulation; NDO, 
neurogenic detrusor overactivity; PST, percutaneous screening test; SNS, sacral nerve stimulation.
a Percutaneous screening test (PST) is regarded successful if stimulation results in a more than 50% increase in the 
bladder volume at the first involuntary detrusor contraction or the maximum cystometric capacity at the second 
cystometry after 10 min. stimulation compared to pre-stimulation cystometry. 
b Both PN stimulation and sacral nerve stimulation were used in each patient for comparison.
c Six patients underwent PN stimulation with the perineum and nine with the posterior approach. All were screened for 
15-45 days. Twelve patients were selected for a permanent implant, because they had an improvement of more than 80% 
on number of daily incontinence episodes.
Increases in cystometric capacity vary significantly between studies using continuous 
stimulation (range 11-177%) and conditional stimulation (range 37-144%).23,25’26’30-
35'3735;37 In several acute studies with few patients, IDC were suppressed conditionally,
23with a subsequent increase in bladder volume and postponement of incontinence. -
28-31‘3528;31;35 Increase in stimulation current results in a more pronounced detrusor
15'32'33inhibition.15;32;33 Besides IDC suppression, increases of the pressure at the bladder
38neck and the urethral sphincter contribute to continence.
In general, patients tolerate conditional stimulation well and they adapt to the
24.37
sensation to continuous stimulation in long-term use.24;37 Stimulation effectively
24'25'30'37suppresses urgency and decreases urgency episodes.24;25;30;37 Suppression of urgency 
during stimulation might contribute to tolerance of stimulation. This might enable
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stimulation at higher current to increase effectiveness when stimulation is applied 
conditionally.
Table II. Electrical stimulation of the dorsal nerve of the penis or clitoris.















- 100% of patients had >1 UDC suppression at 
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- 42% increase in cystometric capacity
- 50% increase in cystometric capacity
Goldman 21? Maximum tolerable Percutaneous Continuous - 55% increase cystometric capacity
et al 37 Urge-
incontinenc
e
amplitude wire (chronic) - 47% has >50% reduction in incontinence episodes c











5-60 mA (1.5-2x 
BCR)
Surface Conditional d 
(acute)
- 17/42 patients had both automatic and patient 
controlled stimulation
- 82% of patient controlled stimulation had >1 UDC 
suppression with 37% increase in cystometric 
capacity














- 88% had >1 UDC suppression

















- 53% increase in cystometric capacity e
- 87% >1 suppressed UDC











- 326% increase in bladder volume at first contraction 
and the last effectively suppressed contraction
- 214% increase in bladder volume at first contraction 











- 66% increase in cystometric capacity













- 57% suppression of urge and increase cystometric 
capacity (mean 94 ml, SD 47.8)
- 31% suppression of urge, no increase cystometric 
capacity





















- 110% increase in cystometric capacity
- 144% increase in cystometric capacity
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- No significant difference in cystometric capacity, 











- 11% increase in cystometric capacity (1x BCR)

































- 177% increase in cystometric capacity (2-3,5x BCR)
- 8/13 patients with DO had UDC suppression
IDC, involuntary detrusor contraction; IDO, idiopathic detrusor overactivity; MS, multiple sclerosis; NDO, neurogenic 
detrusor overactivity; OAB, overactive bladder syndrome; SCI, spinal cord injury. 
a Four excluded.
b Conditional stimulation: cyclic stimulation 10s on and 2s off. 
c One week stimulation.
d 33 out of 42 patients with neurogenic detrusor overactivity had automatic conditional stimulation; 17 out of these 33 
patients had patient controlled stimulation o f whom results are mentioned in the Table. 
e Normal treatment not discontinued.
Sexuality
A positive effect of SNS on sexual function has been reported.3940 SNS probably 
enhances sexual responses, but might also improve the desire for intimacy and sexual 
contact due to a decrease of incontinence. DGN stimulation did not evoke sexual
i c . 3 7
feelings or responses. ; This might be explained by a more complex nerve activity 
pattern during sexual stimulation of the genitals. The influence of long-term DGN 
stimulation on sexuality is not known. DGN stimulation might induce desensitivity of 
sexual responses.
Conditional stimulation
Continuous stimulation gives of stimuli constantly, regardless of the presence of IDC. 
If stimulation is used conditionally, stimulation is only activated during an IDC. 
Conditional stimulation is probably as effective as continuous stimulation to increase
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bladder capacity, but reduces stimulation time.26,35,42’43 A reduction in stimulation time 
increases battery lifespan and might prevent habituation to stimulation.
The most direct method for monitoring of bladder activity are pressure sensors in the 
bladder.44-46 Intraluminal bladder sensors suffer from incrustration.45 Moreover, the 
risk of urinary tract infections, urolithiasis and carcinoma probably might increase. 
Bladder wall sensors have the disadvantage of dislocation and tissue erosion.44 
Improvement in fixation and sensor development to prevent erosion is required for 
these bladder sensors to become clinical feasible.
External anal or urethral sphincter EMG has been used to detect the onset of
47'48neurogenic IDC in an acute setting. ; External urethral sphincter EMG to estimate 
the onset of an IDC is feasible, but it is limited to the combination of neurogenic DO
A Hand detrusor sphincter dyssynergia. A potential limitation of implementing external 
anal sphincter EMG is the low specificity to detect IDC, which results in a high false- 
positive detection rate.3548 The resulting extra stimulation is not harmful and 
stimulation time is still significantly reduced compared to continuous stimulation. 
However, false-positive EMG-recording might increase in physical active patients and 
stimulation is not favourable when sensation to stimulation is less tolerated in the 
absence of urgency.
Electroneurography of the sacral nerve root or PN, which records nerve electric 
activity, is correlated with the bladder pressure and can be used to detect bladder 
contractions in animals and humans.4249 Small amplitudes of neural signals and 
various other sources that contribute to sacral nerve root electroneurography (e.g. 
sacral dermatome and rectal activity) require improvement to detect bladder 
contractions reliably in a chronic application.
As long as no reliable sensor is available for automatic conditional stimulation, patient 
controlled stimulation can be applied. This requires sensation of IDC to start 
stimulation by the patient. Wyndaele et al reported that in idiopathic DO, 49% of 
patients feel IDC.50 In neurogenic patients Opisso et al reported 52% of patients to 
have a sensation of IDC and to be able to use patient controlled stimulation during
3 1 *cystometry. This provides the patient a warning time and ability to postpone 
leakage.2731.
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Conclusions
Electrical stimulation of the PN and the DGN is possible at several sites by minimal 
invasive percutaneous methods. The preferred type of electrode is not known, but if 
electrodes like wires can be implanted and fixated well by a minimal invasive 
procedure, cuff electrodes are not highly desirable. Stimulation of PN and DGN 
effectively increases bladder capacity, inhibits IDC and OAB symptoms. Clinically 
applied studies are recommended for DGN stimulation to assess its value and 
feasibility, because most studies have been done in an acute and experimental setting. 
Before deciding for continuous or conditional stimulation, chronic clinical studies are 
recommended, because acute studies remain inconclusive. The feasibility of 
conditional stimulation depends on the availability of a reliable and clinically 
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Objectives. Electrical stimulation of the dorsal genital nerves (DGN) suppresses 
involuntary detrusor contractions (IDC) in patients with neurogenic detrusor 
overactivity (DO). The feasibility of minimal invasive electrode implantation near the 
DGN and the effectiveness of conditional stimulation to suppress IDC at different 
amplitudes in spinal cord injury (SCI) patients with DO were studied.
Setting. Radboud University Nijmegen MC, the Netherlands.
Methods. In eight healthy volunteers, a needle electrode was inserted from both a 
medial and lateral-to-midline site at the level of the pubic bone. Electrode insertion 
was guided by the genito-anal reflex (GAR) evoked by electrical stimulation and 
sensation to this stimulation. In eight SCI patients with DO, the bladder was repeatedly 
filled and emptied partially in between. Conditional stimulation using a needle 
electrode was applied when an IDC was observed at urodynamics. Different 
amplitudes were used during each filling. Control cystometry was done before 
electrode insertion and after stimulation.
Results. The lateral implant approach was preferred, because it was easier to maneuver 
the needle along the pubic bone and fixate the needle. In SCI patients, the electrode 
was positioned successfully and IDC were suppressed (range 1-6 IDC suppressions) 
with conditional stimulation at maximum tolerable amplitude, except for one patient. 
Stimulation was less effective at lower amplitudes. Stimulation lowered the intensity 
of bladder sensations concomitant with IDC.
Conclusion. The lateral-to-midline implant approach in combination with the GAR 
and sensation to stimulation is feasible for electrode implantation near the DGN in SCI 
patients. Conditional stimulation effectively suppresses IDC.
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Introduction
Detrusor overactivity (DO) with concomitant high intravesical pressures during 
involuntary detrusor contractions (IDC), especially sustained high pressures, is not 
only a risk factor for upper urinary tract deterioration, but also for urinary 
incontinence. Incontinence increases the risk of complications in spinal cord injury 
(SCI) patients, like pressure ulcers and poor wound healing. DO and/or detrusor 
external sphincter dyssynergia occurs in the majority of patients with suprasacral SCI 
(95%), and combined suprasacral and sacral SCI (70%).1
Continuous electrical stimulation of the dorsal nerve of the penis or clitoris (dorsal 
genital nerves, DGN) using surface electrodes increases bladder capacity in SCI
9 . 3
patients. ; However, the same can be obtained with conditional stimulation. With 
conditional stimulation stimuli are only given when an IDC occurs. Conditional
9 . 4
stimulation of the DGN suppresses IDC and increases bladder capacity. ; Pilot studies 
using ambulatory continuous or conditional stimulation of DGN in male SCI patients 
showed the feasibility to improve bladder capacity and continence.56 
Application of surface electrodes is a major limitation for DGN stimulation in daily 
practice, because of electrode fixation and hygienic problems. Therefore, implanted
electrodes for stimulation seem to be more practical. Goldman et al reported the results
. . . . .  1 
of a percutaneous implanted electrode in patients with urge-incontinence. However,
acute effects of stimulation and the feasibility of implantation in neurogenic patients
without sensation to stimulation were not described.
The current study was conducted to determine the feasibility of minimal invasive 
electrode implantation near the DGN guided by electrical burst stimulation to evoke 
the genito-anal reflex (GAR) and sensation to stimulation in SCI patients. Other 
objectives were to obtain reference data for sensation thresholds and maximal tolerable 
amplitudes in SCI patients, and to investigate the acute effect of conditional pulse train 






The approach to the DGN was practiced in a male and female cadaver. Needle 
electrodes were inserted at several positions close to the pubic bone in the direction of 
the DGN. The DGN is a branch of the pudendal nerve. It appears from underneath the 
pubic bone after it left Alcock’s canal (Figure 1). The DGN continues bilaterally on 
the dorsal aspect of the penis. The electrode was directed in between the base of the 
penis and the pubic bone along the suspected course of the DGN. The position of the 
electrode in relation to the pubic bone and the DGN were determined by dissections of 
the perineum.
Figure 1. Study setting and electrode insertion. Healthy volunteers: Lateral insertion site and medial insertion site of the 
needle electrode. SCI patients: A two-lumen catheter was used for bladder filling and recording of vesical pressure (Pves). 
Abdominal pressure (Pabd) and anal contractions (Panal) were recorded with a rectal and anal pressure catheter, 
respectively. The needle electrode (cathode) for stimulation of the DGN was inserted by the lateral approach 
suprapubically approximately 5-7 cm out of the midline and directed over the pubic bone towards the genital nerve for 7-9 
cm. A surface electrode was used as anode.
Healthy volunteers
A study in four male and four female healthy volunteers was conducted to determine 
the feasibility of needle electrode insertion for stimulation. Volunteers were in the 
supine position. The skin was disinfected and sterile covered. Local anesthetics of the 
skin were applied at the electrode suprapubic insertion site. A surface electrode was 
attached to the lower abdomen to serve as anode. A needle electrode (041828,
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Medtronic, Minneapolis, USA) was connected as cathode. Both a midline insertion 
and lateral-to-midline insertion of the electrode were tried (Figure 1).
Sensation to stimulation and the GAR, monitored by anal palpation or anal pressure 
measurements using a pressure balloon catheter, were used to position the electrode 
near the DGN. Electrical stimulation (Medelec Synergy, Oxford Instruments Medical, 
England) with pulse train stimulation (biphasic, rectangular, 20 Hz, pulse width 200 
^s, 0-25 mA) was used in all eight volunteers and burst stimulation (1 Hz, 5 pulses per 
burst, inter-pulse interval 4 ms, biphasic, rectangular, pulse width 200 ^s, 0-10 mA) in 
four out of eight volunteers in additional sessions. Burst stimulation was used in these
four patients, because GAR activation is more effective with burst stimulation
• 8compared to pulse train stimulation.
SCI patients
Two complete and six incomplete SCI patients with IDC at a bladder volume below 
400 ml were included to verify the feasibility of electrode insertion and effect of 
conditional stimulation on IDC. IDC was defined as an involuntary detrusor 
contraction not related to desired and voluntary started voiding. Patients stopped 
anticholinergic treatment five days prior to the study date.
A comparable study setting and method for electrode insertion as in the healthy 
volunteers were used (Figure 1). Detrusor and abdominal pressures were measured 
using water-filled catheters. An additional pressure balloon catheter was positioned 
anally to monitor anal contractions.
The bladder was emptied before needle electrode insertion. The skin of the insertion 
site was disinfected, sterile covered and locally anesthetised. The electrode was 
inserted craniolaterally to the os pubis and directed inferiomedially over the pubic 
bone towards the base of the penis or clitoris according to the lateral-to-midline 
approach in healthy volunteers (Figure 1).
The nearer the tip of the electrode to the DGN is, the lower is the threshold amplitude 
to elicit the GAR with burst stimulation. In addition, patients were asked to describe 
the site where they sensed stimulation. Two surface electrodes were used in patient 3 
on the dorsal site of the penis, because the GAR could not be evoked using the needle
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electrode. In the last four patients, surface electrodes on the dorsum of the penis or 
clitoris were used to test the presence of the GAR and the resulting anal pressure 
responses prior to needle electrode insertion.
The needle electrode was repositioned until the minimum amplitude to elicit the GAR 
was comparable to the results in the study with healthy volunteers and sensation to 
stimulation was described in the glans penis or clitoris, and until repositioning of the 
electrode did not further improve these results. The inserted electrode was kept in this 
final position manually. The lowest pulse train stimulation that resulted in sensation to 
stimulation (sensation threshold) and maximum tolerable amplitude were determined 
in this final position by stepwise amplitude changes (0.05-2 mA). The sensation 
threshold was checked in between fillings with conditional stimulation and the 
electrode was repositioned accordingly if there was a change in sensation to 
stimulation.
After needle insertion, the bladder was filled with water at room temperature at a 
filling rate of 20 ml/min. Pulse train stimulation at maximum tolerable amplitude was 
started manually at an IDC when bladder pressure increased with 10 cmH2O. 
Stimulation was switched off after an IDC was suppressed. IDC was defined as 
suppressed when detrusor and vesical pressure returned back to or decreased to near 
the baseline pressure due to conditional stimulation. After the bladder had been 
emptied partially, filling was started again with conditional stimulation at a lower 
amplitude. These stimulation sessions were repeated two to five times in each patient. 
A control cystometry was done before needle insertion and after the cystometries with 
conditional stimulation. Cystometry was stopped at maximum cystometric capacity or 
at a bladder volume of 500 ml or at a sustained IDC.
Both studies concerning healthy volunteers and SCI patients were approved by the 
local ethical committee. We certify that all applicable institutional and governmental 
regulations concerning the ethical use of human volunteers were followed during the 
course of this research.
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Results
Healthy volunteers
The volunteers’ median age was 26 years (range 20-61). The GAR was elicited by 
electrical stimulation and was detected by anal palpation or anal pressure 
measurements in four out of eight volunteers with pulse train stimulation and in four 
out of four volunteers with burst stimulation. The median minimum threshold to elicit 
a GAR with burst stimulation was 2.0 mA (range 0.75-12.0). The lateral implant 
approach was preferred as it was easier to manoeuvre the needle along the pubic bone 
and to insert the needle over a longer tract for stability. Stability is important as the 
needle is kept in place manually during stimulation in the healthy volunteers and in the 
SCI patients.
Sensation thresholds using pulse trains varied between 0.75 and 2.25 mA, and with 
burst stimulation between 0.25 and 2.00 mA. Mean maximum tolerated pulse train 
amplitude was 10 mA (range 4-25). Overall, stimulation was well tolerated and 
described in the majority as tingling or pulsing depending on the stimulation settings. 
Most male volunteers described sensation to stimulation at the penile base, along the 
left or right site of the penile shaft and eventually in the glans penis when the electrode 
was directed towards the DGN. Female volunteers located stimulation successively at 
the left or right labia and at the clitoris.
SCI patients
All eight SCI patients who were included (Table I) were incontinent. Four patients 
were on anticholinergics and one used Posterior Tibial Nerve Stimulation, which were 
all stopped before the investigation. Five patients used clean intermittent 
catheterization and three used reflex voiding. All SCI patients had DO at baseline 
cystometry with specific or non-specific bladder sensations concomitant with IDC, 
like abdominal fullness and autonomic dysfunction symptoms (e.g. flushes, 
perspiration and pilo-erections). The waveforms of IDC’s were comparable between 
baseline and control cystometry.
In five out of eight patients it was possible to insert the needle successfully using the 
electrically elicited GAR in combination with sensation to stimulation. In two patients
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only sensation to stimulation could be used. In patient 3 it was not possible to insert 
the needle electrode properly. This patient could not give feedback of electrode 
position due to absence of sensation to stimulation and the GAR could not be elicited, 
neither using a needle electrode nor surface electrodes.
Table I  Results of conditional stimulation of the DGN using a needle electrode.
Patient Age Level of Genito-anal Sensation threshold - Amplitude pulse Number of
spinal cord reflex / Sensation maximum tolerable train suppressed
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complete







3 ê 67 T5
complete
No / No N/A a a
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6 ê 33 C6
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a The needle electrode was not successfully inserted in patient 3 due to absence of sensation to stimulation and the GAR 
could not be elicited using surface and needle electrodes. 
b Not clear due to failure of equipment.
c Stimulation was repeated at the same stimulation amplitude, because stimulation had been started during the first 
stimulation cystometry at vesical pressure increase combined with bladder sensation in absence of clear detrusor pressure 
increase. During the second stimulation cystometry, stimulation was stopped during the third stimulation, which resulted 
in an immediate and clear detrusor pressure increase.
d Compliance <10 ml/cmH2O. Stimulation at maximum tolerable stimulation amplitude was repeated, because during the 
first stimulation cystometry stimulation was started too late at first IDC.
e Stimulation at 10 mA did not suppress an IDC to baseline pressures. When stimulation was started, detrusor pressure did 
not increase as fast as before and pressure increased strongly after stimulation was switched off.
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Figure 2. Examples of stimulation effect. Two examples of cystometry at baseline without stimulation, cystometry with 
DGN stimulation and control cystometry without stimulation in (a) patient 1 en (b) patient 4. Start and end of stimulation 
were marked manually at the urodynamic recordings during the study. To be perfectly clear, these manually placed 
markers have been interchanged with other markers in the figure. (a) Patient 1: Conditional pulse train stimulation at 9.0 
mA suppressed two involuntary detrusor contractions. Due to rectal pressure increases, stimulation was started when a 
vesical pressure increase concomitant with a bladder sensation occurred instead of detrusor pressure increase. These rectal 
pressure increases were also recorded during the control cystometry. Stimulation was stopped during the third suppression 
of an involuntary detrusor contraction, which resulted in an increase in detrusor pressure and urgency feeling. (b) Patient 
4: Conditional pulse stimulation at 8.0 mA suppressed three involuntary detrusor contractions. Stimulation failed to
suppress the fourth involuntary detrusor contraction completely.-------- , stimulation o n ;-------- , stimulation off; Pves,
vesical pressure; Pabd, abdominal pressure; Pdet, detrusor pressure.
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Conditional stimulation at maximum tolerable stimulation amplitude suppressed at 
least one IDC (Table I). With lower stimulation amplitudes it was still possible to 
suppress some IDC in five patients. Patients reported that the intensity of bladder 
sensations concomitant with IDC was lower during stimulation. Two examples of 
stimulation effects are shown in Figure 2.
No adverse events related to the needle electrode insertion and electrical stimulation 
occurred. Stimulation did not cause autonomic dysfunction during the test for the 
sensation threshold and maximum tolerable amplitude. Patients who had autonomic 
dysfunction symptoms reported a decrease or relieve of symptoms at IDC when 
stimulation was able to suppress that IDC. However, patients 2, 6 and 7 had leg 
spasms at the start of stimulation, which resolved in a few seconds during stimulation. 
Spasms were amplitude dependent. For example, spasms were almost absent in patient 
7 if the amplitude was decreased to 9.0 mA, which still suppressed two IDC.
Mean stimulation time for all patients was 28 s and varied between patients from a 
mean of 19 to 38 s. Patients reported that the intensity of specific and non-specific 
bladder sensations at IDC was lower during stimulation.
Discussion
Urinary incontinence is not only a social and hygienic burden for patients, but is also a 
risk factor for pressure ulcers and interferes with wound healing, especially in 
neurogenic patients with decreased mobility. It would be beneficial when incontinence 
caused by IDC could be prevented by conditional stimulation of the DGN. Patients 
will have extra time to find a suitable place to empty the bladder. In addition, when 
IDC can be suppressed, this will theoretically result in lower peak detrusor pressures 
during bladder filling and an increase in bladder capacity. Lower detrusor pressures 
will reduce the risk of renal deterioration. As this study did not assess bladder 
capacity, the exact influence on capacity could not be determined and can better be 
studied in clinical trials.
Several studies investigating electrical stimulation of the DGN have been carried out 
in patients with neurogenic DO, non-neurogenic DO, or overactive bladder syndrome
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2 7'9 11(Table II). - ; - These studies show that stimulation suppresses IDC and increases 
bladder capacity using surface or wire electrodes for continuous and conditional 
stimulation.
Table II. Electrical stimulation of the dorsal genital nerves
Author Patients Electrodes Stimulation Outcome
Goldman 21? Percutaneous Continuous 11/20 increase cystometric capacity
e t  a l  7 Urge-
incontinence
wire
Hansen 143, 2 ? Surface Conditional 53% increase in cystometric capacity,
e t  a l 4 DO (SCI) 13/15 >1 suppressed IDC
Kirkham 14tf Surface Continuous 6/14 110% increase in cystometric capacity
e t  a l 2 DO (SCI) Conditional 6/14 144% increase in cystometric capacity, 
IDC suppression
Lee 13 Surface Conditional Catheterisation volume increase from 205 to 353 ml,
e t  a l 5 DO (SCI) Catheterisation interval increase from 242 to 284 min.
Lee 73 Surface Conditional IDC suppression




Nakamura 223, 10? Surface Continuous 8/13 IDC suppression
e t  a l 10 OAB, 
13/32 DO
Opisso 413, 26? Surface Conditional, 16/17 automatic stimulation >1 IDC suppression,
e t  a l  11 Neurogenic, (33/42 automatic 14/17 patient controlled stimulation >1 IDC
42/67 conditional suppression,




Cystometric capacity increase from 186 to 254 ml
Wheeler 63 Surface Continuous 76% increase in cystometric capacity
e t  a l 3 DO (SCI)
DO, detrusor overactivity; IDC, involuntary detrusor contraction; SCI, spinal cord injury.
Regarding this literature, the present results, which met the study objectives, are 
important for two reasons. Firstly, a suitable site and a combination test, consisting of 
the electrical elicitation of the GAR and sensation to stimulation, enabled minimal 
invasive implantation of electrodes near the DGN in neurogenic patients and non- 
neurogenic volunteers. Secondly, an implanted electrode near the DGN enabled acute 
suppression of IDC in SCI patients by conditional stimulation. The effectiveness of 
conditional stimulation to suppress IDC is amplitude dependent.
Lee et al implanted wire electrodes in the midline dorsal penile shaft.9 Electrodes in 
the penile shaft have to endure penile erectile mobility and external mechanical stress, 
especially in sexually active people. To decrease the risks for electrode fracture and
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displacement, it was decided to test positioning of the needle near the DGN between 
the pubic bone and base of the penis or clitoris.
An implanted electrode can make DGN stimulation a feasible treatment for neurogenic 
and non-neurogenic DO in daily life. Goldman et al inserted a wire electrode in the 
midline of the mid-pubis in patients with intact sensation, who located sensation to 
stimulation at the clitoris with a mean sensation threshold of 4.3 mA (range 2-10 
mA). In the current study with neurogenic patients who had absent or decreased 
sensations, the combination of sensation to stimulation and elicitation of the GAR by 
DGN stimulation was successfully used in seven out of eight patients to insert the 
electrode with only a mean sensation threshold of 1.9 mA (range 0.8-3.0 mA). In 
patient 3 without a sensation to stimulation and the inability to evoke a GAR, the latter 
might be due to his complete spinal cord injury preventing the reflex to occur. On the 
other hand, it is not possible to evoke a GAR in all people.
Suppression of IDC with conditional stimulation was most effective at maximum 
tolerable amplitude (mean 12.9 mA, range 8.0-18.6 mA) and less effective at lower 
amplitudes. The stimulation amplitude of the pulse train stimulation during bladder 
filling was not related to the threshold for the GAR as the GAR could not effectively 
be evoked with pulse train stimulation in the majority of patients. Previnaire et al 
showed that continuous stimulation (bipolar surface electrodes, rectangular pulse, 5
Hz, pulse width 500 ^s) at twice the GAR threshold increases bladder capacity more
12than a stimulus at one times the threshold (mean 24.2 mA, range 14.0-40.0 mA). 
Although our study did not assess capacity and stimulation parameters were different, 
it also demonstrated the importance of the amplitude on IDC suppression.
As the positioning of the electrode was controlled manually and only checked in 
between bladder filling with conditional stimulation in case of suspicion of dislocation, 
confounding or failure by movements of the electrode cannot be ruled out. As the 
stimulation surface of the needle electrode tip was small (Figure 3), small movements 
of the electrode could have influenced stimulation effect. In addition, the timing of 
application of stimulation was controlled manually, resulting in a variation in timing 
across repeated fillings and patients.
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Figure 3. Tip of the needle electrode (Medtronic 041828, 20 G, 9 cm). The needle is insulated along the shaft and the 
electrode is only exposed at the end.
Conditional stimulation can reduce power consumption compared to continuous 
stimulation, due to a reduction in stimulation duration. Goldman et al used maximum 
tolerable amplitudes (mean 9.6 mA, range 5-25 mA) at the start of their study with 
continuous stimulation in female patients with overactive bladder symptoms, which 
were comparable to the current study amplitudes, although the exact stimulation 
parameters and wire electrode characteristics were not described. The most effective 
stimulation amplitudes at maximum tolerable level in our study using needle 
electrodes near the DGN were lower than the amplitudes at two times the GAR
threshold required for the optimal effect in the study of Prévinaire et al using surface
12electrodes.
The male healthy volunteers and male SCI patients described a clear distinction of 
feeling the stimulation in the penile shaft or glans penis. This specific localization
13might be due to the penile innervation. At the base of the penile shaft, the DGN 
consists of a single trunk on either side of the shaft. Each trunk consists of two 
populations of axons; one to innervate the penile shaft and urethra, and one to 
innervate the glans penis. It is unknown from our current study, what the clinical 
implications for the effectiveness of stimulation of these different axons are. In 
accordance with the bilateral innervations, patients sensed stimulation more to the left 
or right site of the penile shaft. This suggests that unilateral conditional DGN 
stimulation may be sufficient to suppress IDC.
Stimulation was started manually when an IDC was observed from pressure recordings 
using indwelling catheters, which is not a viable method for application in daily life.
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Patient controlled suppression of IDC provides additional time for patients to empty 
their bladder and therefore a possibility to stay continent.11 Patient controlled 
conditional stimulation seems not to be satisfactory in daily life in SCI patients as the 
detection rate of IDC by bladder sensations is too low.14 Bladder activity monitoring in 
animals and humans has been reported, like external urethral or anal sphincter 
electromyography, sacral root electroneurography and bladder pressure monitoring by
15 18sensor implantation. - Up to now, no suitable device is available for clinical 
application. Further studies for reliable IDC sensors are required to make a fully 
implanted closed loop conditional stimulator possible.
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Patients with overactive bladder syndrome and detrusor overactivity often state that 
the warning time between urge to void and voiding itself is too short to reach the toilet 
in time to prevent incontinence. Continuous electrical stimulation of the dorsal genital 
nerves, comprising the dorsal nerve of the penis and clitoris, suppresses involuntary 
detrusor contractions and increases bladder capacity. Beyond a certain capacity, 
continuous stimulation will not be effective anymore if a constant amplitude is used. 
An increase to a higher stimulation amplitude when an involuntary detrusor 
contraction occurs during continuous stimulation, might theoretically result in 
additional suppression of the involuntary contractions and consequently increase 
warning time. The present study shows that the role of continuous stimulation at low 
amplitude is questionable, because stimulation at low amplitude decreased the bladder 
volume at which the first involuntary detrusor contraction occurred in patients with 
detrusor overactivity. However, bladder capacity could not be determined accurately. 
Conditional increases from low to high amplitude were able to suppress involuntary 
detrusor contractions completely in four out of seven patients. Moreover, high detrusor 
pressures were prevented in another patient. This resulted in an increase in maximum 
cystometric capacity and warning time, because micturition could be postponed and 
incontinence prevented.
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Introduction
The overactive bladder syndrome (OAB) comprises symptoms of urgency with or 
without urinary incontinence, and usually frequency and nycturia.1 Patients often state 
that the warning time between urge to void and voiding itself is too short and that they 
do not reach the toilet in time to prevent incontinence. An increase in warning time 
before incontinence occurs and a decrease in urgency intensity, would improve quality 
of life.
Several studies have been done to investigate the effect of electrical stimulation of the 
dorsal genital nerves (DGN), comprising the dorsal nerve of the penis and clitoris, on
2 7OAB. " These studies included patients with neurogenic detrusor overactivity, non- 
neurogenic detrusor overactivity and OAB. Electrical stimulation of the DGN aims to 
suppress involuntary detrusor contractions (IDC) and to increase bladder capacity in 
patients with an OAB. Most studies with stimulation of the DGN are experimental and
3 7clinical studies are lacking. -
It is possible to stimulate the DGN using surface electrodes attached to the skin at the
• * 3 7dorsum of the penis or around the clitoris. - However, these self-adhering surface 
electrodes are not suitable for long term use, because of electrode fixation and 
hygienic problems. Therefore, implanted electrodes seem to be more practical. The 
DGN has easily accessible sites to implant electrodes for stimulation of these nerves.
Goldman et al the feasibility of continuous stimulation using a percutaneous implanted
• • • 2 electrode near the DGN in females with urge-incontinence.
Not only continuous stimulation, but also conditional stimulation of the DGN also
4*8suppresses IDC’s and increases bladder capacity with comparable results. ; 
Conditional stimulation is a method in which stimulation is started at the moment that 
IDC’s or OAB symptoms occur. Practically, stimulation starts when intravesical 
pressure begins to rise at the onset of an IDC or when OAB symptoms occur. 
Stimulation is turned off when intravesical pressure falls under a predefined threshold, 
OAB symptoms have declined or after a pre-set stimulation time. An important benefit 
is the extra time patients have to get to the toilet, because they can postpone the 
moment of voiding. Other benefits could be reduction of power consumption,
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prolonged lifetime of the electrode contacts and prevention of habituation of the reflex 
loops.
Conditional stimulation can be applied in two different ways. Ideally closed loop 
conditional stimulation would be preferred. A sensor picks up undesired intravesical or 
detrusor pressure rises of IDC’s and stimulation will be activated automatically. 
Stimulation will be switched off automatically when the pressure falls under a 
threshold or after a pre-set stimulation time. So far no sensors are available for clinical 
use to pick up the detrusor pressure rises of IDC’s. An alternative is so-called patient 
controlled stimulation, in which patients activate the stimulator themselves.69 The 
patient activates the stimulator when urge or urgency occur.
Beyond a certain capacity, continuous stimulation will not be effective anymore if a 
constant amplitude is used and IDC’s will occur. This will result in OAB complaints at 
a higher bladder capacity compared to no stimulation, but the patient will only have a 
short warning time from the first contraction till incontinence.
The effect of continuous stimulation on capacity depends on the stimulation 
amplitude.1011 Previnaire et al reported that stimulation at twice the threshold 
amplitude to evoke the genito-anal reflex (GAR) resulted in a significant increase in 
capacity compared to stimulation at the GAR threshold amplitude.11 Changing the 
amplitude to a higher level when IDC’s occur might theoretically result in additional 
suppressions of IDC’s and an increase in warning time. This implies a slightly 
different definition of conditional stimulation compared to the description in the 
previous paragraph: a conditional increase in amplitude from low to high at the onset 
of an IDC.
The primary objective of the current study was to determine whether it is possible to 
suppress IDC’s and relieve OAB symptoms in patients with OAB and detrusor 
overactivity by electrical stimulation of the DGN using a needle electrode without 
causing discomfort. Electrical stimulation was applied continuously at low amplitude 
and increased to high amplitude when an IDC was observed urodynamically. 
Secondarily, the effect on bladder capacity of stimulation at low amplitude was 
determined.
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Methods
Patients
This study included patients with OAB who had neurogenic or idiopathic detrusor 
overactivity at a bladder capacity below 500 ml as registered during recent 
urodynamics. Patients with predominantly stress urinary incontinence, peripheral 
neuropathies, urinary tract infections or pregnancy were excluded. The study was 
approved by the local ethical committee. Written informed consent was obtained of all 
participants.
Study design
Anticholinergics were stopped five days prior to the investigation date and patients 
filled out an 48 hr voiding diary. Three cystometries were done at a filling rate of 20 
ml/min with water at room temperature. The first cystometry (baseline cystometry) 
and third cystometry (control cystometry) were used as controls. The second 
cystometry comprised simultaneous electrical stimulation of the DGN using a needle 
electrode (stimulation cystometry). Control cystometries were stopped at maximum 
cystometric capacity or at a bladder volume of 500 ml or at a sustained IDC.
Preparation
Patients were in the supine position. Vesical (Pves) and abdominal (Pabd) pressures were 
measured using transurethrally and transanally inserted, water-filled catheters to 
determine detrusor activity (Pdet). An IDC was defined as an involuntary detrusor 
contraction not related to desired and voluntary started voiding. An additional anal 
pressure catheter is inserted for anal sphincter pressure measurement (Panal) to monitor 
the genito-anal reflex (GAR). EMG electrodes which recorded stimulation artefact 
signal for registration of stimulation timing were attacted to the skin on the lateral site 
of the proximal thigh.
Electrode insertion
The bladder was emptied before needle electrode insertion. A surface electrode was 
attached to the lower abdomen to serve as anode. The needle electrode (041828,
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Medtronic, Minneapolis, USA) served as cathode. The skin of the insertion site was 
disinfected, sterile covered and locally anesthetised. The electrode was inserted 
craniolaterally to the os pubis and directed inferiomedially over the pubic bone 
towards the base of the penis or clitoris (Figure 1) as described elsewhere.10 
Sensation to stimulation and the GAR, monitored by anal pressure responses, were 
used to position the electrode near the DGN. Burst stimulation was used to evoke the 
GAR (1 Hz, 5 pulses per burst, inter-pulse interval 4 ms, biphasic, rectangular, pulse
width 200 ^s, 0-10 mA), because GAR activation is more effective with burst
12stimulation compared to pulse train stimulation. Surface electrodes on the dorsum of 
the penis or clitoris were used to test the presence of the GAR and the anal pressure 
responses to stimulation prior to needle electrode insertion. The nearer the tip of the 
electrode to the DGN is, the lower the threshold amplitude to elicit the GAR with burst 
stimulation. In addition, patients were asked to describe the site where they sensed the 
stimulation. The needle electrode was repositioned until the sensation to stimulation 
was described in the glans penis or clitoris, and the minimum amplitude that resulted 
in sensation to stimulation (sensation threshold) and the minimum amplitude to elicit 
the GAR did not further decrease.
Figure 1. Study setting. A two-lumen catheter was used for bladder filling and recording of vesical pressure (Pves). 
Abdominal pressure (Pabd) and anal contractions (Panal) were recorded with a rectal and anal pressure catheter, 
respectively. The needle electrode (cathode) for stimulation of the dorsal genital nerve (DGN) was inserted suprapubically 
approximately 5-7 cm out of the midline and directed over the pubic bone towards the genital nerve for 7-9 cm. A surface 
electrode was used as anode.
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The inserted electrode was kept manually in this final position. The sensation 
threshold and maximum tolerable amplitude were determined in this final position by 
stepwise amplitude changes (0.05-2 mA). The sensation of stimulation, the sensation 
threshold and the threshold to elicit the GAR were checked in between fillings when 
multiple stimulation cystometries were done in one patient. The electrode was 
repositioned accordingly if there was a change in one of these parameters.
Stimulation cystometry
Electrical stimulation of the DGN was applied concomitant with the second 
cystometry. Stimulation cystometry was started with continuous stimulation at sub­
maximum tolerable stimulation amplitude (frequency 20 Hz, biphasic, rectangular, 
pulse width 200 ^s, amplitude 0-20 mA), which will be referred to as low amplitude. 
The low amplitude was defined as the amplitude at which patients could clearly feel 
stimulation. If patients did not have sensation to stimulation, the low amplitude was set 
at about half the maximum amplitude (±10 mA). The amplitude was increased to high 
amplitude at maximum tolerable stimulation amplitude (frequency 20 Hz, biphasic, 
rectangular, pulse width 200 ^s, amplitude 0-20 mA) when an IDC with a detrusor or 
vesical pressure rise of at least 10 cmH2O was observed. IDC was defined as 
suppressed when detrusor and vesical pressure returned back to or decreased to near 
the baseline pressure due to the conditional increase in amplitude. When an IDC was 
suppressed the amplitude was reduced back to low amplitude until another IDC was 
recorded. The conditional changes between low and high amplitude were repeated 
until maximum cystometric capacity was reached.
Results
Seven males and one female were included of whom six had neurogenic detrusor 
overactivity and two had non-neurogenic detrusor overactivity (Table I). Patient 8 was 
excluded after the baseline cystometry, because IDC’s occurred at a bladder volume 
above 500 ml. Patient 7 with spinal cord injury was excluded during the first session 
for the same reason. This patient reported a full rectum, which might have suppressed
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13detrusor overactivity. Therefore, the study was repeated with an empty rectum in this 
patient a few months later.
At least one IDC (range 1-3) could be completely suppressed in four out of seven 
patients (Table II) using low amplitudes of 1.0-12.0 mA and high amplitudes of 2.0­
20.0 mA. In two of these patients the detrusor pressure started to rise immediately after 
stimulation was set back to low amplitude. During suppression of an IDC at high 
amplitude, patients mentioned a decrease in urgency. Examples of stimulation effects 
are shown in Figure 2 and 3. All four patients had detrusor pressures below 40 cmH2O 
during control cystometries.
Table I  Patient characteristics.
Patient Medical history Complaints Frequency-volume chart Treatment
1 $ 59 years Stamey suspension, Otis 
urethrotomy, Turner Warwick 
bladder neck incision, 
proctocollectomia, ileoanal 
reservoir, sling, herniated 
nucleus pulposus surgery, 







Daytime frequency 7x 
Night time frequency 4x 
Incontinence +
Anticholinergics
2 S  56 years SCI Th 12 AIS C Incontinence Intermittent catheterisation 2x/day: 
mean volume 225 ml 
Incontinence 200-400 ml/day
Anticholinergics
3 S  42 years SCI C 4-5 AIS A Incontinence Intermittent catheterisation 2-3x/day: 
mean volume 258 ml 
Incontinence 600-1200 ml/day
4 $ 55 years MS Incontinence Incontinence 1530-2530 ml/day Anticholinergics
5 S  31 years SCI C5 AIS A Incontinence Intermittent catheterisation 1x/day: 
mean volume 100-300 ml 
Incontinence 1420-1960 ml/day
6 S  36 years SCI C5 AIS A Incontinence Reflex voiding by suprapubic tapping, 
intermittent catheterisation 2x/day 
Incontinence +
Anticholinergics
7 S  43 years SCI C6 AIS A Incontinence Reflex voiding by suprapubic tapping 
2x/day
Incontinence +
8 S  61 years Vasectomy Frequency Daytime frequency 8-9x 
Night time frequency 2x 
Incontinence -
Anticholinergics
AIS A-E, American spinal injury association Impairment Scale; MS, multiple sclerosis; SCI, spinal cord injury.
Patient 1 (Figure 2) had OAB with urge-incontinence. Her medical history included 
extensive surgery, because of stress urinary incontinence, urethral stenosis, slow 
transit bowel, hernia nucleus pulposis and detrusor overactivity. Baseline and control 
cystometry both showed an end-filling IDC. During stimulation cystometry, 
conditional increases to high amplitude during an IDC were able to suppress one IDC
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completely. Abdominal pressure changes were noticed during bladder filling and 
stimulation amplitude changes, which were not reflected in vesical pressure. Cough 
tests just before the start of cystometry showed equal pressure rises in vesical and 
abdominal pressures with a consequently stable detrusor pressure. Therefore, vesical 
pressure was most appropriate to study the stimulation effects on IDC’s instead of 
detrusor pressure. The second IDC occurred immediately after the amplitude was 
reduced back to low. Conditional increase to high amplitude was not able to suppress 
this second IDC.
Patient 2 (Figure 3) has an incomplete spinal cord injury at thoracic 12 after a 
laminectomy for a hernia nucleus pulposis. Baseline and control cystometry both 
showed an end-filling IDC. During stimulation cystometry, conditional increases to 
high amplitude during IDC’s were able to suppress three IDC’s. At the fourth IDC, the 
amplitude was not increased and remained low, which resulted in a constant IDC with 
leakage.
Table II. Effect of stimulation on involuntary detrusor contractions.
Patient GAR Sensation Maximum Amplitude Amplitude Results
threshold tolerable continuous conditional
(mA) amplitude stimulation stimulation
(mA) (mA) (mA)
1 + 0.5 2.0 1.0 2.0 One suppression of an IDC.
Increase in Pdet after amplitude decrease.
2 + 1.0 10.0 2.0 9.0 Three suppressions of IDC.
During the second suppressed IDC 7 drops 
incontinence.
During the third IDC small amount of incontinence. 
Complete incontinence at fourth IDC (no conditional 
increase in stimulation amplitude).
3 + - - 12 20.0 One suppression of an IDC.
12 20.0 No suppression of IDC.
4 - 2.0 (+/-) 20.0 5.0 20.0 Two suppressions of IDC.
Increase in Pdet after amplitude decease at second IDC 
suppression.
7.5 20.0 Two suppressions of IDC.
Increase in Pdet after amplitude decrease at second IDC 
suppression.
5 + - - 8.0 15.0 No suppression of IDC.
8.0 20.0 No suppression of IDC.
No increase in Pdet during stimulation; increase in Pdet 
when stimulation is stopped.
6 - 8.9 (+/-) 20.0 10.0 18.0 No suppression of IDC.
No effect of start/stop stimulation on Pdet.
9.0 20.0 No suppression of IDC.
No effect of start/stop stimulation on Pdet.
7 - a - - 7.0 15.0 No suppression of IDC. b
a Possibly defect of equipment.
b Up 500 ml no DO. Stimulation was stopped after 500 ml. At 531 ml an IDC occurred at which stimulation was started at 
high amplitude. No obvious suppression.
GAR, genito-anal reflex; IDC, involuntary detrusor contraction.
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Figure 2. Example of stimulation effects in patient 1. Baseline and control cystometry both show an end filling detrusor 
overactivity, which was observed by an increase in vesical and detrusor pressure. Stimulation at low amplitude (L) of 1.0 
mA during stimulation cystometry caused an artefact of the EMG signal of about 160 ^V. When stimulation was 
increased to high amplitude (H) of 2.0 mA, the EMG signal increased to about 300 ^V. The first involuntary contraction 
was suppressed by the high amplitude. Vesical pressure immediately increased after stimulation was reduced to low 
amplitude. Pves, vesical pressure; Pabd, abdominal pressure; Pdet, detrusor pressure (= Pves -  Pabd); EMG, artefact EMG 
signal that reflects electrical stimulation; L, low stimulation amplitude; H, high stimulation amplitude.
cmH;(
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Figure 3. Example of stimulation effects in patient 2. Four IDC’s were observed by an increase in detrusor and vesical 
pressure. Stimulation at low amplitude (L) of 2.0 mA during stimulation cystometry caused an artefact of the EMG signal 
of about 60 ^V. When stimulation was increased to high amplitude (H) of 9.0 mA, the EMG signal increased to about 250 
^V. High amplitude was able to suppress three involuntary detrusor contractions. When stimulation was not increased at 
the fourth contraction, detrusor pressure remained high. Pves, vesical pressure; Pabd, abdominal pressure; Pdet, detrusor 
pressure (= Pves -  Pabd); EMG, artefact EMG signal that reflects electrical stimulation; L, low stimulation amplitude; H, 
high stimulation amplitude.
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All three patients in whom conditional amplitude increases failed to suppress IDC’s 
completely using high amplitudes of 15.0-20.0 mA had complete spinal cord injury 
with maximum detrusor pressures over 40 cmH2O during IDC’s. In one of the three 
patients (patient 5), complete suppression of an IDC to baseline pressure at the start of 
cystometry was not possible. However, in this patient vesical pressure remained stable 
with stimulation at high amplitude during an IDC (Figure 4). As in patient 1, vesical 
pressure was preferred instead of detrusor pressure, because abdominal pressure 
changes were not reflected in vesical pressure during IDC and stimulation. When the 
amplitude was reduced to low amplitude after the first partial suppression of an IDC, 
vesical pressure immediately increased.
Baseline S tim ulation Contro l
l : : : : :h : :l :h : l
Figure 4. Example of stimulation effects in patient 5. Baseline and control cystometry both show an end filling detrusor 
overactivity, which was observed by an increase in vesical and detrusor pressure. When stimulation was increased to high 
amplitude (H) of 20.0 mA a partial suppression of an involuntary detrusor contraction was observed in stabilisation of 
vesical pressure. When the amplitude was reduced to low amplitude (L) of 8.0 mA vesical pressure immediately 
increased. Pves, vesical pressure; Pabd, abdominal pressure; Pdet, detrusor pressure (= Pves -  Pabd); EMG, artefact EMG 
signal that reflects electrical stimulation; L, low stimulation amplitude; H, high stimulation amplitude.
The effect of stimulation on cystometric capacity are shown in Table III. The median 
volume at which the first IDC occurred was lower during stimulation cystometry (201 
ml, range 25-531) compared to baseline and control cystometry (253 ml, range 65­
550). The median maximum cystometric capacity increased during stimulation 
cystometry (271 ml, range 142-550) compared to baseline cystometry (248 ml, range
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91-459), but did not increase compared to control cystometry (289 ml, range 86-550). 
The difference between the median bladder volume at first IDC and maximum 
cystometric capacity was higher (38 ml, range 19-117) compared to no stimulation (17 
ml, range 4-74), even if compared to control cystometry alone (18 ml, range 4-27).
Table III. Effect of stimulation on cystometric capacity.
Patient Bladder volume at first IDC (ml) Maximum cystometric capacity 
(ml)
Difference bladder volume at first 





























1 245 200 288 252 220 293 7 20 5
2 207 179 82 212 274 86 5 95 4
3 65 140 179 91 209 201 26 69 22
201 249 48
4 263 262 260 337 296 278 74 34 17
337 440 63
5 446 197 443 459 217 462 13 20 19
343 367 24
6 146 25 262 155 142 289 9 117 27
233 271 38
7 229 531 >550 a 248 550 >550 a 19 19 a
Median 229 201 262 248 271 289 16 38 18
Mean 229 241 295 251 294 308 22 50 16
Range 65-446 25-531 82-550 91-459 142-550 86-550 5-74 19-117 4-27
a Up 500 ml no detrusor overactivity (DO). Stimulation was stopped after 500 ml. At 531 ml an involuntary detrusor 
contraction (IDC) occurred at which stimulation was started at high amplitude. No obvious suppression. Control 
cystometry was stopped at 550 ml, because of no DO.
If only the results of patients who had a suppression of IDC’s during stimulation 
cystometry were taken into account, stimulation resulted in an increase in median 
maximum cystometric capacity (274 ml, range 209-440) and median difference 
between the bladder volume at the first IDC and maximum cystometric capacity (63 
ml, range 20-95) compared to baseline and control cystometry (maximum cystometric 
capacity 232 ml, range 86-337; difference between the bladder volume at the first IDC 
and maximum cystometric capacity 12 ml, range 4-74). The results of the baseline and 
control cystometry were comparable to each other with a median bladder volume at 
first IDC of 226 ml (range 65-263) versus 220 ml (range 82-288) and maximum 
cystometric capacity of 232 ml (range 91-337) versus 240 ml (range 86-293).
At one month follow-up no serious adverse events due to electrode insertion or 
electrical stimulation occurred.
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Discussion
Studies investigating the effect of electrical stimulation of the DGN on bladder 
function have been carried out in patients with neurogenic detrusor overactivity, non-
2 7'9neurogenic detrusor overactivity and OAB. - ; These studies show that stimulation 
suppresses IDC’s and increases bladder capacity using surface or wire electrodes for 
continuous and conditional stimulation. In a previous study, we were able to approach 
the DGN with a needle electrode and suppress IDC’s in neurogenic patients using 
conditional stimulation concomitant with these IDC’s.10 No stimulation was applied in 
between IDC’s. In the current study, continuous stimulation was used at low amplitude 
in combination with conditional increases to high amplitude when IDC’s occurred. It 
was hypothesised that a high amplitude during IDC’s might result in additional 
suppressions of IDC’s and an increase in warning time.
Wei et al reported a study in which continuous stimulation and conditional stimulation 
of the pudendal nerve in anesthetised male dogs were compared.14 Continuous 
stimulation was applied at a low stimulation amplitude at the threshold level that 
elicited an anal EMG response. In one group of filling cystometries, the amplitude was 
increased when an IDC occurred. This high amplitude was set at the threshold of 
generating maximum urethral pressures in combination with the most optimal 
frequency for the urethral pressure. Conditional change of stimulation amplitude and 
frequency resulted in a higher urethral pressure, bladder capacity and warning time. 
The increase in warning time could be due to an increase in urethral pressure by 
stimulation of pudendal nerve efferents, but also because of suppression of IDC’s by 
stimulating pudendal nerve afferents.
Conditional increases to high amplitude concomitant with IDC’s during continuous 
stimulation enabled suppression of at least one IDC in four out of seven patients and 
lower detrusor pressures without incontinence in another patient. Micturition can be 
postponed in this way to provide extra time after the onset of an IDC to find a proper 
place for micturition or catheterization to prevent incontinence. The warning time 
during stimulation cystometry was higher than during cystometry without conditional 
amplitude increases as the difference between bladder volume of first IDC and 
maximum cystometric capacity is higher. A filling rate of 20 ml/min during
115
Chapter 8
stimulation cystometry resulted in a median increase in difference between the median 
bladder volume at first IDC and maximum cystometric capacity of 21 ml compared to 
baseline and control cystometry. An increase in warning time of 63 s was calculated 
(21 ml / 20 ml per min). Patients in whom the conditional amplitude increases were 
effective to suppress IDC’s had an increase of the difference in bladder volume of 51 
ml, which results in an increase in warning time of 153 s (51 ml / 20 ml per min). As 
the natural filling rate is much lower than the filling rate of 20 ml/min that was used in 
this study, the increase in warning time will be higher in daily life.
No increase in the median volume at which the first IDC occurred was found 
compared to baseline cystometry using stimulation. Probably, the applied amplitude 
was too low to be effective. The volume at which the first IDC occurred even 
decreased during continuous stimulation, which is in contrast with other studies using
2 5'7continuous stimulation of the DGN. - ; However, the present study setting was not 
optimal to determine bladder capacities accurately. Firstly, patients were in the supine 
position. Secondly, the bladder was emptied before and after each cystometry through 
the filling port of the catheter for urodynamics. As this catheter was fixated to the 
body, no movement of the catheter was allowed. As a result, catheterisation could not 
be done properly and varying differences between the filled volume and residual urine 
were observed. Volumes should therefore be interpreted with caution.
The maximum cystometric capacity increased consecutively during the baseline, 
stimulation and control cystometry if all included patients were taken into account. 
From this, it might be concluded that the increase in maximum cystometric capacity 
between baseline cystometry and stimulation cystometry is not an effect of the 
stimulation, but a result of repetition of bladder filling. However, the increase in 
maximum cystometric capacity in consecutive cystometries is not apparent anymore if 
only the cystometries are considered of patients in whom conditional increases to high 
amplitude were effective to suppress IDC’s. In these latter patients, the maximum 
cystometric capacity was higher in the stimulation cystometries compared to baseline 
as well as control cystometries. The capacities between baseline and control 
cystometries were comparable. Therefore, it can be concluded that conditional
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amplitude increases are effective to suppress IDC’s and increase the maximum 
cystometric capacity and warning time.
Five out of seven patients had a decreased sensation to stimulation or no sensation at 
all. This might be caused by the high number of neurogenic patients with spinal cord 
injury or MS. Decreased sensation to stimulation complicated electrode positioning, 
especially in combination with an absent GAR on stimulation. Therefore, results could 
improve in patients with idiopathic detrusor overactivity, due to better feedback during 
electrode positioning. Goldman et al studied DGN stimulation in 21 non-neurogenic 
females with urge incontinence. Patients with spinal cord injury were excluded. 
Bladder cystometry at non-physiological filling rate without and with dorsal clitoral 
nerve stimulation using percutaneous electrodes was performed. A coiled wire 
electrode with a barbed tip was used. Patients were sent home with the electrode in situ 
for seven days. Stimulation was applied continuously. An increase in volume at first 
desire (10 of 20 patients), strong desire (16 of 20 patients) and maximum volume (11 
of 20 patients) with stimulation was seen during cystometry at non-physiological 
filling rate. Nineteen of the 21 patients completed the week of stimulation at home. Of 
these patients, 79% reported a reduction in incontinence periods per day and 47% 
experienced a >50% reduction (mean reduction in this group was 89%). The number 
of pads per day decreased in 88%, with 47% being completely dry.
As the positioning of the electrode was controlled manually and only checked in 
between bladder filling with conditional stimulation in case of suspicion of dislocation, 
confounding or failure by movements of the electrode cannot be ruled out. As the 
stimulation surface of the needle electrode tip was small, little movements of the 
electrode could have influenced stimulation effect. In addition, the timing of 
application of stimulation was controlled manually, resulting in a variation in timing 
across repeated fillings and patients.
Stimulation was started manually when an IDC was observed from pressure recordings 
using indwelling catheters, which is not a viable method for application in daily life. 
Patient controlled suppression of IDC’s provides additional time for patients to empty 
their bladder and therefore a possibility to stay continent.6 To develop a closed loop 
system, a sensor for continuous monitoring of the bladder activity is required. Bladder
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activity monitoring in animals and humans has been reported, like external urethral or 
anal sphincter electromyography, sacral root electroneurography and bladder pressure
15 18monitoring by sensor implantation. - Up to now, no suitable device is available for 
clinical application.
Conclusion
The role of continuous stimulation at low amplitude is questionable. Continuous 
stimulation of the dorsal genital nerves at low amplitude using a needle electrode 
decreased the bladder volume at which the first involuntary detrusor contraction 
occurred in patients with detrusor overactivity. However, bladder capacity could not 
be determined accurately as a consequence of the study design. Conditional increases 
from low to high amplitude were able to suppress involuntary detrusor contractions 
completely in four out of seven patients. Moreover, high detrusor pressures were 
prevented in another patient. This resulted an increase in maximum cystometric 
capacity and warning time, because micturition could be postponed and incontinence 
prevented.
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Abstract
Aims. Conditional stimulation of dorsal genital nerves suppresses undesired detrusor 
contractions (UDC) and consequently increases bladder capacity and prevents 
incontinence. No clinically applicable sensor exists for reliable bladder activity 
monitoring as a trigger for conditional stimulation. Primary objective of this study was 
to determine whether bladder sensation concomitant with UDC may be used for spinal 
cord injury (SCI) patients to trigger neurostimulation in daily life.
Methods. Nineteen male and 7 female SCI patients suspected of detrusor overactivity 
(DO) underwent conventional and 6-hour ambulatory urodynamics. Patients were 
instructed to do normal daily activities and to activate event buttons of the ambulatory 
recorder to mark events: physical activity, bladder sensation, micturition or 
intermittent catheterisation and urinary incontinence. Detection rate was defined as the 
number of recorded bladder sensation divided by the total number of recorded UDC 
during ambulatory urodynamics.
Results. Bladder sensation was reported by 73% of patients in daily life. Only 41% of 
patients had analysable bladder sensation concomitant with UDC during ambulatory 
urodynamics. For ambulatory and conventional urodynamics, mean detection rates 
were 23% and 72%, respectively, with mean recording delays of 57 s and 16 s after 
UDC onset, respectively.
Conclusions. Bladder sensation only occurs in a small group of SCI patients combined 
with a rather low detection rate and long reaction time. Therefore, bladder sensation as 
a trigger for conditional stimulation does not seem to be suitable for SCI patients with 
DO. Reliable techniques for chronic bladder activity monitoring are a prerequisite for 
successful clinical application of conditional stimulation.
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Introduction
Neurogenic detrusor overactivity (DO) and/or detrusor external sphincter dyssynergia 
is present in 94.9%, 14.3% and 69.7% of patients with suprasacral, sacral and 
combined suprasacral and sacral spinal cord injury, respectively.1 The primary aim of 
DO treatment is preservation of renal function by creating a low-pressure reservoir. 
Conservative treatment consists of anticholinergics with or without clean intermittent
9 4catheterisation. - Surgical interventions for patients who are refractory to conservative 
treatment are bladder augmentation, continuous neurostimulation (Interstim) and 
Brindley procedure, which combines sacral anterior root stimulation for bladder 
emptying with a dorsal rhizotomy to treat DO.5-9 Botulinum toxin detrusor injection is 
increasingly used for DO despite impermanent effects and absence of registration as an 
indication for DO.10 Another treatment option would be conditional 
neurostimulation.
Conditional neurostimulation only applies stimulation if an undesired detrusor 
contraction (UDC) occurs during the filling phase, which requires a reliable sensor. 
Acute conditional stimulation of the dorsal genital nerves using surface electrodes at 
the dorsum of the penis and clitoris suppresses UDC and consequently increases 
bladder capacity and may prevent incontinence.11-15 UDC is accompanied by an 
increase in detrusor pressure. However, due to the need for indwelling pressure 
catheters for the vesical and abdominal pressure measurement, automatic conditional 
stimulation using detrusor pressure increases as a trigger is not suitable for chronic 
application in daily life. An alternative method to detect UDC is needed.
Besides studies with indwelling pressure catheters, other bladder activity monitoring 
methods in animals and humans have been reported: external urethral or anal sphincter 
electromyography, sacral root elektroneurography and bladder pressure monitoring by 
sensor implantation.16-19 However, no suitable clinically applicable device is available 
as a trigger for stimulation.
An alternative to automatic conditional stimulation is open-loop conditional 
stimulation controlled by the patient, which requires presence of bladder sensation
concomitant with UDC to start stimulation. Spinal cord injury patients with DO sense
20-21bladder-filling sensations and UDC to some extent. ; Bladder sensation in these
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patients can be specific or non-specific. Non-specific bladder sensation are abdominal 
fullness, tingling feelings or vegetative symptoms like flushes, perspiration and pilo- 
erections.
The primary objective of this study was to determine whether bladder sensation that 
concomitantly occurs with UDC can be used by spinal cord injury patients as a trigger 
for conditional neurostimulation in daily life.
Materials and Methods
Patients
All spinal cord injury patients who visited the Department of Rehabilitation Medicine 
(St. Maartenskliniek Nijmegen, the Netherlands) and the Department of Urology 
(Radboud University Nijmegen Medical Centre, the Netherlands) from January 2008 
till September 2008 were eligible for inclusion. Both complete and incomplete spinal 
cord injury patients were included if conventional urodynamics were indicated in their 
regular health care and if they were suspected of DO because of their level of spinal 
cord injury or a micturition pattern indicative for DO, especially urinary incontinence. 
Patients were required to be able to manage the marker buttons of the portable device 
for ambulatory urodynamics. The presence of bladder sensations was not a prerequisite 
for participation. The study was approved by the local ethical committee and written 
informed consent was obtained from the patients.
Protocol
Included patients were asked if bladder sensation appeared during daily life. Patients 
underwent both conventional and ambulatory urodynamics on the same day. 
Anticholinergics were stopped at least three days prior to urodynamics except in 
patients who still had overactive bladder symptoms despite anticholinergics or refused 
to stop medication temporarily.
The International Continence Society (ISC) defined DO as a urodynamic observation 
characterised by involuntary detrusor contractions during the filling phase that may be
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22spontaneous or provoked. DO was used in this study as a clinical diagnosis based on 
the results of urodynamics according to this ICS definition.
To describe a single UDC, UDC was defined as a detrusor pressure (Pdet) rise of at 
least 10 cmH2O, which was not related to desired micturition. This threshold was used 
to avoid false-positive UDC recording due to catheter artefacts. Detrusor pressure was 
calculated by subtracting abdominal pressure (Pabd) from vesical pressure (Pves) 
recorded by transanal and transurethral catheters respectively (Figure 1).
A) B)
Figure 1. A) Transurethral and transanal pressure catheters for ambulatory urodynamics with event recording. Events 
were recorded by pushing the event buttons on top of the portable recorder for ambulatory urodynamics. B) An example 
of recorded data. Pves, vesical pressure; Pabd, abdominal pressure; Pdet, detrusor pressure; DC: undesired detrusor 
contraction. (*) Recording of events ‘bladder sensation’ and ‘urinary incontinence’, respectively.
First, conventional urodynamics (Medical Measurement Systems, Enschede, the 
Netherlands) were started after the bladder had been emptied by catheterisation. 
Cystometry with water-filled catheters or air-charged catheters for pressure recording 
was applied at a filling rate of 20 ml/min with sterile saline at room temperature in 
supine or upright position, depending on the mobility of the patient. Bladder filling
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was stopped at maximum cystometric capacity or a bladder capacity of 500 ml or a 
sustained UDC. Patients were asked to report all bladder sensations, which were 
marked on the urodynamics recording by selecting the marker button on the computer 
screen.
Next, a portable recorder for 6-hour ambulatory urodynamics (Luna, Medical 
Measurement Systems, Enschede, the Netherlands) was connected to the air-charged 
catheters or the water-filled catheters were changed for microtip catheters directly after 
conventional urodynamics (Figure 1). Catheters were carefully fixed and patients were 
instructed to do normal daily activities and to use the event buttons on the ambulatory 
recorder to mark events: both specific and non-specific bladder sensation, micturition 
or intermittent catheterisation, urinary incontinence and physical activities like moving 
around in a wheelchair, walking and sports. Additionally, an event diary was filled out 
by the patients to compare with the recorded events and to correct for wrongly 
recorded events at the end of ambulatory urodynamics.
Analysis
The detection rate was defined as the percentage of recorded bladder sensation divided 
by the total number of UDC within one patient during conventional and ambulatory 
urodynamics, respectively. The detection rate and the time delay between the onset of 
UDC and the recording of a bladder sensation were analysed in patients with DO as 
well as bladder sensation during conventional and ambulatory urodynamics.
Results
Informed consent for both conventional and ambulatory urodynamics was obtained 
from 19 male and 7 female spinal cord injury patients with a median age of 41.5 years 
(range 21 -  72 years). Twenty-three of 26 patients finished the study according to the 
protocol. Three patients did not stick to the protocol (Table I). One of these three 
patients did not have conventional urodynamics. The other two patients underwent 
conventional urodynamics at a filling rate of 50 ml/min and one of these last two
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patients also had his conventional urodynamics and ambulatory urodynamics at 
different days.
Prevalences of UDC, DO and bladder sensation during daily life, conventional 
urodynamics and ambulatory urodynamics (Table II) have been summarised in Figure 
2. Nineteen patients (73%) reported presence of bladder sensation during daily life. 
Table I shows patient characteristics and the results of conventional and ambulatory 
urodynamics.
During conventional urodynamics 76% of 25 patients reported bladder sensation and 
DO was diagnosed in 60% of those 25 patients. Eleven patients with DO (73%) had 
bladder sensation concomitant with UDC with a detection rate of 72%. If all patients 
with DO were taken into account, the detection rate decreased to 48%. All recorded 
bladder sensations were recorded after the onset of the UDC with a mean time delay of 
16 s.
Nine patients (41%) with DO had analysable bladder sensation concomitant with UDC 
during ambulatory urodynamics. Three patients with bladder sensation during 
ambulatory urodynamics were not suitable for analysis; patients 3 and 11 only had 
sensations of a full bladder, which were not related to UDC, and patient 7 had 
continuous bladder sensation after catheter insertion combined with discomfort of the 
anal catheter. Patient 22 did not have analysable bladder sensation, because he only 
wrote down the presence of bladder sensation in his event diary without the time of 
occurrence and without pushing the event button.
In the 9 patients with DO and analysable bladder sensation during ambulatory 
urodynamics 23% of UDC were sensed. The detection rate within the total group of 
patients with DO at ambulatory urodynamics (n=23) was about 9%. All recorded 





Table I. Patient characteristics and results of urodynamics and analysis.
Patient
Patients
1 2 3 4 5 6 7 S 9 10 11 12 13 14 15 16 17 IS 19 20 21 22 23 24 25 26
Lesion
Level C4 C3 TS T10 C5 TS 13 T4 T2 T6 C4 TS G6 C5 T12 T6 T4 T6 T4 T12 C5 T6 L3 C6 T5 T7
Complete + - - + - + - + + + + - - - + + - - - - + +
Daily life
Bladder + + + - + - + + + + + + + - - - + + + + + + + + - -
sensation
Conventional uiodynamics
DO - + + - + - + +c - - - + + + + +c + - + - - - + + +
Bladder - + + - + +a + + + a + a + a + + + - + - +a + +a + a + a + - -
sensation
UDC - 100% 100% - 100% - 100% 100% - - - 29% 100% 100% - 100% - - 100% - -■= - - 100% - -
detection rate (1/1) (2/2) (1/1) (1/D (1/D (2/7) (1/D (1/1) (1/1) (1/D (1/1)





DO - + + + + + + + + + + + + + + + + - + - + + + + + +
Bladder - + +a - + - +b - - + + a - + - + + - - + - + + - + - -
sensation
UDC detection - 17% - - 33% - - - - 4% - - 33% - 1% (1/70) 1% - - 50% - 2% _ d - 67% - -
rate (S/47) (V5) (1/25) (VS) (1/74) (10/20) (1/51) (2/3)
M ean delay - 9.5 - - 33 - - - - 12 - - 21S - = d - - 75.9 - 34 _ d - 17.5 - -
of sensation
recording after
UDC onset ( sec)
DO, detrusor overactivity; UDC, undesired detrusor contraction. 
a Sensations related to filling capacity of the bladder and not related to UDC. 
b Continuous urgency. 
c Filling rate 50 ml/min. 
d No exact time recording. 
e Not performed.
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Table II. Bladder sensation during daily life, conventional and ambulatory urodynamics.
Conventional urodynamics Ambulatory urodynamics
(n=25) (n=26)
Daily life Bladder sensation No bladder sensation Bladder sensation No bladder sensation
Bladder sensation 16 2 11 8
No bladder sensation 3 4 2 5
IS & 7














Sensation at UDC* 








Sensation at UDC* 
41% of patients with DO
Data analysis
Figure 2. Presence of bladder sensation and detrusor overactivity in daily life, conventional urodynamics and ambulatory 
urodynamics. DO, detrusor overactivity; UDC, undesired detrusor contraction. (*) Patients with bladder sensation 
concomitant with UDC as a percentage of patients with DO at conventional and ambulatory urodynamics, respectively.
Discussion
Conditional stimulation can suppress UDC and consequently increase bladder 
capacity.11-15 This kind of stimulation is started when a UDC is detected, which 
requires a reliable sensor. Although several sensing methods have been investigated in 
both human and animal experiments, no clinically suitable sensor for bladder activity 
monitoring is available for home usage.16-19 The primary objective of this study was to 
determine whether bladder sensation that concomitantly occurs with UDC during daily 
life may be used for self-triggered conditional stimulation in spinal cord injury 
patients.
Self-triggered conditional stimulation has several advantages. Firstly, UDC is 
suppressed, which results in an increase in bladder capacity and postponement of 
incontinence. Secondly, the patient will be warned when UDC occurs and may have
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extra time to find a toilet or catheterise due to suppression of UDC with a consequent 
increase in capacity and prevention of incontinence. Additionally, electrical 
stimulation of the dorsal genital nerves not only suppresses UDC, but also reduces the
23rise in blood pressure that could otherwise accompany UDC.
Opisso et al. studied automatic conditional stimulation of the dorsal genital nerves
21using surface electrodes in 33 neurogenic patients with DO at first cystometry. Of 
this group, 17 patients underwent self-triggered stimulation, because most other 
patients had no sensations of UDC onset. A number of contractions were suppressed, 
resulting in bladder capacity increase and urinary leakage postponement. Self­
triggered conditional stimulation delayed the onset of the stimulation with a mean of 
5.7 s (SD 6.1) compared to automatic conditional stimulation if detrusor pressure 
increased at least 10 cmH2O compared to an adjusted baseline.
Although conditional stimulation is effective in acute experimental studies with or 
without using bladder sensation, only few attempts have been made to study its clinical 
effectiveness in more chronic daily use. One case report has been published, which 
describes an increase in catheterised volume and catheterisation interval duration 
during home application of bladder sensation-triggered dorsal penile nerve
24stimulation. This spinal cord injury patient could not catheterise in time without the 
stimulation system, while self-controlled stimulation enabled catheterisation before 
incontinence occurred. Only voiding diaries were applied during home stimulation. 
Perhaps, ambulatory urodynamics would have been more informative about detrusor 
pressures.
Not all recorded sensations were related to UDC and few UDC were noticed by the 
patients. Despite the fact that 73% of patients reported the presence of any bladder 
sensation in daily life and 73% had bladder sensation simultaneous with UDC in 
conventional urodynamics, bladder sensation concomitant with UDC was recorded 
during ambulatory urodynamics in only 9 patients (41%). Mean detection rate of UDC 
by bladder sensation was 23% and only 9% if all patients with DO during ambulatory 
urodynamics were taken into account. Further studies for the application of bladder 
sensation in conditional stimulation should not be discouraged by these low detection 
rates. Detection rates were better during conventional urodynamics. The detection rate
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for patients with DO and bladder sensations concomitant with UDC was 72% and for 
all patients with DO 48%.
The detection rate of UDC during ambulatory urodynamics could have been 
negatively biased. Besides ambulatory urodynamics could be more sensitive in 
detecting UDC and DO than conventional urodynamics, it could also be possible that 
ambulatory urodynamics had more false-positively marked UDC using the definition 
of UDC as an undesired detrusor pressure rise of at least 10 cmH2O. More false- 
positively marked UDC due to artefact recordings of catheter movements during daily 
life could have biased the detection rates.
Despite a possible bias, especially during ambulatory urodynamics, screening patients 
by ambulatory urodynamics before patient inclusion in studies with bladder sensation 
triggered stimulation could improve results of these studies, because of the variance in 
detection rate (0-67%). It remains to be seen what detection rate is needed to provide 
safe bladder pressures regarding renal function and continence. Therefore, patients for 
further studies could also be screened by a combination of thorough history taking 
about the presence of bladder sensations indicative of UDC and conventional 
urodynamics.
The delay between the onset of a detrusor contraction and operating the event buttons 
was much larger compared to other studies, especially during daily life activities 
measured with the portable recorder for ambulatory urodynamics. In an acute setting 
Fjorback et al. previously reported an average interval time of 5 s from urgency to a 
detrusor pressure rise of 10 cmH2O in multiple sclerosis patients in automatic
• 13conditional stimulation. Opisso et al. reported a delay of 5.7 s between the start of 
automatic and self-triggered conditional stimulation in neurogenic patients. The 
substantial time delay in our study can, to some extent, be explained by the difficulties 
experienced with the management of the marker buttons on the ambulatory device and 
the absence of an effect for the patient as the marker button for recording of a bladder 
sensation was pushed. The management of the buttons was hampered due to some 
degree of disabled hand function in some patients and all patients wore the device 
underneath clothes or in a pocket or shoulder bag so that they could easily perform 
their daily activities. The shorter time delay during conventional urodynamics and
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results of previous studies showed that it is perhaps possible to shorten the time delay
13*21if a better user interface were to be designed. ; Studies with bladder sensation as a 
trigger for stimulation activation during daily life in spinal cord injury patients as well 
as other patients with DO are needed to determine the feasibility of this trigger for 
conditional stimulation.
No relation between bladder sensation and occurrence of incontinence was found. 
Incontinence was not recorded well enough by patients due to absence of perineal 
sensations or condom catheter usage.
According to the data in our study bladder sensation does not seem to be suitable as a 
trigger for conditional stimulation in spinal cord injury patients, but technical 
improvements of the user interface of the trigger device may increase the detection 
rate and decrease reaction time. Other, more reliable techniques for chronic bladder 
activity monitoring as a trigger for conditional stimulation are needed.
Conclusions
Spinal cord injury patients can detect UDC by specific and non-specific bladder 
sensation in conventional as well as ambulatory urodynamics. Bladder sensation as a 
trigger for conditional stimulation does not seem to be suitable for these patients, 
because bladder sensation only occurs in a small group of patients combined with a 
rather low detection rate and a long reaction time during daily life. The user interface 
needs to be improved to definitively determine whether or not these sensations are 
feasible as a trigger for conditional stimulation. Reliable techniques for chronic 
bladder activity monitoring are a prerequisite for a successful clinical application of 
conditional stimulation.
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Urodynamics aim at reproducing the complaints of patients while monitoring activity 
of the detrusor muscle in the bladder wall. Detrusor overactivity (DO) can be 
diagnosed during the filling phase of the voiding cycle of the bladder. DO and/or 
detrusor-external sphincter dyssynergia are prevalent in spinal cord injury (SCI) 
patients. Conventional urodynamics use artificial filling of the bladder at non- 
physiological filling rates. Ambulatory urodynamics enable measurement of detrusor 
activity during a longer period, at physiological filling rate and during daily activities. 
The primary aim of DO treatment is to accomplish a low-pressure urinary reservoir for 
preservation of renal function and treatment of urgency, frequency and incontinence to 
prevent complications and improve quality of life.
The first part of this thesis concerns current and new diagnostic tools for DO, 
especially in neurogenic patients. The second part of this thesis describes the effect of 
a Brindley procedure on the quality of life in SCI patients. The third part of this thesis 
describes the application of conditional stimulation of the dorsal genital nerve (DGN), 
including the dorsal penile and clitoral nerve, using a needle electrode in mostly 
neurogenic patients. In addition, the possibility of patient controlled stimulation using 
sensation of involuntary detrusor contractions (IDC) by SCI patients in daily life is 
studied.
Urodynamics
Chapter 2 discusses the value of ambulatory urodynamics for the evaluation of bladder 
function in SCI patients who are suspected for DO due to their level of injury and 
symptoms. The results of ambulatory urodynamics were compared to conventional 
urodynamics. Traces were analysed for both IDC’s of at least 10 cmH2O and for the 
overall diagnosis of DO according to the ICS definition. Ambulatory urodynamics 
were more sensitive to diagnose IDC’s and DO. When the maximum detrusor pressure 
at conventional urodynamics did not exceed 40 cmH2O, 83% of the 26 analysable 
patients had a mean maximum detrusor pressure lower than 40 cmH2O at ambulatory 
urodynamics. It can be concluded that conventional urodynamics, if done properly, in
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this patient group are representative for the bladder function during the day and 
ambulatory urodynamics do not seem necessary.
The exact role of conventional and ambulatory urodynamics in treatment decision 
could not be determined. The ratings of two urologists with experience in urodynamics 
revealed a lower inter-individual diagnostic agreement of DO for ambulatory 
urodynamics compared to conventional urodynamics (58%, K=0.201 versus 77%, 
K=0.552). However, the agreement for treatment was higher for ambulatory 
urodynamics (58% versus 42%).
Near infrared spectroscopy (NIRS) is an optical technique that can detect 
hemodynamic changes in biological tissues. This technique non-invasively measures 
changes in the concentration of tissue chromophores, including oxygenated 
haemoglobin (O2Hb) and deoxygenated haemoglobin (HHb). Chapter 3 describes the 
preliminary results of an experimental study in which NIRS was used to diagnose DO 
in neurogenic and non-neurogenic patients with overactive bladder (OAB) symptoms. 
Patients underwent one or more conventional urodynamics with simultaneous NIRS 
measurements via optodes that were attached to the abdomen, just above the pubic 
bone. The results of conventional urodynamics and NIRS were rated separately by 
three experienced urodynamicists for respectively the presence of DO and marked 
relative changes in chromophores. NIRS traces correlated well with DO episodes 
detected by conventional urodynamics in an optimised data sample that was not 
contaminated with motion artefacts. Therefore, NIRS can be a potential non-invasive 
diagnostic tool for DO in non-neurogenic as well as neurogenic patients with OAB. 
The sensitivity and specificity using NIRS in a general population remain to be 
determined.
Brindley Procedure and Quality of Life
Chapter 4 described the Brindley procedure, including technique, surgical 
implantation, selection of suitable patients and clinical results. A Brindley procedure 
can be used in complete SCI patients with DO, who respond well to pre-operative 
urodynamic and electrical stimulation tests. This procedure involves a dorsal 
rhizotomy of the sacral nerve roots to treat DO and the implantation of electrodes on
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the sacral anterior roots for sacral anterior root stimulation (SARS). SARS enables 
stimulation of micturition, defecation and penile erections. SARS was used for 
micturition in 73-100% of patients, for defecation in 29-100% of patients and erections 
for sexual intercourse in 0-32% of patients. Stimulation is used in combination with 
other methods to empty the bladder or rectum, because stimulation alone is not always 
completely successful. The percentages of patients who had urinary tract infections 
and the frequency of urinary tract infections decreased after the Brindley procedure 
compared to the pre-operative situation. Continence is achieved by the dorsal 
rhizotomy in 57-100% of patients, which included some additional treatments like 
anticholinergics and stress-incontinence surgery. The rhizotomy also decreased 
autonomic dysreflexia.
In chapter 5, the effects of the Brindley procedure on quality of life (QoL) were 
evaluated with the Qualiveen and SF-36 questionnaire compared to a control group of 
complete SCI patients who were treated according to standard treatment. The patients 
with a Brindley implant were divided into two groups; one group of patients who still 
used the Brindley stimulator for micturition and one group of patients who did not use 
the stimulator anymore. The latter group still had their dorsal rhizotomy, because this 
is an irreversible procedure. Patients who still used their stimulator had a significant 
better Specific Impact of Urinary Problems (SIUP) score and QoL index (Qualiveen) 
than the patients in the control group. It seemed that patients also benefitted from a 
rhizotomy only, because SIUP and QoL index were better in these patients compared 
to the control group. The SF-36 measures general health and did not seem suitable for 
application in SCI patients to determine differences in QoL in this study.
Conditional stimulation
Chapter 6 discussed the clinical application of electrical stimulation according to the 
anatomy of the pudendal nerve (PN) and its nerve branches, especially the dorsal nerve 
of the penis and clitoris (DGN). The PN can be stimulated at the ischial spine with 
electrode implantation via a posterior or perineal approach. The perineal approach can 
also be used to stimulate the PN at Alcock’s canal. The DGN lies superficially to the 
skin outside the pelvis, which enables transcutaneous stimulation via surface
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electrodes or percutaneous implantation of electrodes along its course from the 
branching of the PN to its distal end. Implantation of various electrodes types, like 
wire and cuff electrodes, is possible. The preferred type is not known, but if electrodes 
like wires can be implanted and fixated well by a minimal invasive procedure, cuff 
electrodes are not highly desirable. Continuous and conditional stimulation of PN and 
DGN effectively increase bladder capacity, suppress IDC’s and decrease OAB 
symptoms. Most studies on DGN stimulation have been done using surface 
electrodes.
Chapter 7 describes a method to insert a needle electrode near the DGN, which has 
been used for the studies described in Chapter 7 and Chapter 8. The electrode was 
inserted craniolaterally to the pubic bone and directed inferiomedially over the pubic 
bone towards the DGN at the base of the penis or clitoris. Electrode insertion was 
guided by the genito-anal reflex (GAR) evoked by electrical stimulation and by 
sensation to this stimulation.
In Chapter 7, conditional stimulation was used in SCI patients with DO. The needle 
electrode could be positioned successfully in seven out of eight patients. Stimulation 
was applied at different stimulation amplitudes during each filling of the bladder. At 
least one IDC (range 1-6) was suppressed in each of the seven patients at maximum 
stimulation amplitude. Stimulation was less effective at lower amplitudes. Stimulation 
lowered the intensity of bladder sensations concomitant with IDC’s as reported by the 
patients.
Continuous stimulation of the DGN increases bladder capacity. Conditional 
stimulation suppresses IDC’s by applying stimulation only when an IDC occurs. An 
important benefit of conditional stimulation could be that patients have extra time to 
get to a toilet after the onset of the first IDC (warning time). An increase to a higher 
stimulation amplitude when an IDC occurs during continuous stimulation, might 
theoretically result in additional suppression of the involuntary contractions and 
consequently increase warning time. Chapter 8 evaluated the use of electrical 
stimulation of the DGN applying continuous stimulation at low amplitude in 
combination with conditional increases to a higher amplitude when IDC’s occurred. 
Five patients with SCI, one patient with multiple sclerosis and one patient with
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idiopathic DO were studied. The study showed that the role of continuous stimulation 
at low amplitude is questionable, because stimulation at low amplitude decreased the 
bladder volume at which the first IDC occurred in patients with DO. However, bladder 
capacity could not be determined accurately. Conditional increases from low to high 
amplitude were able to suppress IDC’s completely in four out of seven patients. 
Moreover, high detrusor pressures were prevented in another patient. This resulted in 
an increase in maximum cystometric capacity and warning time, because micturition 
could be postponed and incontinence prevented.
Indwelling pressure catheters were used to measure detrusor pressures to determine the 
onset of IDC’s as a trigger to start stimulation in Chapter 7 and Chapter 8. Indwelling 
catheters are not favourable in daily life to be used as sensors for conditional 
stimulation. Chapter 9 discusses the value of bladder sensations as a trigger for 
conditional stimulation in SCI patients during normal daily activities. Patients were 
instructed to push a button at the ambulatory urodynamics device to mark specific and 
non-specific bladder sensations. Non-specific bladder sensations included abdominal 
fullness, tingling feelings or autonomic dysreflexia symptoms like flushes, perspiration 
and pilo-erections. Bladder sensations were reported by 73% of patients to occur in 
daily life. Only 41% had analysable bladder sensations concomitant with IDC’s during 
ambulatory urodynamics. Mean detection rates of IDC’s for ambulatory and 
conventional urodynamics were 23% and 72%, respectively. The mean delay in onset 
of IDC and marking by the patient was 57 s and 16 s for respectively ambulatory and 
conventional urodynamics. From the low detection rate of IDC and long reaction time 
during daily life it was concluded that bladder sensations as a trigger for conditional 




Urodynamica hebben als doel de klachten van de patiënt te reproduceren terwijl de 
activiteit van de musculus detrusor van de blaaswand wordt beoordeeld. Detrusor 
overactiviteit (DO) kan tijdens de vulfase van de mictiecyclus van de blaas worden 
gediagnosticeerd. DO met of zonder detrusor-externe sfincter dissynergie komen 
regelmatig voor bij dwarslaesiepatiënten. Conventionele urodynamica maken gebruik 
van kunstmatige vulling van de blaas met een onnatuurlijke vulsnelheid. Met 
ambulante urodynamica kan de detrusor activiteit gedurende een langere periode, met 
fysiologische vulsnelheid en gedurende dagelijkse activiteiten worden gemeten. De 
behandeling van DO heeft als primaire doel om een lage druk reservoir te verkrijgen 
ter bescherming van de nierfunctie en om urgency, frequente mictie en incontinentie te 
verhelpen ter preventie van complicaties en verbetering van kwaliteit van leven.
Het eerste deel van dit proefschrift betreft huidige en nieuwe methoden om DO te 
diagnosticeren, voornamelijk bij neurogene patiënten. Het tweede deel van dit 
proefschrift beschrijft het effect van een Brindley procedure op de kwaliteit van leven 
bij dwarslaesiepatiënten. Het derde deel van dit proefschrift beschrijft de toepassing 
van conditionele stimulatie van de dorsale genitale zenuwen (DGN) via een 
naaldelektrode bij voornamelijk dwarslaesiepatiënten. De DGN betreft de nervus 
dorsalis penis bij mannen en nervus dorsalis clitoridis bij vrouwen. In dit derde deel 
wordt tevens de mogelijkheid van door dwarslaesiepatiënten zelf aangestuurde 
stimulatie bestudeerd, waarbij gebruik wordt gemaakt van het gevoel van onvrijwillige 
detrusor contracties (IDC).
Urodynamica
Hoofdstuk 2 bediscussieert de waarde van ambulante urodynamica voor de analyse van 
de blaasfunctie bij dwarslaesiepatiënten waarbij verdenking bestaat op DO vanwege 
hun dwarslaesieniveau en klachten. De resultaten van ambulante urodynamica werden 
vergeleken met conventionele urodynamica. Curves werden voor zowel IDC’s van ten 
minste 10 cmH2O als voor de diagnose van DO volgens de ICS definitie geanalyseerd. 
Ambulante urodynamica waren sensitiever om IDC’s en DO te diagnosticeren. Als de
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maximale detrusor druk bij conventionele urodynamica niet boven de 40 cmH2O 
uitkwam, had 83% van de 26 analyseerbare patiënten bij ambulante urodynamica een 
gemiddelde maximale detrusor druk die lager was dan 40 cmH2O. Hieruit kan worden 
geconcludeerd dat correct uitgevoerde conventionele urodynamica bij deze 
patiëntenpopulatie representatief zijn voor de blaasfunctie gedurende het dagelijks 
leven. Ambulante urodynamica lijken daarom niet noodzakelijk.
De exacte rol van conventionele en ambulante urodynamica voor de therapiekeuze kon 
niet worden bepaald. De beoordelingen van twee urologen met ervaring in 
urodynamica lieten een lage inter-individuele diagnostische overeenkomst van DO 
zien voor ambulante urodynamica in vergelijking tot conventionele urodynamica 
(58%, K=0,201 versus 77%, K=0,552). De overeenkomst voor de behandelingskeuze 
was echter hoger voor ambulante urodynamica (58% versus 42%).
Near infrared spectroscopie (NIRS) is een optische techniek die hemodynamische 
veranderingen in biologische weefsels kan detecteren. Deze techniek meet op een niet- 
invasieve manier de veranderingen in de concentratie van chromoforen, waaronder 
geoxideerd hemoglobine (O2Hb) en gedeoxideerd hemoglobine (HHb). Hoofdstuk 3 
beschrijft de voorlopige resultaten van een experimentele studie, waarin NIRS werd 
gebruikt om DO te diagnosticeren bij neurogene en niet-neurogene patiënten met 
overactieve blaas (OAB) klachten. Patiënten ondergingen één of meerdere 
conventionele urodynamische onderzoeken met gelijktijdige NIRS metingen via 
optoden die iets boven het os pubis op de buikwand waren bevestigd. De resultaten 
van conventionele urodynamica en NIRS werden apart beoordeeld voor de 
aanwezigheid van DO en aanzienlijke relatieve veranderingen in chromofoor 
concentraties door drie ervaren urodynamici. NIRS curves correleerden goed met de 
DO periodes die door conventionele urodynamica werden geregistreerd. Dit betrof een 
geoptimaliseerde dataselectie die niet door bewegingsartefacten werd verstoord. NIRS 
kan daarom een potentiële niet-invasieve diagnostische methode zijn voor DO bij 
zowel niet-neurogene als neurogene patiënten met OAB. De sensitiviteit en 




Brindley procedure en Kwaliteit van Leven
Hoofdstuk 4 beschrijft de Brindley procedure inclusief de techniek, chirurgische 
implantatie, selectie van geschikte patiënten en klinische resultaten. Een Brindley 
procedure kan worden toegepast bij patiënten met een complete dwarslaesie met DO 
die goed reageren tijdens pre-operatieve urodynamica- en elektrische stimulatietesten. 
Deze procedure bestaat uit een dorsale rhizotomie van de sacrale zenuwwortels om 
DO te behandelen en de implantatie van elektroden op de sacrale voorwortels voor 
stimulatie van deze zenuwwortels (SARS). SARS maakt stimulatie voor mictie, 
defecatie en erecties mogelijk. SARS wordt bij 73-100% van de patiënten voor mictie, 
bij 29-100% van de patiënten voor defecatie en bij 0-32% van de patiënten voor 
erecties ten behoeve van geslachtsgemeenschap gebruikt. Stimulatie wordt in 
combinatie met andere methoden gebruikt om de blaas en het rectum leeg te maken, 
omdat alleen stimulatie niet altijd volledig effectief is. Het percentage patiënten met 
een urineweginfectie en de frequentie waarmee urineweginfecties voorkomen, daalden 
na de Brindley procedure in vergelijking met de pre-operatieve situatie. Met de dorsale 
rhizotomie werd bij 57-100% continentie bereikt, waarbij ook aanvullende 
behandeling, zoals anticholinergica en chirurgie voor stressincontinentie, zijn 
meegerekend. De rhizotomie verminderde tevens autonome disregulatie.
In Hoofdstuk 5 werd het effect van de Brindley procedure op de kwaliteit van leven 
(QoL) geëvalueerd met de Qualiveen en SF-36 vragenlijst. Hierbij werd vergeleken 
met een controlegroep bestaande uit patiënten met een complete dwarslaesie die 
volgens standaard therapie werden behandeld. De patiënten met een Brindley 
implantaat werden in twee groepen verdeeld; één groep met patiënten die nog steeds 
de Brindley stimulator gebruikten voor mictie en één groep met patiënten die de 
stimulator niet meer gebruikten. De laatste groep behield de dorsale rhizotomie, omdat 
dit een irreversibele ingreep is. Patiënten die nog steeds hun stimulator gebruikten, 
hadden een significant betere Specific Impact of Urinary Problems (SIUP) score en 
QoL index (Qualiveen) dan de patiënten in de controle groep. Het leek erop dat 
patiënten ook voordeel hadden van alleen een rhizotomie, omdat de SIUP en QoL 
index beter waren bij de patiënten met alleen nog een rhizotomie in vergelijking tot de
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controlegroep. De SF-36 meet algehele gezondheid en leek bij deze studie niet 
geschikt voor toepassing bij dwarslaesiepatiënten om de verschillen in QoL te bepalen.
Conditionele stimulatie
Hoofdstuk 6 bediscussieert de klinische toepassing van elektrische stimulatie volgens 
de anatomie van de nervus Pudendus (PN) en de aftakkingen van de deze zenuw, 
waarbij met name aandacht voor de nervus penis dorsalis en nervus clitoridis dorsalis 
(DGN). De PN kan ter hoogte van de spina ischiadicus worden gestimuleerd met 
behulp van een elektrode die via een posterior of perineale toegang kan worden 
geïmplanteerd. De perineale toegang kan ook worden gebruikt om de PN ter hoogte 
van het kanaal van Alcock te stimuleren. De DGN verloopt buiten het bekken 
oppervlakkig onder de huid. Dit maakt het mogelijk om de DGN transcutaan te 
stimuleren via elektroden op de huid of om percutaan elektrodes te implanteren in het 
verloop van de aftakking van de PN tot het distale einde van de DGN. Implantatie van 
verscheidene typen elektrodes is mogelijk, zoals draadelektrodes en cuff elektrodes. 
Welk type elektrode het meest geschikt is, is niet bekend. Echter, indien 
draadelektrodes op een minimaal ingrijpende manier geïmplanteerd en gefixeerd 
kunnen worden, zijn cuff elektrodes niet het meest wenselijk. Continue en conditionele 
stimulatie van de PN en DGN vergroten effectief de blaascapaciteit, onderdrukken 
IDC’s en verminderen OAB klachten. De meeste studies met DGN stimulatie zijn 
uitgevoerd met huidelektroden.
Hoofdstuk 7 beschrijft een methode om een naaldelektrode in de buurt van de DGN te 
plaatsen. De elektrode werd craniolateraal ten opzichte van het os pubis ingebracht en 
in inferiomediale richting over het os pubis naar de DGN bij de basis van de penis of 
clitoris geleid. Het inbrengen van de elektrode werd ondersteund door het opwekken 
van de genito-anale reflex (GAR) met behulp van stimulatie en door het gevoel dat 
door stimulatie werd opgewekt. Deze methode is gebruikt voor de studies in Hoofdstuk 
7 en Hoofdstuk 8.
In Hoofdstuk 7 werd conditionele stimulatie gebruikt bij dwarslaesiepatiënten met DO. 
De naaldelektrode kon bij zeven van de acht patiënten succesvol worden geplaatst. De 
stimulatie werd met verschillende stimulatie amplitudes gedurende iedere blaasvulling
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toegepast. Bij elk van de zeven patiënten kon ten minste één IDC (range 1-6) worden 
onderdrukt bij maximale amplitude. Stimulatie was minder effectief bij lagere 
amplitudes. Patiënten gaven aan dat stimulatie de intensiteit van blaassensaties tijdens 
IDC’s verminderde.
Continue stimulatie van de DGN vergroot de blaascapaciteit. Conditonele stimulatie 
onderdrukt IDC’s door alleen stimulatie toe te passen indien een IDC aanwezig is. Een 
belangrijk voordeel van conditionele stimulatie zou kunnen zijn dat patiënten extra tijd 
hebben om naar het toilet te gaan na het begin van de eerste IDC (waarschuwingstijd). 
Een toename naar een hogere stimulatie amplitude tijdens een IDC gedurende continue 
stimulatie, zou theoretisch tot een aanvullende onderdrukking van de IDC’s leiden met 
een toename in waarschuwingstijd als gevolg. Hoofdstuk 8 evalueert het gebruik van 
elektrische stimulatie van de DGN, waarbij gebruik wordt gemaakt van continue 
stimulatie op een lage amplitude in combinatie met conditionele toename naar een 
hogere amplitude indien een IDC optreedt. Vijf dwarslaesiepatiënten, één MS patiënt 
en één patiënt met idiopathische DO werden onderzocht. De studie toonde dat de rol 
van continue stimulatie met lage amplitude niet geheel zeker is, omdat stimulatie met 
een lage amplitude leidde tot een verlaagd blaasvolume waarbij de eerste IDC bij de 
patiënten met DO optrad. De blaascapaciteit kon echter niet accuraat worden bepaald. 
Conditionele toename van een lage naar een hoge amplitude konden bij vier van de 
zeven patiënten de IDC’s compleet onderdrukken. Tevens werden hoge detrusor 
drukken voorkomen bij een andere patiënt. Dit resulteerde in een toename van de 
maximale capaciteit en waarschuwingstijd, omdat de mictie kon worden uitgesteld en 
incontinentie voorkomen.
Voor het meten van de detrusor drukken om het begin van IDC’s als startsignaal voor 
de stimulatie in Hoofdstuk 7 en Hoofdstuk 8 werden verblijfskatheters gebruikt. 
Verblijfskatheters hebben niet de voorkeur om in het dagelijks leven voor conditionele 
stimulatie gebruikt te worden. Hoofdstuk 9 bespreekt de waarde van blaasgevoelens als 
startsignaal voor conditionele stimulatie bij dwarslaesiepatiënten gedurende dagelijkse 
activiteiten. Patiënten werden geïnstrueerd om op een knop op het registratiekastje van 
het ambulante urodynamisch onderzoek te drukken om specifieke en niet-specifieke 
blaasgevoelens te markeren. Niet-specifieke blaasgevoelens zijn abdominaal
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drukgevoel, tintelingen of verschijnselen van autonome disregulatie, zoals opvliegers, 
zweten en pilo-erecties. Blaasgevoelens kwamen bij 73% van de patiënten gedurende 
het dagelijks leven voor. Slechts 41% had analyseerbare blaasgevoelens die 
gelijktijdig optraden met IDC’s tijdens ambulant urodynamisch onderzoek. Bij 
ambulant urodynamisch onderzoek en conventioneel urodynamisch onderzoek werd 
respectievelijk 23% en 72% van de IDC’s door de patiënt bemerkt. De gemiddelde 
vertraging tussen het begin van de IDC en de markering door de patiënt bedroeg 
respectievelijk 57 sec. en 16 sec. voor ambulant en conventioneel urodynamisch 
onderzoek. Vanwege het lage percentage IDC’s dat door dwarslaesiepatiënten met DO 
tijdens het dagelijks leven werd opgemerkt met daarbij een hoge reactietijd werd 












The first part of this thesis focused on current and new diagnostic tools for detrusor 
overactivity (DO) in especially spinal cord injury (SCI) patients, including 
conventional urodynamics, ambulatory urodynamics and near infrared spectroscopy 
(NIRS). The second part of this thesis concerned clinical results and quality of life 
(QoL) of a Brindley procedure. The third part of this thesis assessed stimulation of the 
dorsal genital nerves (DGN), including the dorsal penile and clitoral nerve, and 
especially conditional stimulation. The current position and future perspectives of all 
three topics, including urodynamics, Brindley procedure and conditional stimulation of 
the DGN, will be discussed.
Urodynamics
The ultimate challenge in the urologic care of SCI patients with DO, especially in 
combination with detrusor-external sphincter dyssynergia (DESD), is to accomplish a 
low-pressure urinary reservoir for preservation of renal function and treatment of 
urgency, frequency and incontinence to prevent complications and improve QoL.
Although treatment options for SCI patients with DO have increased, they still suffer
1'2from urological complications and mortality. ; Therefore, SCI patients need careful 
evaluation of their bladder function, including urodynamics, to start proper treatment. 
Conventional urodynamics, including cystometry in an outpatient clinic, or ambulatory 
urodynamics can be used. Urodynamics aim at reproducing the complaints of the 
patients while monitoring activity of the detrusor muscle. Ambulatory urodynamics 
provide information about bladder behaviour during daily life, including maximum 
detrusor pressures, frequency of involuntary detrusor contractions (IDC) and relative 
duration of high detrusor pressures. This provides the physician more insight in the 
patient and also enables a more thorough evaluation of treatment. For example, an 
increase in the catheterisation frequency of time dependent catheterisation might 
substantially decrease the number and duration of IDC’s by reducing the maximum 




In non-neurogenic as well as neurogenic patients ambulatory urodynamics at 
physiological filling rate diagnose DO in more patients than conventional urodynamics 
at supra-physiological filling rates, in other words, ambulatory urodynamics have a
3 ihigher diagnostic rate of DO than conventional urodynamics. - The clinical relevance 
of this higher diagnostic rate, including the consequences for treatment, is not clear. 
On the one hand, the higher diagnostic rate of ambulatory urodynamics can be 
indicative for a higher sensitivity to detect DO compared to conventional urodynamics. 
Patients indicate that their symptoms are better represented by ambulatory 
urodynamics than video-urodynamics.5 On the other hand, the higher rate might be 
caused by a higher false-positive rate. Symptom and voiding diaries in combination 
with two vesical pressure sensors instead of one, which is standard, can reduce the
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diagnosis of DO by ambulatory urodynamics up to 64%. ; Even in non-symptomatic
volunteers DO has been detected in considerable rates with a higher rate for
8 ' 10ambulatory urodynamics compared to conventional urodynamics. ; As a consequence 
of the false-positivity, the sensitivity of ambulatory urodynamics is over-estimated and 
the actual sensitivity will be lower. This raises the question whether ambulatory 
urodynamics are really needed to diagnose DO. In SCI patients suspected for DO, 
ambulatory urodynamics do not have a primary role for diagnosis of DO and risk 
assessment when conventional urodynamics are done properly, but might remain
. . 3indicated if conventional urodynamics are inconclusive for treatment decision. 
Ambulatory urodynamics might be used as a primary tool when ‘bedside’ 
urodynamics are recommended or more comfortable for the patient. For example when 
analysis of bladder function is needed after the spinal shock phase has resolved in 
patients who stay at a rehabilitation ward or in a rehabilitation centre. Immobile 
patients do not have to be transported to another ward or centre. Active patients do not 
have to interrupt their daily therapies and activities. Recordings and catheter 
positioning can easily be checked during registration time. The urodynamics can be 
stopped when adequate results have been obtained. The recordings can digitally be 




Nosseir et al advocate regular urodynamic follow-up in SCI patients for evaluation of 
treatment effect.11 Urodynamically assessed treatment success was defined as a 
detrusor storage pressure <40 cmH2O in the absence of autonomic dysreflexia. In case 
of reflex voiding or sacral anterior root stimulation, a leak point pressure <40 cmH2O 
in the absence of autonomic dysreflexia combined with a maximum detrusor pressure 
<90 cmH2O was regarded as a success. Although the evaluation of this urodynamic 
strategy showed good clinical results, including renal function, follow-up was only 5 
years in this relatively young patient group. However, it was also shown that during 
this follow-up the majority needed a treatment change.
High detrusor leak point pressures (>40 cmH2O), especially sustained high pressures,
are a risk factor for renal deterioration, which has been studied in myelodysplastic
12patients. Also SCI patients with detrusor pressures >40 cmH2O have an increased
13risk for renal damage. Up to now, it is not known to what extent the height of the 
detrusor pressure rises, the leak point pressure or the duration of the detrusor pressure 
rises is of importance for prognosis and treatment decision.
Further studies on the effects of treatment on DO and detrusor pressures in an 
individual patient are needed to determine prognostic factors and to define guidelines 
for patient evaluation, management and follow-up. Meanwhile, empirical treatment 
based on only patient symptoms or occurrence of complications, like renal damage, 
should be avoided, because renal damage can easily occur without apparent clinical 
signs of urinary tract deterioration. An exception to this is a high risk patient who is 
suspected for DO and/or DESD, based on the level of injury and symptoms of OAB or 
autonomic dysreflexia in whom urodynamics failed to diagnose DO.
Conventional and ambulatory urodynamics require insertion of transurethral and 
transanal or transvaginal pressure catheters to fill the bladder with saline and to 
register intravesical and abdominal pressures. This can cause patient discomfort and 
morbidity, like urinary tract infections.14-16 Several attempts have been made to 
develop less invasive urodynamics, to decrease this morbidity and to improve patients 
comfort during urodynamics. Many of these studies focus on the voiding phase to 
diagnose BOO, while only a few studies involve the filling phase, including the 
diagnosis of DO. Examples of these less-invasive methods to diagnose DO are
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ultrasonic measurement of bladder wall thickness, detrusor wall thickness and 
estimation of bladder weight or determination of the concentration of nerve growth
17 27factor in urine. - The value of ultrasonography in neurogenic patients is not clear, 
because studies about bladder wall thickness, detrusor wall thickness and estimation of 
bladder weight focussed on non-neurogenic patients and mostly included women. 
Comparable studies should be done in neurogenic patients to determine specific cut­
off values in neurogenic patient groups. However, the ultrasound methods are still 
invasive if done transvaginally. All mentioned methods do not inform about real time 
bladder activity. Nerve growth factor concentration is affected by various pathologies, 
like interstitial cystitis and bladder pain syndrome. The value in neurogenic patients 
for their prognosis and patient management is therefore questionable and remains to be 
determined.
These problems might be overcome by use of NIRS as this technique was able to 
diagnose DO during real time detrusor monitoring in an experimental study (Chapter 
3). NIRS is non-invasive, because only an adhesive patch with two optodes (sender 
and receiver) is applied to the abdominal skin. However, NIRS is not yet ready for 
clinical application. NIRS is prone to movement artefacts and it is not exactly known 
of which tissue haemodynamic changes are measured as there are many tissues, like 
the abdominal muscles, in between the optode and bladder wall.
Technical improvements and stability of the registration traces are required for NIRS 
to become a real non-invasive and future alternative to the current urodynamics. 
Firstly, it should be clear that the NIRS signal changes are really reflections of near 
infrared signals by the detrusor wall and consequently representing detrusor activity. 
Standard NIRS signal patterns during detrusor contractions should be determined. This 
could be done, by studying NIRS directly applied to the bladder wall in for example 
animals. Secondly, influences of artefacts, like optode movement and activity of the 
abdominal wall muscles, on NIRS recordings should be studied first to improve the 
technique or to filter out artefacts from the NIRS signals. Standard NIRS signal 
patterns should be obtained from standardized activities, like abdominal straining, 
coughing and several body movements. Probably, multiple source-detector pairs and 
algorithms can help to correct traces for artefacts and to translate the relative changes
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in NIRS signals into absolute numbers comparable to pressures in the current 
urodynamics.2930
Non-physiological filling of the bladder should be omitted, because this would require 
catheterisation of the bladder and turn NIRS into an invasive method. Consequently, 
registration should be possible during an extended period compared to conventional 
urodynamics. This requires an ambulatory device with traces that can easily be 
interpreted.
Less invasive methods for urodynamics are preferred, but the mainstay will remain to 
receive a proper diagnosis. None of the current and new urodynamic techniques are 
able to do this alone. Therefore, future studies should also include combinations of 
current and new urodynamic techniques. If NIRS would not develop into a clinical 
useful diagnostic tool, the technique might be helpful in basic research to study 
hemodynamic physiology, pathology and therapeutic effects.
Future perspectives
In SCI patients suspected for DO, ambulatory urodynamics do not have a primary role 
to diagnose DO and for risk assessment when conventional urodynamics are done 
properly. This limits ambulatory urodynamics to be indicated only if conventional 
urodynamics are inconclusive for treatment decision. The role of ambulatory 
urodynamics will not increase due to their requirement of long recording time, which 
is uncomfortable for patients and physician.
Conventional urodynamics have been applied for many years. Although technical 
equipment improved, the principal remained the same. Most studies in the past focused 
on the diagnoses based on urodynamics. Further studies on the effects of treatment on 
DO and detrusor pressures in an individual patient are necessary to determine 
prognostic factors and to define guidelines for individual patient evaluation, 
management and follow-up.
The ultimate urodynamic tool should be non-invasive for the patient, quick, easy to 
apply, reliable and accurate at low cost. Less invasive diagnostic tools, like NIRS, 
might be safer and more comfortable for patients. The advantages of these new tools 
should be weighted versus their accuracy. Of the current less invasive tools that have
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been studied, none could really substitute conventional urodynamics, because they are 
not accurate enough. This is often caused by extensive influence of other pathologic or 
physiologic factors to the measured parameter. Futhermore, real time monitoring of 
detrusor activity is often not possible. This limits the use of these less invasive tools in 
the future. Probably, these new techniques can contribute to define prognostic factors 
in combination with conventional urodynamics to optimize treatment strategies in an 
individual patient. To be clinical feasible, all new techniques should be easy to apply, 
techniqually stable and at low costs.
Brindley procedure & Quality of Life
The Brindley procedure focuses on two items. Firstly, DO is treated by a sacral dorsal 
rhizotomy, which results in low bladder pressures, a higher bladder capacity and a
31' 32decrease of incontinence. ; The dorsal rhizotomy also decreases autonomic 
dysreflexia, including muscle spasm, and DESD. Hohenfellner et al therefore 
advocates a sacral rhizotomy as a single therapy in selected patients with DO and/or
31autonomic dysreflexia. Secondly, stimulation of the anterior sacral roots enables 
micturition, defecation and penile erections or vaginal lubrication. Good clinical 
results have been demonstrated in the past and more recently with long term follow-up 
(Chapter 4). Besides these clinical results, the psychological and social impact, 
including the practical difficulties of incontinence and non-physiological bladder 
emptying, should not be forgotten.
Chapter 5 showed that the Brindley procedure improved QoL in selected SCI patients. 
Continence seems to be an important issue, because QoL remained higher, although 
insignificant, in patients who did not use their stimulator anymore and only had profit 
of their dorsal rhizotomy. Studies on the specific impact of neurogenic bladder 
problems on QoL and its treatment are rare. Only one other study reported the effect of
33the Brindley procedure on QoL using the Qualiveen questionnaire. However, this 
study used data of a heterogeneous control group of neurogenic patients, which 
included not only SCI patients, but many neurogenic disorders. Two other studies 
reported high patient satisfaction after implantation using non-validated self-developed 
questionnaires.3435 These questionnaires only concerned bladder management.
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The Brindley procedure does not only have influence on bladder problems, like 
micturition, incontinence and urinary tract infections. The procedure also concerns 
defecation and erectile function. Chapter 5 and Wielink et al showed no change in
35general indicators of QoL. However, these general questionnaires do not seem to be 
suitable for SCI patients as these questionnaires include items about walking and 
standing.
The Brindley procedure is a suitable technique for selected patients, but also comprises 
extensive surgery. A danger is the delicate technique, which has not changed 
substantially since its introduction. The stimulator consists of an external stimulator 
box, which evokes stimuli in the subcutaneously implanted receiver block via 
radiofrequency. The receiver block is connected by cables to the intra- or extradural 
electrodes of the implant. The external part can easily be analysed and replaced. 
However, thorough analysis of the implanted part can only be obtained with surgery 
that requires techniques that are not allowed by all national legislations (Chapter 5). 
When the Brindley procedure was introduced, management of patients with SCI 
differed from current strategies and treatments. Nowadays, many patients are on clean 
intermittent (self) catheterisation instead of indwelling catheters to empty their 
bladder. Catheterisation is started directly after their injury, which familiarises the 
patients with this method. Therefore, treatments like anticholinergics and Botulinum 
toxin A intravesical injections, which result in urinary residue or retention, are more 
accepted. Botulinum toxin A is the least invasive one from the current surgical options 
to treat DO. Injections can be done under local anaesthetics of the bladder at an 
outpatient clinic basis.36 37 Despite its requirement of repeated injections, many 
patients prefer this method over the Brindley procedure, which is far more extensive 
surgery and diminishes hope for future treatments of nerve repair or regeneration due 
to the irreversible rhizotomy. Whether this hope for nerve repair or regeneration is 
justified is questionable, because no studies with major progress appeared currently. 
Although Botulinum toxin A is not yet registered for urological purposes, the 
application of and the experience in terms of effectiveness and QoL with this option is
38 43growing, including some limited studies about safety results. - However, the exact 
working mechanism remains to be determined.44
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Changes in the technique of the Brindley procedure are required to be a valuable 
treatment for the future in selected patients. Firstly, the sacral dorsal rhizotomy should 
be omitted and replaced by a nerve-sparing option. Continuous or conditional 
electrical stimulation of the dorsal sacral nerve roots or the pudendal nerve (PN) and 
nerve branches (Chapter 6) for IDC suppression could be an option. A combination of 
stimulation of the dorsal roots for suppression of IDC and anterior sacral roots for 
micturition does not result in complete bladder emptying in all patients due to 
persisting DESD in the gaps between bursts of stimulation (post stimulus voiding).45 
This combination could be useful if selective detrusor stimulation could be obtained to 
improve the micturition pattern. Development of clinical applicable techniques for 
selective detrusor stimulation are a requirement, like selective anodal block and high 
frequency block.46-49 Secondly, the technique of the implant should be changed to 
enable revision with standard surgical techniques and preferably external analysis of 
the implant. Too complex techniques should be avoided for both improvement items to 
prevent changes that are more vulnerable to failure, which would decrease the 
durability and reliability of the Brindley procedure.
Future perspectives
The ultimate treatment of neurogenic disorders of the lower urinary tract would be 
resolvement of the neurogenic disorder that causes the bladder problems to restore the 
innervation of the bladder. As long as this causal treatment is not available, 
symptomatic treatment options are required.
Intravesical Botulinum toxin A injections are an evolving option in the current 
treatment arsenal. At the time when this thesis is written, approval for urological 
application is expected within short time. However, the Brindley procedure has several 
advantages for suitable patients compared to Botulinum toxin A in combination with 
intermittent catheterisation, especially if not only the urological properties of the 
treatments are taken into account. SCI comprises a variety of coherent, physical 
problems. Therefore, management of multiple organ dysfunctions should be 
advocated. The Brindley procedure does not only enable continence and micturition, 
but also complete defecation or improvement of defecation pattern, penile erections,
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and reduction of autonomic dysreflexia and spasms. Patients become less dependent, 
because they do not need assistance for intermittent catheterisation anymore and can 
empty their bladder where-ever and whenever. When the treatment options are 
discussed with a patient, this more extensive application of the Brindley procedure 
should be mentioned.
The Brindley procedure should be limited to specialised centres to maintain experience 
and quality, because of the complexity of the procedure and the limitation for general 
application due to selection of patients. To remain a viable option in the future, 
technical improvements are required to enable thorough analysis of implant failures 
and to revise the implant safely with standard surgical techniques. Moreover, the 
dorsal rhizotomy should be replaced by a less invasive procedure to abolish DO, like 
electrical stimulation of the dorsal roots or DGN stimulation. This requires application 
of stimulation techniques that prevent backward stimulation when the anterior roots 
are stimulated.
Conditional stimulation of the dorsal penile and clitoral nerve
Currently, there are several therapeutic options to regain a low-pressure urinary 
bladder in SCI patients with DO. In the majority of patients conservative treatment is 
started with anticholinergics alone or in combination with (intermittent) 
catheterization.50-52 Side effects, like dry mouth and constipation, strongly decrease 
compliance of patients to treatment and are an important reason to discontinue 
treatment. More invasive treatments can be considered in patients who do not tolerate 
the side effects or in whom DO does not respond satisfactorily to anticholinergics. 
Botulinum toxin A injections and nerve repair or nerve regeneration are discussed in 
the previous paragraph. More extensive surgery for DO in neurogenic patients includes 
the Brindley procedure as described in the previous paragraph, a bladder augmentation 
and urinary diversion.
Continuous electrical stimulation of the sacral root (SNS), mainly S3, has been widely 
used in non-neurogenic patients with OAB or non-obstructive urinary retention.53-56 
However, SNS does not completely resolve symptoms in the majority of non- 
neurogenic patients. Stimulation is reported to be effective at 5-year follow-up in a
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considerable number of patients, but only after selection of patients who passed a
cn
screening phase. SNS is also applied in patients with neurogenic lower urinary tract 
dysfunction due to varied pathology, including multiple sclerosis and SCI.58-60 
Neurogenic lower urinary tract dysfunction involved both DO and acontractility with 
urinary retention. Lombardi et al studied SNS in 11 incomplete (AIS C-D) SCI 
patients with OAB in which SNS was effective during a median follow-up of 5 
years.60 Three out of the 11 patients experienced pain or spasticity in the leg due to 
stimulation. Too much damage to the spinal cord seems to limit the function of the 
stimulation, due to the assumed involvement of sacral and supraspinal reflex arcs in 
SNS.59 The sacral roots contain afferent as well as efferent nerves. Other stimulation 
sites that allow stimulation of other nerve fibres might result in a better outcome with 
fewer side effects.
The DGN involves only sensory afferent nerves and lies for a substantial part 
superficially in the perineum and penis. Continuous and conditional stimulation of the 
DGN in experimental studies with surface electrodes on the dorsum of the penis or 
clitoris are able to suppress IDC’s and increase bladder capacity.61-63 
Attempts have been made to implant electrodes near the DGN.64-66 Lee et al positioned 
wire electrodes in the penile shaft of SCI patients.65 The penis is prone to external 
mechanical forces, which increases the risk of electrode failure. Electrode stability is 
not easy to acquire due to penile erectile function, which might cause electrode 
migration or damage of nerves that are attached to the electrode. Goldman et al 
applied continuous stimulation via a wire electrode in females with OAB.64 The 
electrode was inserted in the pre-pubic area in the direction of the DGN. A comparable 
technique was used to insert the needle electrode in neurogenic patients as described in 
Chapter 7 and 8. In males, this location does not suffer from penile erections. 
Although an electrode in this location is less prone to external mechanical forces, it is 
still pre-pubically and consequently not protected by a bony structure. A risk for 
electrode damage remains. Therefore, electrode positioning and clinical effectiveness 
at other stimulation sites as described in Chapter 6 should be studied and compared to 
find the optimal status of accessibility versus electrode safety.
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Not only the electrode insertion method and location are of importance. Effectiveness 
also dependents on the stimulation current.6667 Dislocation away from the optimal 
position near the nerve will result in a reduced effect. Because the pre-pubic area 
consists of fatty tissue for a substantial part, the development of minimal invasive 
electrodes, like wire electrodes, in combination with proper fixation will be a 
challenge. Probably, more extensive surgery should be considered, because fixation of 
electrodes is of utmost importance for electrical stimulation of the DGN to become a 
feasible, safe and reliable treatment option of neurogenic and non-neurogenic 
DO/OAB or an alternative for the dorsal rhizotomy in the Brindley procedure. Most of 
the current studies are only experimental and in an acute setting. Chronic clinical 
studies are necessary to determine long-term effects and influences on for example 
sexuality.
DGN stimulation could be of additional value in SCI patients compared to SNS and 
the Brindley procedure if also micturition can be evoked. Stimulation of the PN and 
DGN can generate bladder contractions, which could enable micturition without 
residue if low bladder outflow can be obtained. Promising results were reported in 
anesthetised cats with or without SCI.68-71 The stimulation effect seems stimulation 
frequency and bladder volume dependent. Only a few attempts have been made in
72 74humans with SCI by stimulation of the PN or intra-urethral stimulation. - Electrical 
stimulation of the urethral nerves may be activating the same augmenting reflex that is 
evoked by fluid flow along the urethra. The combination of suppression of IDC’s and 
evocation of micturition like detrusor contractions by PN or DGN stimulation should 
be further studied. This might be a less invasive alternative to the Brindley procedure. 
Other stimulation patterns than trains of single pulses could be evaluated for their 
effectiveness to suppress IDC’s and evoke detrusor contractions.
Instead of continuous stimulation, stimulation can be applied conditionally, in which 
stimulation is only activated when IDC’s occur. This might have several advantages 
compared to continuous stimulation. Neurogenic patients and non-neurogenic patients 
who can sense stimulation have the benefit that stimulation time is reduced, which 
reduces bother due to stimulation. Conditional stimulation seems less irritating during
75an IDC, which allows higher stimulation current compared to continuous stimulation.
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This will increase effectiveness, because stimulation effect depends on the current.6667 
Shorter stimulation times will reduce power consumption, prolong the lifetime of the 
electrode contacts, and reduce or prevent habituation of the reflex loops of the 
stimulus. The latter might be of importance as the exact influence of long-term DGN 
stimulation on sexuality is not clear yet.
Another advantage, which is for the patient probably most of interest, is the increase in 
warning time between the start of the first IDC and the maximum capacity.63 66 
Patients can sense the involuntary contractions themselves or can be warned by the 
stimulator that contractions are occurring and the stimulator is activated. This provides 
the patient not only with an increase of bladder capacity, but also with a warning sign 
to give the patient extra time to find a suitable place for micturition or catheterisation 
without getting incontinent.
Conditional stimulation requires a reliable trigger to start stimulation when an IDC 
occurs. In studies about conditional stimulation transurethral catheters for pressure 
registration have been used to determine detrusor activity. These indwelling bladder 
catheters are not recommended in daily life. Alternative sensors for monitoring of 
detrusor activity could be external urethral or anal sphincter electromyography (EMG), 
sacral root or PN electroneurography and bladder pressure monitoring by implantation 
of a sensor in the bladder wall.76-85
Intraluminal bladder sensors suffer from incrustation and the risk for urinary tract
81'83'84infections increases. ; ; Bladder wall sensors have the disadvantage of dislocation
81and tissue erosion. Improvement in fixation and sensor development to prevent 
erosion is required for these bladder sensors to become clinical feasible.
External urethral sphincter EMG is feasible, but it is limited to patients with a
nn
combination of neurogenic DO and DESD. A potential limitation of implementing 
external anal sphincter EMG is a low specificity for the detection of IDC from external
78'85anal sphincter EMG activity, which results in a high false positive detection rate. ; 
Long term use should be investigated to determine its value as false-positive EMG- 
recording might increase in physical active patients. Although extra stimulation due to 
false-positive EMG is not harmful, it is not favourable when sensation to stimulation is 
less tolerated in the absence of urgency.
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Electroneurography of the PN or sacral root (S3), which records nerve electric activity, 
is correlated with the bladder pressure in animal models and is also feasible in 
humans.76,79,80,82’86 However, small amplitudes of neural signals and various other 
sources that contribute to sacral nerve root activity (e.g. sacral dermatome and rectal 
activity) require improvement of this method to reliably detect bladder contractions in 
a chronic application.
In Chapter 3 NIRS was studied to diagnose DO. If this technique could be optimised 
and be available in an ambulatory device, it would also be of value as a sensor to 
detect IDC’s in conditional stimulation.
Currently, no clinical applicable bladder sensor for chronic use is available. An 
alternative could be patient controlled stimulation, in which the patient activates the 
stimulator when he or she has urgency to void. This open loop system is probably a 
less complex technique compared to a closed loop system with a sensor as a trigger for 
stimulation. Opisso et al reported 52% of neurogenic patients to have a sensation of 
IDC and to be able to use patient controlled stimulation during cystometry.63 Whether 
this result will be accomplished in clinical use in SCI patients is questionable, because
an
of a low detection rate of IDC by patients during daily activities. During daily life, 
patients are not continuously focused to start stimulation. Moreover, the detection rate 
was determined only by pushing a button to set a mark without any resulting 
stimulation effect to the patient. The absence of a positive response for the patient 
could have negatively influenced the detection rate, because the patient will have been 
less motivated. The detection rate could also be improved by a better interface, 
because the device that was used was not optimal to control. Moreover, patient 
controlled stimulation could have better results in patients with a lower degree of SCI 
or idiopathic DO who have an intact sensibility. Therefore, clinical and long-term 
studies are recommended to evaluate the effectiveness in daily practice.
For DGN stimulation to become a successful therapy, a device should be safe, durable, 
efficacious and cost-effective. Eventually, developments in technique will enable a 
safe, closed loop device for conditional stimulation of the DGN, with or without the 
possibility of patient controlled stimulation, to be efficacious. This technique might 
also be a danger for its durability and reliability. The risk for technical failures will
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increase when the technique becomes more complex. Because the national expenses 
on health care are increasing, expensive techniques are not preferred. More complex 
techniques increase the development costs and probably treatment costs, which 
endanger the risk for stimulators that are not cost-effective.
Future perspectives
The ultimate stimulation device should be easy to implant and automatically apply 
stimulation to suppress IDC’s without discomfort to the patient. Moreover, the system 
would notify the patient in time to go a toilet to void when the bladder has reached 
maximum capacity and IDC’s can no longer be suppressed.
Conditional stimulation of the DGN suppresses IDC’s and increases bladder capacity 
in SCI patients, but could be useful in other patients with DO. An important advantage 
of conditional stimulation compared to continuous stimulation will be an increase in 
warning time for patients between the start of the first IDC and the maximum capacity. 
DGN stimulation could be of additional value in SCI patients compared to SNS, 
Brindley procedure and intravesical Botulinum toxin A injections if also stimulation of 
micturition can be accomplished using different stimulation settings.
Stimulation of the DGN is possible at several sites. Electrode implantation and clinical 
effectiveness at different stimulation sites should be compared to find the optimal 
status of accessibility versus electrode safety.
Conditional stimulation requires a reliable trigger to start stimulation at the onset of an 
IDC. Transurethral indwelling catheters are not preferred, but other bladder sensors to 
trigger stimulation are not clinical applicable yet. An alternative could be patient 
controlled stimulation. However, patients do not want to be aware of their bladder the 
whole day. If they need to activate the stimulator themselves at every IDC, this will 
still interfere with their daily practice and awareness of their bladder. Clinical and 
long-term studies are necessary to evaluate efficaciousness in daily practice.
Future techniques will be able to accomplish a safe and efficacious system for 
automatic conditional stimulation. However, complex techniques should be avoided as 
these will decrease application of conditional stimulation of the DGN due to limitation 




Het eerste deel van dit proefschrift behandelde de huidige en nieuwe technieken voor 
het diagnosticeren van detrusor overactiviteit (DO) bij met name dwarslaesiepatiënten, 
waaronder conventioneel urodynamisch onderzoek, ambulant urodynamisch 
onderzoek en near infrared spectroscopie (NIRS). Het tweede deel van dit proefschrift 
betrof de klinische resultaten en kwaliteit van leven (QoL) van de Brindley procedure. 
Het derde deel van dit proefschrift richtte zich op stimulatie van de dorsale genitale 
zenuw (DGN), die de nervus dorsalis penis en clitoridis omvat. Hierbij was specifieke 
aandacht voor conditionele stimulatie. De huidige positie en toekomstverwachtingen 
van deze drie onderwerpen, waaronder urodynamica, de Brindley procedure en 
conditionele stimulatie van de DGN, worden hier bediscussieerd.
Urodynamica
Een belangrijk doel bij de urologische zorg van dwarslaesiepatiënten met DO, met 
name in combinatie met detrusor-externe sfincter dissynergie (DESD), is het 
verkrijgen van een urinereservoir met een lage druk ter behoud van de nierfunctie en 
behandeling van urgency, frequente mictie en incontinentie ter preventie van 
complicaties en verbetering van QoL. Ondanks dat de behandelingsmogelijkheden 
voor dwarslaesiepatiënten met DO zijn toegenomen, lijden zij nog aan urologische
1.2
complicaties en sterfte. ; Daarom hebben dwarslaesiepatiënten zorgvuldige evaluatie 
van hun blaasfunctie nodig, waaronder urodynamisch onderzoek, voor de juiste 
behandeling.
Conventionele urodynamica, wat bestaat uit poliklinisch uitgevoerde cystometrie, of 
ambulante urodynamica kunnen worden gebruikt. Urodynamica hebben als doel om de 
klachten van patiënten te reproduceren terwijl de blaasactiviteit wordt geregistreerd. 
Ambulante urodynamica geven informatie over de blaasactiviteit gedurende het 
dagelijks leven, waaronder maximale detrusor drukken, frequentie van onvrijwillige 
detrusor contracties (IDC) en relatieve duur van de hoge detrusor drukken. Dit geeft de 
arts beter inzicht in de patiënt en maakt tevens een grondigere evaluatie van de 
behandeling mogelijk. Een toename in de katheterisatie frequentie bij tijdsafhankelijke
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katheterisatie kan bijvoorbeeld leiden tot een afname van het aantal en de duur van 
IDC’s door respectievelijk vermindering van het maximale blaasvolume tussen iedere 
katheterisatie en katheterisatie tijdens een IDC.
Bij zowel neurogene als niet-neurogene patiënten wordt door ambulante urodynamica 
met fysiologische vulsnelheid vaker DO gediagnosticeerd in vergelijking tot 
conventionele urodynamica met vulsnelheden hoger dan de fysiologische
3 1vulsnelheid. - In andere woorden, ambulante urodynamica hebben een groter 
diagnostisch vermogen voor DO dan conventionele urodynamica. De klinische 
relevantie en ook de consequenties voor de behandeling van dit grotere diagnostische 
vermogen zijn niet duidelijk. Aan de ene kant kan het groter diagnostisch vermogen 
van ambulante urodynamica duiden op een hogere sensitiviteit om DO vast te stellen 
in vergelijking tot conventionele urodynamica. Patiënten geven aan dat hun klachten 
beter worden weergegeven door ambulante urodynamica dan video-urodynamica.5 
Aan de andere kant zou het grotere diagnostische vermogen door een hogere 
foutpositieve kans kunnen worden veroorzaakt. Klachten- en mictiedagboeken in 
combinatie met twee in plaats van de standaard enkele blaasdrukkatheter kunnen het
S'9vaststellen van DO door ambulante urodynamica tot wel 64% verminderen. ’ Zelfs bij
een aanzienlijk aantal van asymptomische vrijwilligers werd DO vastgesteld, vaker bij
8 ’ 10ambulante dan conventionele urodynamica. ’ Als gevolg van de foutpositieve kans 
wordt de sensitiviteit van ambulante urodynamica overschat en ligt de daadwerkelijke 
sensitiviteit lager. Hierdoor rijst de vraag of ambulante urodynamica nodig zijn om 
DO te diagnosticeren. Ambulante urodynamica hebben geen primaire rol voor het 
diagnosticeren van DO en risico-inschatting bij dwarslaesiepatiënten waarbij de 
verdenking op DO bestaat indien conventionele urodynamica adequaat worden 
uitgevoerd. Ambulante urodynamica kunnen geïndiceerd zijn als conventionele 
urodynamica onvoldoende resultaat opleveren om een behandeling te kiezen. 
Ambulante urodynamica kunnen wel primair gebruikt worden indien urodynamica aan 
het bed de voorkeur hebben of comfortabeler zijn voor de patiënt. Bijvoorbeeld als 
analyse van de blaasfunctie nodig is nadat de spinale shockfase voorbij is bij patiënten 
die op een revalidatieafdeling of in een revalidatiecentrum verblijven. Immobiele 
patiënten hoeven niet naar een andere afdeling of centrum te worden vervoerd. Actieve
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patiënten hoeven hun behandelingen en dagelijkse activiteiten niet te onderbreken. De 
registratie en katheterpositie kunnen tussentijds gemakkelijk worden gecontroleerd 
gedurende de registratietijd. De urodynamica kunnen worden gestopt, zodra afdoende 
resultaat is verkregen. De registraties kunnen digitaal naar de uroloog worden gestuurd 
en worden bediscussieerd om adequate therapie zo snel mogelijk te starten.
Nossier et al zijn voorstander van regelmatige urodynamische controle van 
dwarslaesiepatiënten ter evaluatie van het behandelingseffect.11 Urodynamisch bepaald 
succes van behandeling werd gedefinieerd als een detrusor druk <40 cmH2O tijdens de 
opslagfase, waarbij er geen autonome disregulatie voorkomt. Indien sprake is van 
tapotage of sacrale voorwortel stimulatie, wordt een leak point druk van <40 cmH2O 
zonder autonome disregulatie in combinatie met een maximale detrusor druk van <90 
cmH2 O als succes beschouwd. Ondanks dat deze urodynamische strategie goede 
klinische resultaten liet zien, waaronder de nierfunctie, was de follow-up duur slechts 
5 jaar in een relatief jonge patiëntengroep. Er werd tevens duidelijk dat bij de 
meerderheid van de patiënten tijdens de follow-up een wijziging in de behandeling 
noodzakelijk was.
Hoge detrusor leak point drukken (>40 cmH2O) en met name aanhoudende hoge
drukken zijn een risico voor verslechtering van de nierfunctie bij patiënten met
12myelumdysplasie. Ook dwarslaesiepatiënten met detrusor drukken >40 cmH2O
13hebben een verhoogd risico op nierschade. Tot op heden is het niet bekend in welke 
mate de hoogte van de detrusor drukstijgingen, de leak point drukken of de duur van
• 3de detrusor drukstijgingen van belang zijn voor de prognose en behandeling.
Verdere studies naar het effect van behandeling op DO en detrusor drukken bij 
individuele patiënten zijn nodig om de prognostische factoren te bepalen en richtlijnen 
op te stellen voor evaluatie van patiënten, behandelingsstrategie en controle. In de 
tussentijd moet empirische behandeling op basis van alleen de klachten van de patiënt 
of optreden van complicaties, zoals nierschade, worden vermeden, omdat nierschade 
gemakkelijk kan ontstaan zonder klinische tekenen van schade aan de urinewegen. Een 
uitzondering hierop is een patiënt met hoog risico zonder aanwijzingen van DO bij 
urodynamisch onderzoek, die verdacht wordt van DO en/of DESD op basis van zijn 
dwarslaesieniveau en OAB klachten of autonome disregulatie.
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Conventionele en ambulante urodynamica vereisen inbrengen van transurethrale en 
transanale of transvaginale drukkatheters om de blaas met fysiologische zoutoplossing 
te vullen en om intravesicale en abdominale drukken te meten. Dit kan ongemak en 
morbiditeit, zoals urineweginfecties, veroorzaken bij de patiënt.14-16 Er zijn meerdere 
pogingen gedaan om minder invasieve urodynamica te ontwikkelen om de morbiditeit 
te verminderen en het onderzoek patiëntvriendelijker te maken. Veel van deze studies 
richten zich op de mictiefase om blaasuitgangsobstructie (BOO) te diagnosticeren, 
waar maar enkele studies de vullingsfase betreffen, zoals voor de diagnose van DO. 
Voorbeelden van deze minder invasieve methoden om DO vast te stellen zijn 
echogeleide metingen van de blaaswanddikte, detrusorwanddikte en schatting van de
17 27blaasmassa of bepaling van de concentratie van zenuwgroeifactoren in de urine. - 
De waarde van echografie bij neurogene patiënten is niet duidelijk, omdat studies over 
de blaaswanddikte, detrusorwanddikte en schatting van de blaasmassa zich richtten op 
niet-neurogene patiënten en voornamelijk vrouwen includeerden. Vergelijkbare studies 
zouden bij neurogene patiënten uitgevoerd moeten worden om afkapwaarden te 
bepalen bij neurogene patiëntengroepen. Echogeleide methoden zijn echter nog steeds 
invasief van aard indien zij transvaginaal worden gedaan. Alle genoemde methoden 
geven geen real time informatie over de blaasactiviteit. Zenuwgroeifactoren
concentratie wordt door diverse pathologie beïnvloed, zoals interstitiële cystitis en
28blaaspijnsyndroom. De waarde bij neurogene patiënten voor hun prognose en 
behandeling is daarom niet duidelijk en zal nog bepaald moeten worden.
NIRS zou een oplossing kunnen zijn, omdat deze techniek DO kan vaststellen tijdens 
real time meting van de detrusor activiteit, zoals bij een experimentele studie werd 
vastgesteld (Hoofdstuk 3). NIRS is een niet-invasieve methode, omdat alleen een 
zelfklevende houder met twee optodes (zender en ontvanger) op de buikwand worden 
bevestigd. NIRS is echter nog niet geschikt voor klinische toepassing. NIRS is 
gevoelig voor bewegingsartefacten en het is niet exact duidelijk welke weefsels 
worden gemeten aangezien er zich meerdere weefsellagen tussen de optode en de 
blaaswand bevinden, zoals de buikspieren.
Technische verbeteringen en stabiliteit van de registratiesignalen zijn vereist, voordat 
NIRS een niet-invasief en toekomstig alternatief voor de huidige urodynamica wordt.
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Allereerst zal duidelijk moeten worden of NIRS signalen daadwerkelijk reflecties zijn 
van het near infrared licht door de detrusor en dus de detrusor activiteit representeren. 
De standaard patronen van NIRS signalen tijdens detrusor contracties zullen bepaald 
moeten worden. Dit kan worden gedaan door NIRS direct op de blaaswand toe te 
passen in bijvoorbeeld dier experimenteel onderzoek. Ten tweede zal de invloed van 
artefacten op NIRS signalen moeten worden bestudeerd, zoals beweging van de optode 
en activiteit van de buikspieren, ter verbetering van de techniek en om artefacten uit 
het NIRS signaal te filteren. Standaard patronen van NIRS signalen bij 
gestandaardiseerde activiteiten, zoals buikspieren aanspannen, hoesten en enkele 
lichaamsbewegingen, zullen moeten worden bepaald. Mogelijk dat paren van multi- 
brondetectoren en algoritmes kunnen helpen om NIRS signalen te corrigeren voor 
artefacten en tevens de relatieve veranderingen in NIRS signalen te vertalen naar 
absolute getallen die vergelijkbaar zijn met drukken van de huidige 
urodynamica.2930
Non-fysiologische vulling van de blaas moet vermeden worden, omdat dit 
katheterisatie van de blaas noodzakelijk maakt en NIRS in een invasieve methode zou 
veranderen. Daarom moet registratie gedurende een langdurigere periode mogelijk zijn 
dan bij conventionele urodynamica. Dit vereist een draagbare NIRS recorder, waarvan 
de signalen gemakkelijk te analyseren zijn.
Minder invasieve methoden voor urodynamica hebben de voorkeur, maar het 
belangrijkste is om een juiste diagnose te verkrijgen. Geen van de huidige en nieuwe 
urodynamische technieken kan dit alleen. Daarom zullen toekomstige studies ook 
combinaties van de huidige en nieuwe urodynamische technieken moeten bevatten. 
Als NIRS niet tot een klinisch toepasbare techniek is te ontwikkelen, dan kan de 
techniek bruikbaar zijn voor basaal onderzoek om hemodynamische fysiologie, 
pathologie en therapeutische effecten te onderzoeken.
Toekomstverwachtingen
Bij dwarslaesiepatiënten met verdenking op DO heeft ambulant urodynamisch 
onderzoek geen primaire rol voor het vaststellen van DO en risico-inschatting indien 
conventioneel onderzoek adequaat wordt uitgevoerd. Dit beperkt de indicatie voor
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ambulante urodynamica tot gebruik indien conventionele urodynamica inconclusief 
zijn om het therapeutisch beleid vast te stellen. De rol van ambulante urodynamica zal 
niet toenemen, omdat langdurige registratie noodzakelijk is. Dit leidt tot ongemak bij 
patiënt en beoordelend arts.
Conventionele urodynamica worden reeds jaren toegepast. Ondanks dat de technische 
apparaten verbeterden, bleef het principe onveranderd. De meeste studies uit het 
verleden richtten zich op de diagnose gebaseerd op urodynamica. Toekomstige studies 
naar de effecten van behandelingen van DO en detrusor drukken in een individuele 
patiënt zijn noodzakelijk om prognostische factoren te bepalen en richtlijnen voor de 
individuele patiënt evaluatie, behandeling en follow up op te stellen.
Het ultieme urodynamica apparaat zou niet-invasief voor de patiënt, snel, gemakkelijk 
toepasbaar, betrouwbaar en accuraat moeten zijn met lage kosten. Nieuwe, minder 
invasieve diagnostische methoden kunnen veiliger en comfortabelere zijn voor 
patiënten. De voordelen van deze nieuwe technieken moeten tegen hun 
meetcapaciteiten worden afgewogen. Van de huidige minder invasieve technieken die 
onderzocht zijn, kan geen enkele techniek de huidige conventionele urodynamica 
vervangen, omdat ze niet nauwkeurig genoeg zijn. Dit wordt vaak veroorzaakt door 
sterke invloed van andere pathologische en fysiologische factoren op de gemeten 
parameter. Dit beperkt het gebruik van deze minder invasieve technieken in de 
toekomst. Mogelijk dat deze technieken bij kunnen dragen aan het bepalen van 
prognostische factoren in combinatie met conventionele urodynamica om de 
behandelingsstrategie voor de individuele patiënt te optimaliseren. Om klinisch 
toepasbaar te zijn, moeten alle nieuwe technieken gemakkelijk toepasbaar, technisch 
stabiel en tegen acceptabele kosten beschikbaar zijn.
Brindley procedure & Kwaliteit van Leven
De Brindley procedure bestaat uit twee delen. Ten eerste wordt de DO opgeheven door 
een dorsale rhizotomie van de sacrale wortels. Dit leidt tot een lage druk in de blaas,
31.
een grotere blaascapaciteit en een afname van incontinentie. ; De dorsale rhizotomie 
vermindert ook autonome disregulatie, waaronder spierspasmen, en DESD. 
Hohenfellner et al zijn daarom voorstander van een dorsale rhizotomie als een op
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zichzelf staande behandeling bij een selecte groep patiënten met DO en/of autonome
• * 3 1disregulatie. Ten tweede maakt stimulatie van de sacrale voorwortels mictie, 
defecatie en erecties of vaginale lubricatie mogelijk. In het verleden zijn mooie 
klinische resultaten gepresenteerd en recentelijk ook met langdurige follow up 
(Hoofdstuk 4). Naast deze klinische resultaten mogen de psychologische en sociale 
impact niet worden vergeten, waaronder ook praktische problemen van incontinentie 
en niet-fysiologisch ledigen van de blaas.
Hoofdstuk 5 liet zien dat de Brindley procedure de QoL verbeterde in een 
geselecteerde groep van dwarslaesiepatiënten. Continentie lijkt een belangrijke factor 
te zijn, omdat de QoL hoger bleef, hoewel niet significant, bij patiënten die hun 
stimulator niet meer gebruikten en alleen nog voordeel van hun rhizotomie hadden. 
Studies naar de specifieke impact van neurogene blaasproblemen op QoL en de 
behandeling zijn zeldzaam. Maar één andere studie rapporteerde het effect van de
33Brindley procedure op QoL met gebruik van de Qualiveen vragenlijst. Deze studie 
gebruikte echter data van een heterogene controle groep met neurogene patiënten, die 
niet alleen dwarslaesiepatiënten bevatte, maar ook andere neurologische 
aandoeningen. Twee andere studies gaven een hogere tevredenheid bij patiënten na 
implantatie, waarbij gebruik werd gemaakt van zelfgemaakte vragenlijsten die niet 
gevalideerd waren.3435 Deze vragenlijsten omvatten alleen blaasproblemen.
De Brindley procedure heeft niet alleen invloed op de blaasproblemen, zoals de mictie, 
incontinentie en urineweginfecties. De procedure beïnvloedt ook defecatie en erectiele 
functie. Hoofdstuk 5 en Wielink et al lieten geen verandering van algehele indicatoren
35van QoL zien. Algehele vragenlijsten lijken echter niet geschikt voor 
dwarslaesiepatiënten, omdat deze vragenlijsten ook onderwerpen als lopen en staan 
bevatten.
De Brindley procedure is een geschikte techniek voor bepaalde patiënten, maar bevat 
ingrijpende chirurgie. In de kwetsbare techniek schuilt gevaar. De techniek is niet 
ingrijpend veranderd sinds de introductie van de Brindley procedure. De stimulator 
bestaat uit een extern stimulatiekastje dat via radiogolven stimuli kan opwekken in de 
subcutaan geïmplanteerde ontvangstplaat. De ontvangstplaat is via kabeltjes 
verbonden met de intra- of extradurale elektroden van het implantaat. Het externe
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gedeelte kan gemakkelijk worden geanalyseerd en vervangen. Grondige analyse van 
het geïmplanteerde gedeelte kan alleen met behulp van een operatie worden verkregen 
en vereist technieken die niet door alle nationale wetgevingen worden toegestaan 
(Hoofdstuk 5).
De behandeling van dwarslaesiepatiënten ten tijde van introductie van de Brindley 
procedure verschilt ten opzichte van de huidige behandelingsmogelijkheden en 
strategieën. Tegenwoordig passen veel patiënten intermitterende (zelf)katheterisatie 
toe in plaats van een verblijfskatheter om de blaas leeg te maken. Katheterisatie wordt 
direct na het optreden van de ruggenmergschade gestart, waardoor patiënten gewend 
zijn aan deze methode. Behandelingen zoals anticholinergica en intravesicale Botuline 
toxine A injecties die tot urineresidu of retentie kunnen leiden, worden daardoor meer 
geaccepteerd. Botuline toxine A injecties zijn de minst ingrijpende optie binnen de 
huidige chirurgische mogelijkheden om DO te behandelen. De injecties kunnen onder 
lokale anesthesie van de blaas op poliklinische basis worden gedaan.3637 Vele 
patiënten hebben de voorkeur voor Botuline toxine A boven de Brindley procedure 
ondanks dat herhaling van de injecties nodig is. De Brindley procedure is veel 
ingrijpendere chirurgie en vermindert de hoop op een toekomstige behandeling die 
herstel of regeneratie van zenuwen door de irreversibele rhizotomie. Of deze hoop 
terecht is, is niet duidelijk, omdat nog geen grote progressie in studies naar 
zenuwherstel of regeneratie is gemaakt. Ondanks dat Botuline toxine A momenteel 
nog niet geregistreerd is voor urologische toepassingen neemt de toepassing ervan en 
de ervaring betreffende effectiviteit en QoL ermee toe, waaronder ook studies naar de 
veiligheid.38-43 Het exacte werkingsmechanisme is echter nog niet bekend.44 
Veranderingen in de Brindley procedure zijn noodzakelijk om een waardevolle 
behandeling voor de toekomst te blijven in een geselecteerde patiëntengroep. Ten 
eerste zal de dorsale rhizotomie van de sacrale zenuwwortels moeten worden 
vervangen door een zenuwsparende methode. Continue of conditionele elektrische 
stimulatie van de dorsale sacrale zenuwwortels of de nervus pudendus (PN) en zijn 
zenuwtakken (Hoofdstuk 6) om IDC te onderdrukken zou een optie kunnen zijn. Een 
combinatie van stimulatie van de dorsale zenuwwortels om IDC te onderdrukken en de 
sacrale voorwortels voor mictie leidt niet tot een compleet lege blaas bij alle patiënten
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ten gevolge van aanhoudende DESD tijdens de intervallen tussen stimulatieperiodes 
(post stimulus voiding).45 De combinatie is bruikbaar indien selectieve stimulatie van 
de detrusor mogelijk is ter verbetering van het mictiepatroon. Het ontwikkelen van 
klinisch toepasbare technieken voor selectieve stimulatie van de detrusor zijn 
noodzakelijk, zoals selectief anode blok en hoog frequentie blok.46-49 Ten tweede moet 
het implantaat worden aangepast, zodat revisie met standaard chirurgische technieken 
en bij voorkeur externe analyse van het implantaat mogelijk is. Te complexe 
technieken moeten worden vermeden voor beide verbeteringsmogelijkheden om 
veranderingen die gevoeliger zijn voor gebreken te voorkomen. Dit zou de 
duurzaamheid en betrouwbaarheid van de Brindley procedure verminderen.
Toekomstverwachtingen
De ultieme behandeling van neurogene aandoeningen van de lage urinewegen zou 
bestaan uit het verhelpen van de neurogene aandoening die voor de blaasproblemen 
zorgt om de innervatie van de blaas te herstellen. Zolang causale therapie niet 
beschikbaar is, zijn symptomatische behandelingsopties noodzakelijk.
Intravesicale injecties met Botuline toxine A is een opkomende toepassing binnen de 
huidige behandelingsmogelijkheden. Ten tijde van het schrijven van dit proefschrift 
wordt goedkeuring voor urologische toepassing binnen afzienbare tijd verwacht. De 
Brindley procedure heeft bij geschikte patiënten echter een aantal voordelen ten 
opzichte van Botuline toxine A in combinatie met intermitterend katheteriseren. Dit 
geldt met name indien niet alleen de urologische eigenschappen van de behandelingen 
worden bekeken. Dwarslaesiepatiënten hebben verscheidene, samenhangende 
lichamelijke problemen. Aanpak van disfunctioneren van meerdere organen heeft 
daarom de voorkeur. De Brindley procedure zorgt niet alleen voor continentie en 
mictie, maar vermindert ook autonome disregulatie en spierspasmen, maakt stimulatie 
van complete defecatie of verbetering van defecatie patroon en erecties mogelijk. 
Patiënten worden hierdoor onafhankelijker, omdat ze geen assistentie meer nodig 
hebben voor intermitterend katheteriseren. Ze kunnen hun blaas overal en op ieder 
moment zelf leegmaken. Als behandelingsmogelijkheden met patiënten worden
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besproken, moet deze bredere behandelingsmogelijkheid van de Brindley procedure 
worden genoemd.
De Brindley procedure moet alleen in gespecialiseerde centra worden uitgevoerd om 
expertise en kwaliteit te behouden vanwege de complexiteit van de procedure en de 
beperkingen van algehele toepassing van deze techniek ten gevolge van de selectie van 
patiënten. Om een toekomstige optie te blijven, zijn technische verbeteringen vereist, 
die grondige analyse van implantaat defecten en revisie van het implantaat op een 
veilige manier met standaard chirurgische technieken mogelijk maken. Tevens zal de 
dorsale rhizotomie worden vervangen door een minder invasieve procedrue om DO op 
te heffen, zoals elektrische stimulatie van de dorsale wortels of DGN stimulatie. Dit 
vereist de toepassing van stimulatie technieken die terugstroom van stimulatie 
voorkomen tijdens stimulatie van de voorwortels.
Conditionele stimulatie van de nervus dorsalis penis en clitoridis
Momenteel bestaan er verscheidene behandelingsmogelijkheden om een lage druk in 
de blaas te krijgen bij dwarslaesiepatiënten met DO. Bij de meerderheid van deze 
patiënten wordt gestart met een conservatieve aanpak die bestaat uit alleen 
anticholinergica of een combinatie met (intermitterende) katheterisatie.50"52 
Bijwerkingen, zoals een droge mond en obstipatie, verminderden de compliantie van 
patiënten sterk en zijn een belangrijke reden om te stoppen met de behandeling. 
Ingrijpendere behandelingen kunnen bij patiënten worden overwogen indien 
bijwerkingen niet worden verdragen of indien onvoldoende respons wordt verkregen 
op anticholinergica. Botuline toxine A injecties en herstel of regeneratie van zenuwen 
zijn in de vorige paragraaf besproken. Uitgebreidere chirurgie voor DO bij neurogene 
patiënten zijn onder andere de Brindley procedure zoals in de vorige paragraaf 
besproken, een blaasaugmentatie en urinederivatie.
Continue elektrische stimulatie van de sacrale zenuwwortels (SNS), met name S3, 
wordt wijdverbreid toegepast bij niet"neurogene patiënten met OAB en niet" 
obstructieve urineretentie.53"56 SNS verhelpt echter niet alle klachten volledig bij de 
meerderheid van de niet"neurogene patiënten. Bij een follow up van 5 jaar worden
51goede resultaten weergegeven bij een aanzienlijk aantal patiënten. Dit betreft echter
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geselecteerde patiënten die door een testfase heen zijn gekomen. SNS wordt ook 
gebruikt bij neurogene disfunctie van de lage urinewegen ten gevolge van diverse 
pathologie, zoals MS en dwarslaesie.58-60 Neurogene disfunctie van de lage 
urinewegen bestond hierbij uit DO en acontractiliteit met urineretentie. Lombardi et al 
bestudeerde SNS bij 11 patiënten met een incomplete dwarslaesie (AIS C-D) en OAB, 
waarbij SNS gedurende een mediane follow up van 5 jaar effectief was.60 Drie van de 
11 patiënten ondervonden pijn of spasmen in de benen ten gevolge van de stimulatie. 
Te uitgebreide schade aan het ruggenmerg beperkt de functie van SNS vanwege 
betrokkenheid van sacrale en suprasacrale reflexbogen.59 De sacrale zenuwwortels 
bevatten zowel afferente als efferente zenuwen. Andere stimulatieplaatsen, waarbij 
andere zenuwvezels kunnen worden gestimuleerd, zouden tot betere resultaten kunnen 
leiden met minder bijwerkingen.
De DGN bestaat uit alleen sensorische afferente zenuwvezels en verloopt voor een 
aanzienlijk deel oppervlakkig in het perineum en de penis. Experimentele studies met 
continue en conditionele stimulatie van de DGN via huidelektroden op de dorsale zijde 
van de penis of clitoris laten zien dat onderdrukking van IDC’s en een toename van de 
blaascapaciteit mogelijk zijn.61-63
Er zijn pogingen gedaan om elektroden in de buurt van de DGN te implanteren.64-66 
Lee et al plaatsten bij dwarslaesiepatiënten draadelektroden in de schacht van de 
penis.65 De penis staat bloot aan mechanische krachten van buitenaf die het risico op 
mankementen van de elektrode vergroten. Stabiliteit van de elektrode is niet 
gemakkelijk te bewerkstelligen als gevolg van de erectiele functie van de penis. Dit 
kan tot dislocatie van de elektrode leiden of beschadiging van de zenuwen waaraan de 
elektrode is bevestigd. Goldman et al gebruikten continue stimulatie via een 
draadelektrode bij vrouwen met OAB.64 De elektrode werd ter hoogte van het os pubis 
ingebracht in de richting van de DGN. In Hoofdstuk 7 en Hoofdstuk 8 werd een 
vergelijkbare techniek beschreven om de naald in te brengen bij neurogene patiënt. Bij 
mannen heeft deze locatie geen last meer van erecties. Ondanks dat de elektrode 
minder bloot staat aan externe mechanische druk, blijft de elektrode pre-pubisch. 
Hierdoor wordt de elektrode niet door een benige structuur beschermd. Het risico op 
beschadiging van de elektrode blijft bestaan. Daarom moet het inbrengen van
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elektrodes en de klinische effectiviteit op andere plaatsen zoals in Hoofdstuk 6 werden 
beschreven, worden onderzocht en vergeleken om de optimale verhouding tussen 
toegankelijkheid en veiligheid van de elektrode te bepalen.
Niet alleen de methode voor het inbrengen van de elektrode en de locatie van de 
elektrode zijn van belang. De effectiviteit is ook afhankelijk van het gebruikte 
stimulatievermogen.6667 Indien de elektrode van de meest optimale positie ten 
opzichte van de zenuw verschuift, leidt dit tot een afname van de effectiviteit. De 
ontwikkeling van minimaal invasieve elektroden, zoals draadelektroden, in combinatie 
met een goede fixatie van de elektrode zal een uitdaging zijn, omdat het gebied voor 
het os pubis voor een aanzienlijk deel uit vetweefsel bestaat. Mogelijk dat 
uitgebreidere chirurgie overwogen moet worden vanwege het grote belang van fixatie 
van de elektrode om elektrische stimulatie van de DGN een bruikbare, veilige en 
betrouwbare behandelingsoptie te laten worden voor neurogene en niet-neurogene 
DO/OAB of een alternatief voor de dorsale rhizotomie van de Brindley procedure. Het 
merendeel van de huidige studies zijn slechts experimenteel en in een acute opzet 
uitgevoerd. Langdurige klinische studies zijn noodzakelijk om het lange termijn effect 
en de invloed op bijvoorbeeld seksualiteit te bepalen.
DGN stimulatie kan een aanvullende waarde hebben voor dwarslaesiepatiënten in 
vergelijking tot SNS en de Brindley procedure indien tevens stimulatie van mictie 
mogelijk is. Stimulatie van de PN en DGN kan blaascontracties opwekken waarbij 
mictie zonder residu mogelijk zou zijn indien een lage uitstroomdruk van de blaas kan 
worden verkregen. Studies bij katten onder anesthesie met of zonder dwarslaesie laten 
veelbelovende resultaten zien.68-71 Het effect van stimulatie lijkt afhankelijk van de 
stimulatiefrequentie en het blaasvolume. Er zijn slechts enkele pogingen gedaan bij 
mensen met een dwarslaesie, waarbij gebruik werd gemaakt van stimulatie van de PN
72 74of intra-urethrale stimulatie. - Elektrische stimulatie van de urethrale zenuwen 
activeert waarschijnlijk dezelfde zichzelf versterkende reflex die wordt opgewekt door 
urinestroom door de urethra. Aanvullend onderzoek naar de combinatie van het 
onderdrukken van IDC’s en het opwekken van mictie door stimulatie van de PN en 
DGN voor detrusor contracties is van belang. Dit zou een minder ingrijpend alternatief 
voor de Brindley procedure kunnen zijn. Andere stimulatiepatronen dan pulsreeksen
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moeten geëvalueerd worden op hun effectiviteit om IDC’s te onderdrukken en detrusor 
contracties op te wekken.
In plaats van continue stimulatie kan conditionele stimulatie worden toegepast, waarbij 
stimulatie alleen wordt geactiveerd indien IDC’s voorkomen. Dit kan meerdere 
voordelen hebben in vergelijking tot continue stimulatie. Neurogene en niet-neurogene 
patiënten die stimulatie kunnen het profiteren van een verminderde stimulatieduur, wat 
het ongemak ten gevolge van de stimulatie vermindert. Conditionele stimulatie lijkt 
minder vervelend tijdens een IDC, waardoor met een hoger stimulatievermogen kan
75worden gestimuleerd ten opzichte van continue stimulatie. Dit vergroot de 
effectiviteit, omdat het effect van stimulatie afhankelijk is van het vermogen.66 67 
Kortere stimulatieduur vermindert het stroomverbruik, verlengt de levensduur van de 
contactpunten van de elektrode en reduceert of voorkomt het optreden van gewenning 
van de reflexboog van de stimulus. Dit laatste kan van belang zijn, omdat de exacte 
invloed van langdurige stimulatie van de DGN op seksualiteit nog niet duidelijk is.
Een ander voordeel, dat voor de patiënt misschien het belangrijkste is, is de toename 
van de waarschuwingsperiode tussen het begin van de eerste IDC en de maximale 
capaciteit.63 66 Patiënten kunnen de IDC’s zelf voelen of door de stimulator worden 
gewaarschuwd dat er contracties optreden en de stimulator geactiveerd wordt. Dit 
levert voor de patiënt niet alleen een toename van de blaascapaciteit op, maar ook een 
waarschuwingssignaal dat de patiënt extra tijd geeft om een geschikte plaats te zoeken 
voor de mictie of katheterisatie zonder incontinent te worden.
Conditionele stimulatie vereist een betrouwbaar triggersignaal om de stimulatie te 
starten als een IDC voorkomt. Bij de studies met conditionele stimulatie worden 
transurethrale drukmeetkatheters gebruikt om de detrusoractiviteit te meten. Deze 
verblijfskatheters zijn niet wenselijk tijdens het dagelijks leven. Als alternatieve 
sensoren voor het registreren van de detrusoractiviteit kunnen elektromyografie 
(EMG) van de externe urethrale of anale sfincter, sacrale zenuwwortel of PN 
elektroneurografie en blaasdrukmeting met behulp van geïmplanteerde sensoren in de 
blaaswand worden gebruikt.76-85
Sensoren in het blaaslumen ondergaan kristallisatie en verhogen het risico op
81'83'84urineweginfecties. ; ; Sensoren in de blaaswand hebben als nadeel dat dislocatie en
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81weefselerosie optreedt. Verbeteringen in de fixatie en ontwikkeling van sensoren om 
weefselerosie te voorkomen, zijn een vereiste om blaassensoren klinisch toepasbaar te 
maken.
EMG van de externe urethrale sfincter is mogelijk, maar is beperkt tot patiënten met
77een combinatie van neurogene DO en DESD. Een mogelijke beperking voor het 
gebruik van EMG van de externe anale sfincter is een lage specificiteit voor het 
detecteren van IDC vanuit de EMG activiteit van de externe anale sfincter, wat
78*85resulteert in een hoge foutpositieve detectiegraad. ’ Langdurig gebruik moet worden 
onderzocht om de waarde hiervan vast te stellen, aangezien de foutpositieve EMG- 
registraties toe kunnen nemen bij lichamelijk actieve patiënten. Ondanks dat extra 
stimulatie door foutpositieve EMG-registratie niet schadelijk is, is het niet wenselijk 
als het gevoel van de stimulatie minder goed wordt verdragen in de afwezigheid van 
urgency.
Elektroneurografie van de PN of sacrale zenuwwortel (S3), waarbij elektrische 
zenuwactiviteit wordt gemeten, correleert met de blaasdruk in diermodellen en is ook 
toepasbaar bij mensen.76,79,80’82’86 Kleine amplitudes van het zenuwsignaal en meerdere 
andere bronnen die bijdragen aan de activiteit van de sacrale zenuwwortel (onder 
andere sacrale dermatoom en rectale activiteit) vereisen verbetering van de methode 
om betrouwbaar blaascontracties te bepalen bij chronische toepassing.
In Hoofdstuk 3 werd NIRS bestudeerd om DO te diagnosticeren. Als deze techniek 
geoptimaliseerd kan worden en beschikbaar is als een draagbaar systeem, zou ik ook 
van waarde kunnen zijn als een sensor voor het detecteren van IDC’s bij conditionele 
stimulatie.
Momenteel is er geen klinisch toepasbare blaassensor voor langdurig gebruik 
beschikbaar. Door de patiënt aangestuurde stimulatie zou een alternatief kunnen zijn, 
waarbij de patiënt de stimulator activeert wanneer hij of zij mictie-aandrang heeft. Dit 
open circuit systeem is mogelijk een eenvoudigere techniek in vergelijking met een 
gesloten circuit systeem met een sensor als trigger voor stimulatie. Opisso et al 
beschreven dat 52% van de neurogene patiënten een gevoel heeft van IDC en in staat 
zijn om stimulatie te bedienen tijdens cystometrie.63 Of dit resultaat ook bij klinische 
toepassing wordt bereikt is niet zeker, omdat bij patiënten tijdens dagelijkse
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87activiteiten slechts een lage opmerkzaamheid van IDC’s werd vastgesteld. 
Gedurende het dagelijks leven zijn patiënten er niet continu op gericht om stimulatie te 
starten. Bovendien moesten patiënten op een knop drukken om een blaasgevoel te 
markeren, maar leverde dit geen effect van stimulatie voor de patiënt op. De 
afwezigheid van deze positieve respons voor de patiënt heeft de registratie mogelijk 
negatief beïnvloed, omdat de patiënt minder gemotiveerd is. De registratie van IDC’s 
had ook verbeterd kunnen worden door een betere bediening, omdat het 
registratiekastje niet optimaal was voor deze toepassing. Daarnaast kan door de patiënt 
aangestuurde stimulatie beter resultaat opleveren bij patiënten met minder schade aan 
het ruggenmerg of idiopathische DO met een intacte sensibiliteit. Klinische en 
langdurige studies worden daarom aangeraden om de effectiviteit in de dagelijkse 
praktijk te evalueren.
Om een succesvolle therapie te worden, zal een systeem voor DGN stimulatie veilig, 
duurzaam, efficiënt en kosteneffectief moeten zijn. Uiteindelijk zullen technische 
ontwikkelingen een veilig, efficiënt, gesloten circuit systeem voor conditionele 
stimulatie van de DGN opleveren, met of zonder door de patiënt aangestuurde 
stimulatie. De techniek kan echter ook een gevaar zijn voor de duurzaamheid en 
betrouwbaarheid. Het risico op technische mankementen neemt toe als de techniek 
complexer wordt. Omdat de landelijke uitgaven aan zorg toenemen, hebben dure 
technieken niet de voorkeur. Complexere technieken zullen de ontwikkelingskosten 
verhogen en waarschijnlijk ook de behandelingskosten. Dit bedreigt de 
kosteneffectiviteit van stimulatoren.
Toekomstverwachtingen
De ultieme stimulator moet eenvoudig te implanteren zijn en automatisch stimulatie 
toepassen om IDC’s te onderdrukken zonder ongemak voor de patiënt te veroorzaken. 
Bovendien moet het systeem de patiënt tijdig waarschuwen om een toilet op te zoeken 
wanneer de blaas de maximale capaciteit begint te naderen of IDC’s niet langer 
onderdrukt kunnen worden.
Conditionele stimulatie van de DGN onderdrukt IDC’s en vergroot de blaascapaciteit 
bij dwarslaesiepatiënten, maar kan ook bruikbaar zijn voor andere patiënten met DO.
179
Chapter 11
Een belangrijk voordeel van conditionele stimulatie ten opzichte van continue 
stimulatie is een toename van de waarschuwingstijd voor patiënten tussen het begin 
van de eerste IDC en de maximale capaciteit. DGN stimulatie kan voor 
dwarslaesiepatiënten meerwaarde hebben in vergelijking tot SNS, Brindley procedure 
en intravesicale Botuline toxine A injecties indien tevens stimulatie van mictie kan 
worden verkregen door gebruik te maken van andere stimulatie-instellingen.
Stimulatie van de DGN is mogelijk op verscheidene plaatsen. Implantatie van 
elektroden en de klinische effectiviteit moeten op verschillende plaatsen worden 
vergeleken om de optimale verhouding tussen toegankelijkheid en veiligheid van de 
elektrode te bepalen.
Conditionele stimulatie vereist een betrouwbaar triggersignaal om de stimulatie bij het 
begin van een IDC te starten. Transurethrale verblijfskatheters hebben niet de 
voorkeur, maar andere blaassensoren om stimulatie te starten zijn momenteel nog niet 
klinisch toepasbaar. Aansturing van stimulatie door de patiënt kan een alternatief zijn. 
Patiënten willen zich echter niet de gehele dag bewust zijn van hun blaas. Indien zij de 
stimulator zelf moeten activeren bij iedere IDC, zal dit interfereren met hun dagelijkse 
activiteiten en bewustzijn van de blaas. Langdurige klinische studies zijn wenselijk om 
de effectiviteit in de dagelijkse praktijk te evalueren.
Toekomstige ontwikkelingen zullen een veilig en efficiënt systeem voor automatische 
conditionele stimulatie mogelijk maken. Complexe technieken moeten echter 
voorkomen, omdat deze de toepassing van DGN stimulatie zullen verminderen door 
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AUC Area under the curve
BMI Body mass index
BOO Bladder outlet obstruction
BPH Benign prostatic hypertrophy
CIC Clean intermittent catheterisation
CU Conventional urodynamics
CVD Cerebral vascular disease
DESD Destrusor-external sphincter dyssynergia
DGN Dorsal genital nerve, including the dorsal penile and clitoral nerve
DO Detrusor overactivity
DPR Detrusor pressure rise
EMG Electromyography
EMGabd Electromyography of the abdomen
GAR Genito-anal reflex
HHb Deoxyhaemoglobin; deoxygenated haemoglobin
Hbsum Summation of oxygenated and deoxygenated haemoglobin
ICS International continence society
IDC Involuntary detrusor contractions (= UDC)
IDO Idiopathic detrusor overactivity




MES Maximal electrical stimulation
MS Multiple sclerosis
NA Not applicable
NIRS Near infrared spectroscopy
NDO Neurogenic detrusor overactivity
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OAB Over active bladder syndrome




Pdet max Maximum detrusor pressure
PN Pudendal nerve
PST Percutaneous screening test
Pves Vesical pressure
QoL Quality of life
SARS Sacral anterior root stimulation
SCI Spinal cord injury
SD Standard deviation
SIUP Specific impact of urinary problems
SNS Sacral nerve root stimulation
SUI Stress urinary incontinence
UDC Undesired detrusor contraction (= IDC)





Dit was dan promoveren. Maar is dit nou een afsluiting van een periode? Ja, en toch 
ook nee. Toen ik met promoveren begon, zat onderzoek nog niet in mijn bloed. Het 
was het ontdekken van een nieuwe wereld met vallen en opstaan. Zo groei je op en 
word je groter. Groei en ontwikkeling gaan door. Promoveren is dan ook niet het 
eindstation. Voor mij is promoveren een afsluiting van mijn jeugd in het onderzoek 
doen, waarbij een nieuwe, volwassen periode volgt. Hierin kan ik mij hopelijk de 
komende tientallen jaren nog verder ontwikkelen. Dit is een goed moment om iedereen 
te bedanken die heeft meegewerkt of emotioneel heeft ondersteund. Opgroeien, en dus 
ook promoveren, doe je niet alleen. Het is een proces waar iedereen zijn steentje aan 
bijdraagt.
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